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General introduction
 8 
 
As the dairy industry has focused on genetic gains for milk production, cows commonly 
encounter a negative energy balance (NEB) during early lactation (up to first 100 days in milk.), and 
particularly during the transition period, which stretches from 3 weeks before to 3 weeks after 
calving (Grummer, 1995; Drackley, 1999). Excessive elevation of blood beta-hydroxybutyrate 
(BHBA) and nonesterified fatty acids (NEFA) concentrations however indicates poor metabolic 
adaptation of cows in this period (Herdt, 2000; Chapinal et al., 2011; Ospina et al., 2013). Between 9 
to 34% (Duffield, 2000) up to 44 to 59% (Duffield et al., 1998; McArt et al., 2011) of the early 
lactating cows were reported to suffer from hyperketonemia. These hyperketonemic cows have a 
high risk of disease development after calving such as displaced abomasum, metritis, often resulting 
in impaired milk production (Duffield et al., 2009; Ospina et al., 2010a; McArt et al., 2012a), as well 
as reduced reproductive performance (Walsh et al., 2007) all of which can cause economic losses 
(Geishauser et al., 2001; Inchaisri et al., 2010).  
Accordingly, monitoring metabolic disorders in early lactating cows is increasingly used to 
evaluate cow management and guide strategies to improve health and reproductive performance in 
dairy production. Several cow-side tests for ketone bodies are now available for blood, urine and 
milk to determine hyperketonemic cows. Blood BHBA is regarded as a gold standard for diagnosis 
of hyperketonemia, but is considered an invasive method and less practical compared with milk 
sampling as blood collection needs to be done by a veterinarian for routine evaluation. Nowadays, 
milk has been increasingly used as a tool to diagnose hyperketonemic cows based on milk fat 
content or fat to protein ratio (Grieve et al., 1986; Mulligan et al., 2006; Toni et al., 2011) in 
combination with assessments of milk ketone bodies by Fourier transform infrared spectroscopy 
(FTIR) (Heuer et al., 2000) and including additional test-day information (such as parity and season) 
(Van der Drift et al. (2012). Nevertheless, blood NEFA have been suggested to be a better indicator 
for NEB than blood BHBA as the former precede hyperketonemia, but currently no cow-side tests 
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for blood or serum NEFA are available and hence, these analyses are performed in the lab at an 
average  cost of $11.00 (Ospina et al., 2013).  
As mobilised fat reserves are transferred to milk fat and these NEFA are particularly rich in long-
chain FA (Hostens et al., 2012),  several studies  (Craninx et al., 2008; Stoop et al., 2009; Gross et al., 
2011)already suggested changes in milk fatty acid (FA) composition during early lactation such as a 
greater proportion of milk fat C18:1 cis-9 and C18:0 while short and medium chain fatty acids, 
including milk fat odd-chain C5:0 to C15:0 are lower. However, whether milk FA effectively could 
be proposed as a diagnostic tool for NEB and/or hyperketonemia requires further research. (Klein 
et al., 2013) 
Objective and outline of this study 
The objective of this thesis was to assess whether milk FA, monitored during early lactation in 
dairy cows, are potential biomarkers for elevated blood plasma NEFA concentration, 
hyperketonemia, as well as subsequent reproductive performance. The first chapter, a literature 
review, describes the physiological background and occurrence of NEB, as well as the relation 
between fat mobilisation and changes in the milk FA composition. The potential of milk FA for 
monitoring NEB and hyperketonemia is then explored in Chapter 2A and 2B. The robustness of 
the cut-off value of milk fat C18:1 cis-9, as deduced in chapter 2A, was further validated (Chapter 
3). As NEB might negatively affect reproductive performance, the relationship between milk FA 
and subsequent reproductive performance was evaluated (Chapter 4). Finally, results of the PhD 
research are generally discussed and future perspectives are proposed in Chapter 5. An outline of 
the thesis is scheduled in Figure 1.  
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Figure 1. Overview of the PhD research to investigate milk fatty acids as biomarkers to 
diagnose elevated blood plasma BHBA and NEFA and the relationship between the latter 
blood metabolites and their biomarkers with reproductive performance. 
 
  
 
 
 
 
 
 
 
 
 
CHAPTER 1 
 
Literature review: 
 
Mobilised fatty acids during the transition period of dairy cattle and 
their link with metabolic and reproductive health, transfer to milk fat 
and their potential as biomarker 
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ABSTRACT 
In the beginning of lactation, dairy cows encounter enormous energy demands by the mammary 
gland to support milk production. Body fat reserves are mobilised to counteract this energy output. 
However, for many cows, this lipid mobilisation will result in excessive levels of nonesterified fatty 
acids (NEFA) and β−hydroxybutyrate (BHBA) in blood which might induce metabolic health 
problems and impaired reproductive performance. Accordingly, biomarkers reflecting the animal’s 
energy status in early lactation are of importance to signal emerging health problems. As NEFA and 
BHBA are also transferred to the mammary gland, increased milk fat content, milk fat to protein 
ratio and milk BHBA have been proposed for this purpose and offered as cow side tests (BHBA) or 
included in test-day registrations. Additionally, the milk fatty acid (FA) profile is influenced by 
lactation stage and NEB, with lower concentrations of short and medium chain fatty acids during 
periods of excessive mobilisation of body reserves, whereas long chain fatty acids in milk – in 
particular C18:1 cis-9 – increase, reflecting the release of the latter from adipose tissue during 
mobilisation. As milk sampling is easy and noninvasive (as compared with the blood reference tests) 
and several milk FA now can be determined routinely through progress in spectrophotometric 
analysis, milk FA are potential biomarkers of NEB or hyperketonemia which merit further research.  
 
INTRODUCTION 
Cows in the transition period inevitably encounter a state of negative energy balance (NEB) 
(Herdt, 2000) . This period is defined as the last 3 weeks before to 3 weeks after calving (Grummer, 
1995; Drackley, 1999). During this period energy requirements increase coupled with a decrease in 
dry matter intake (DMI) (Hayirli et al., 2002). In an attempt to supply the required energy, body fat 
reserves are mobilised into the bloodstream as NEFA (Rukkwamsuk et al., 1999b; Herdt, 2000; 
Ospina et al., 2010b). Others regard mobilisation of body reserves as a genetically driven process 
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and hence a ‘natural component’ of the reproductive cycle rather than a response (Friggens et al., 
2004). Irrespective of the origin of this negative energy status, blood NEFA largely contribute to the 
overall energy supply during this period. Generally, an elevation of NEFA and BHBA is a normal 
physiological adaptation, however, excessive elevation of NEFA (> 0.6 mmol/L) and BHBA (>1.2 
mmol/L) in the blood can indicate poor adaptation to NEB (Herdt, 2000).Hence, blood metabolites 
such as NEFA and BHBA are common indicators of severe NEB in the transition period (Duffield 
et al., 2009). The latter could then result in increasing occurrence of metabolic disorders (primarily, 
hyperketonemia or subclinical ketosis), decreasing milk production and impairing reproductive 
performance (Ospina et al., 2010a; Chapinal et al., 2011; Chapinal et al., 2012; Roberts et al., 2012; 
Garverick et al., 2013). Furthermore, cows suffering from subclinical ketosis had 1.5 and 9.5 times 
more odds to develop meteritis and clinical ketosis, respectively (Suthar et al., 2013). Also Raboisson 
et al. (2014) indicated cows suffering from subclinical ketosis had 1.75, 1.61 and 5.38 times more 
odds to develop meteritis, mastitis and clinical ketosis, respectively. Contrarily, Ospina et al. (2010b) 
reported that primiparous cows with NEFA concentrations greater than 0.57 mmol/L and BHBA 
concentrations above 0.9 mmol/L in the first 2 weeks of lactation showed a higher 305-d milk yield. 
In addition, Duffield et al. (2009) found the 305-d milk yield was higher in cows with blood BHBA 
concentrations in week 2 of lactation exceeding a threshold of 1.0 mmol/L. Also Chapinal et al. 
(2012) found  no association between high serum concentrations of NEFA (> 0.7 mmol/L) and 
BHBA (> 0.8 mmol/L) in week 3 of lactation and milk loss.  
Excessive amounts of NEFA, released during body fat mobilisation, are transferred to the milk, 
resulting in increased concentrations of milk fat in early lactation. As these NEFA are particularly 
rich in long−chain fatty acids, such as C18:1 cis−9 and C18:0 (Hostens et al., 2012), concentrations 
in milk fat of those FA and particularly of the former also might be linked to the severity of the 
NEB (Van Haelst et al., 2008). In this chapter, mobilisation of FA during NEB in the transition 
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period in relation to metabolic health of dairy cows, their reproductive performance, as well as 
changes in milk fat content and composition are reviewed. Further, the latter changes are discussed 
from the perspective of potential biomarkers to alert impaired metabolic health.  
 
2. Mobilisation of fatty acids during the transition period 
2.1 Negative energy balance and homeorhetic regulation 
The negative energy balance encountered by high yielding dairy cows in early lactation can be 
regarded as the result of the homeorhetic drive of these animals to sustain high levels of milk 
production (Bell, 1995; Drackley, 1999) . The lag time in DMI, reaching its peak only 5 to 7 weeks 
after parturition (Grummer et al., 2004), as compared with the immediate increase in nutrient 
requirements for milk production (Block et al., 2001) is assumed to be a predominant reason for the 
status of NEB. This theory views mobilisation of body reserves as a response to limitation in 
nutrient intake. In line with this, expression of genes encoding for lipogenic enzymes in adipose 
tissue of cows at 30 days in milk (DIM) was reported to respond to changes in energy intake (Roche 
et al., 2009). However, other studies (Koenen et al., 2001; Friggens et al., 2007a) suggested genetic 
selection physiologically ‘predisposed’ high genetic merit cows to encounter a period of NEB in the 
beginning of lactation. Within the latter view, the pattern of body lipid changes during early lactation 
(mobilisation) and pregnancy (body reserve gain) is particularly genetically driven and is a ‘natural’ 
component of the reproductive cycle rather than a response to constrained conditions (i.e., 
limitation of DMI) (Friggens et al., 2004). Furthermore, not only metabolisable energy demands 
increase two− to threefold after calving (Drackley et al., 2001), but the specific demand for glucose 
is critical as its uptake by the mammary gland is essential for the synthesis of milk lactose. The 
glucose demand by the mammary gland amounts up to 2.5 kg/d or more (Reynolds et al., 2003) and 
is precarious as the direct absorption of glucose from the small intestine is relatively marginal in 
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ruminants (Lohrenz et al., 2011).  To compensate for the increased glucose requirements of the 
mammary gland, homeorhetic regulation changes nutrients partitioning (Ingvartsen and Andersen, 
2000). This involves increased hepatic gluconeogenesis, decreased peripheral glucose utilisation 
mediated via insulin resistance, increased lipolysis and increased amino acid mobilisation from 
muscle tissue (Bell, 1995). Hypo−insulinemia, a low ratio of insulin to glucagon, and decreased 
insulin responsiveness (increased insulin resistance) of skeletal muscle and adipose tissue occur 
simultaneously in early lactation (Bell and Bauman, 1997; Xia et al., 2012), leading to a decrease in 
insulin−mediated glucose uptake in peripheral tissues and, prioritizing insulin−independent glucose 
uptake by the mammary gland (Bell, 1995). Moreover, insulin resistance in peripheral tissues changes 
the relative rates of lipolysis resulting in greater mobilisation of tissue reserves (Sadri et al., 2010). 
The latter is further supported by differences in response between normally and over−conditioned 
cows. Indeed, the latter have been suggested to suffer from more extensive mobilisation of body 
reserves (Roche et al., 2009), most probably driven by a combination of a greater drop in DMI 
(Grummer et al., 2004) and reduced insulin responsiveness (De Koster et al., 2015), which in turn 
might be influenced by factors secreted by the adipose tissue such as tumor necrosis factor−α 
(TNF−α) and NEFA (Arner, 2003). Recently, Rico et al. (2015) reported that plasma ceramides (e.g., 
C24:0-ceramide) were positively correlated with plasma NEFA and inversely correlated with insulin 
sensitivity. 
 
2.2 Metabolism of mobilised fatty acids in the liver 
Given the particular lack of glucose in early lactation, Bell (1995) estimated that only 65% of the 
glucose uptake by the mammary gland during the postpartum transition period could be supplied 
from dietary glucose precursors, propionate and amino acids, the rest would be supplied from 
glycerol from body fat reserves and amino acids from muscles. Nonesterified fatty acids from the 
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body fat reserves are partially carried in the blood to the liver from where they ultimately could be 
exported again after esterification to triacylglycerols (TAG) (Drackley, 1999). The TAG can be 
transported as very low density lipoproteins (VLDL), but this process is limited in ruminants 
(Bauchart, 1993), due to their reduced capacity to generate apoprotein B, which is believed to 
control the overall rate of VLDL synthesis and secretion (Drackley, 1999). If TAG cannot be 
excreted as VLDL, they are stored in the liver, resulting in the fatty liver syndrome which 
considerably downregulates several liver processes such as gluconeogenesis (Rukkwamsuk et al., 
1999a). Accumulation of liver TAG particularly occurs in cases of extensive mobilisation, associated 
with an up to tenfold increase in plasma NEFA concentrations (Ingvartsen and Andersen, 2000). 
Fortunately, NEFA oxidation rather than TAG accumulation is the primary route to deal with 
NEFA in the liver. However, oxidation in the Krebs cycle needs glucose, but its supply during the 
transition period is limited as indicated before. Although liver glucose production in 
normal−conditioned cows is enhanced during early lactation (Schulze et al., 1991), incomplete 
NEFA oxidation often occurs (Drackley et al., 2001) as an ‘escape’ pathway (Figure 1) in which 
acetyl CoA generated from β−oxidation is converted into ketone bodies, which comprise of acetone 
(2%), acetoacetate (20%) and BHBA (78%) (Moorby et al., 2000). These ketone bodies are highly 
water soluble, and hence easily transported in the bloodstream allowing further use as fuel for many 
tissues such as the mammary gland in an attempt of sparing glucose (Figure 1) (Drackley et al., 
2006). Accordingly, the former description of processes indicates that both limitation of NEFA 
supply and enhanced glucose production are critical to avoid severe metabolic disorders such as 
hyperketonemia and fatty liver.  
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Figure1. Relationships among lipid metabolism in adipose tissue, liver, and mammary gland. 
Adapted from Drackley et al. (2006) 
 
2.3 Transfer of mobilised fatty acids to the mammary gland 
Milk fatty acids are almost equally derived from 2 sources, de novo synthesis in the mammary 
gland or absorbed from the blood stream (Parodi, 2004). Fatty acids in milk fat can be grouped 
based on the metabolic pathways of their production. The short and medium chain fatty acids (C4:0 
to C14:0 and about half of C16:0) are synthesized de novo. The remaining C16:0 and the long chain 
fatty acids (chain length of 18 and more carbons) are included in the milk fat as preformed fatty 
acids and originate either from the diet, potentially after some metabolism in the rumen, or are from 
adipose triglycerides (Palmquist, 2006). Accordingly, both physiological and environmental factors 
might affect milk fat components with the former being mainly related to energy balance and the 
‘environmental factor’ referred to as variation in dietary management (Grummer, 1991; Palmquist et 
al., 1993; Loor et al., 2007; Moate et al., 2007). Generally, the contribution of mobilised fatty acids is 
of particular importance during the transition period when cows suffer from NEB. This most often 
results in a greater milk fat percentage in early as compared with mid and late lactation (Grieve et al., 
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1986; Heuer et al., 2000; Friggens et al., 2007b). Due to excessive NEFA mobilisation during the 
transition period not only the milk fat content but also milk FA composition changes, reflecting the 
FA mobilised from the adipose tissue. A study from Hostens et al. (2012) indicated blood NEFA are 
particularly enriched in C16:0, C18:0 and C18:1 cis−9. The increased uptake of long chain fatty acids 
further results in a decrease in the proportion of short and medium chain fatty acids (SMCFA) in 
milk fat (Craninx et al., 2008; Stoop et al., 2009; Martin et al., 2015). Inversely, SMCFA were 
reported to increase when energy status improves (Van Knegsel et al., 2007b). 
 
3. Mobilised fatty acids in relation to metabolic health and reproductive performance 
3.1 Occurrence of hyperketonemia  
Mobilisation of fat reserves can lead to metabolic disorders such as ketosis or hyperketonemia 
and hepatic lipidosis (Drackley, 1999). Hyperketonemia is a metabolic disorder associated with 
reduced milk production (Duffield, 2000; Ospina et al., 2010b), impaired reproductive performance 
(Walsh et al., 2007) and increased other metabolic problems (LeBlanc et al., 2005; Ospina et al., 
2010c). High prevalence of hyperketonemia takes place in the first 2 weeks of lactation (Table 1) 
which is related to the nadir of NEB. Duffield (2000) reviewed the worldwide prevalence of 
hyperketonemia which ranges between 9 to 34% in the first 2 months of lactation, although wider 
ranges with prevalence rates up to 56% have been reported (Table 1). Moreover, McArt et al. 
(2012b) found the peak of hyperketonemia to occur at 5 DIM. Prevalence, refers to the proportion 
of diseased cases in a herd at a certain point in time. It is determined by one test and is therefore 
easier to estimate than incidence, which relates to the number of new cases of the disease that 
develop in a defined time period (McArt et al., 2013b). Accordingly, determination of the incidence 
needs repeated testing within the pre−defined period. In case of hyperketonemia, measurement 
frequency should be twice or more per week for an accurate determination of the incidence (McArt 
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et al., 2012b). On the other hand, for point prevalence measurements, repeated testing of cows is 
not necessary. As a consequence, almost all herd−level evaluations for hyperketonemia are 
conducted as prevalence testing as reported before and reviewed by Berge and Vertenten (2014).  
 
3.2 Mobilised fatty acids or their derivatives and reproductive performance 
A link between NEB and declined fertility has been investigated as the former is a physiological 
adaptation commonly seen in early lactating, high−yielding cows, and decreased fertility is 
concomitantly observed with increasing production rates (Ingvartsen, 2006). As all cows inevitably 
experience a period of NEB, the severity and duration of NEB have been suggested key parameters 
negatively affecting reproductive performance (Butler, 2003), which might be related to various 
physiological changes. As an example, energy status is an important regulator of the resumption of 
estrous cycling after parturition, which might result in earlier and more successful first insemination 
as observed for cows having lower NEFA and greater glucose concentrations measured at 3 DIM 
(Garverick et al., 2013). In line with the latter observation, Walsh et al. (2007) and Ospina et al. 
(2010b) found associations between elevated blood BHBA and NEFA concentrations during the 
first 2 weeks of lactation and decreased pregnancy. Nevertheless, elevated blood BHBA and NEFA 
concentrations had no effect on the odds of pregnancy at the first artificial insemination in a report 
of Chapinal et al. (2012). Inversely, low insulin and insulin-like growth factor−I status around 
calving have been associated with failure to conceive (Taylor et al., 2004). Impaired immune 
function, due to a lack of nutrients for this key process, and resulting in the increased development 
of infections such as endometritis and mastitis has an indirect and adverse effect on uterine recovery 
after calving, embryo survival, follicular development and resumption of ovulatory cycles (Wathes, 
2010). Further, mobilised fatty acids or their metabolites also might exert a direct toxic role, e.g. high 
NEFA concentrations in follicular fluid seemed toxic to oocytes, resulting in deficient oocyte 
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maturation and developmental competence, based on apoptosis and necrosis of the cumulus cells as 
tested in vitro (Leroy et al., 2008). Follicular and blood NEFA and BHBA concentrations are 
correlated, although correlations between blood and follicular fluid were lower in large follicles 
(Leroy et al., 2004), suggesting some ‘buffering effect’ in dominant follicles against detrimental blood 
metabolites. Additionally, Van Hoeck et al. (2013) found that the impact of NEFA on the oocyte 
quality largely depends on the extent of mitochondrial β−oxidation of these NEFA, which further 
might induce profound changes in metabolic regulation and gene expression in the resulting embryo. 
The negative relation between blood BHBA and NEFA concentrations and key performance 
parameters of reproduction are summarised in Table 2.  
 
4. Monitoring of negative energy balance and hyperketonemia during the transition period 
4.1 Reference analysis in blood of NEFA and BHBA 
The 2 most common blood metabolites related to energy status that can be used as predictors of 
excessive NEB in dairy cows during the transition period are blood NEFA and BHBA. Blood 
NEFA reflect the magnitude of mobilised fat reserves, while blood BHBA reflects oxidised fat in 
the liver (LeBlanc, 2010). Most commonly used blood thresholds for BHBA vary between 1.2 to 1.4 
mmol/L (Geishauser et al., 1998a; Enjalbert et al., 2001; Oetzel, 2004; Duffield et al., 2009; Roberts 
et al., 2012; McArt et al., 2013a), as lower concentrations do not seem to be detrimental for cows’ 
health. Blood NEFA concentrations in the prepartum and postpartum of 0.29 and 0.57 mmol/L, 
respectively were used to predict the development of diseases, i.e. displaced abomasum, clinical 
ketosis and metritis (Ospina et al., 2010a). Other blood NEFA concentrations of 0.4 mmol/L 
prepartum and of 0.8 to 1.0 mmol/L or more postcalving were associated with increased culling 
rates in the first 2 months of lactation (LeBlanc et al., 2005; Chapinal et al., 2011; Seifi et al., 2011; 
Roberts et al., 2012). Although blood BHBA and NEFA are regarded as the reference tests, their 
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determination is costly (about US$11 per sample of blood NEFA; Ospina et al. (2013)), which 
together with the invasive nature of blood sampling, impairs the routine use of these tests for 
monitoring purposes.  
 
4.2 Current cow−side tests for diagnosis of NEB and hyperketonemia  
Besides the reference blood BHBA measurement, nowadays, determination of blood BHBA 
concentrations can be assessed qualitatively and quantitatively with several cow−side tests of varying 
sensitivity and specificity. This already answers to the major concern of cost (see 4.1). However, no 
cow−side tests are available for quantitative analysis of blood NEFA concentrations (Ospina et al., 
2013). Cow−side tests which might be of particular interest are those relying on milk rather than 
urine or blood samples given the ease of sampling (Hamann and Krömker, 1997). They are 
commonly available for the diagnosis of hyperketonemia with relatively accurate results (Table 3), 
although sensitivity and specificity of some tests are quite low. The effectiveness of a test to 
diagnose hyperketonemia depends both on the reference threshold value in blood, metabolite 
determined in milk, as well as the method for its determination (type of test) and its cut−off value.  
 
4.3 Current test−day milk for NEB and hyperketonemia  
Even though the determination of blood BHBA and NEFA are the reference tests to monitor 
hyperketonemia and NEB, respectively, there are practical limitations and concerns related to 
suitability of blood tests for routine analysis, as well as animal welfare (Duffield, 2000). Alternatively, 
routine determination of milk fat and protein is done by Fourier transform infrared spectroscopy 
(FTIR), and has been available for decades. Accordingly, this information has been used for a long 
time to substantiate pedigree information and later also to support nutritional advice and diagnose 
health status at herd level. Generally, cows suffering from NEB showed increased percentages of 
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milk fat and lowered milk protein than cows not suffering from NEB. As such, several studies 
investigated the potential of the milk fat to protein ratio to identify NEB. Grieve et al. (1986) found 
that the milk fat to protein ratio was a more sensitive and consistent indicator and better predictor 
of energy status than either component by itself. Heuer et al. (1999) identified cows with a milk fat 
to protein ratio above 1.5 had higher risks for ketosis, displaced abomasum, ovarian cyst, lameness, 
and mastitis. Nevertheless, de Vries and Veerkamp (2000) reported that neither the percentage of 
protein nor the fat to protein ratio were useful in effectively predicting  the energy status although in 
practice, elevated milk fat to protein ratios have been used to indicate the proportion of early 
lactating animals at risk for NEB and particularly to diagnose hyperketonemia (Hamann and 
Krömker, 1997; Heuer et al., 1999; Mulligan et al., 2006). The latter was assessed using the deviation 
of the milk fat to protein ratio from the average milk fat to protein ratio of the herd. Although the 
sensitivity (58%) and specificity (69%) of such milk fat to protein based models are still very low 
(Duffield et al., 1997). Van Knegsel et al. (2010) confirmed the milk fat to protein ratio was far less 
sensitive (Se = 66%) as compared with milk ketones (acetone and BHBA) (Se = 80%) to diagnose 
hyperketonemia, but milk ketones still showed a high false positive rate. Hence, combination of the 
milk fat to protein ratio with milk BHBA and acetone concentrations, as well as additional 
information which is routinely available on test days (i.e., parity and season) was needed to enhance 
accuracy of hyperketonemia detection (Van Knegsel et al., 2010; Van der Drift et al., 2012). Indeed, 
Duffield et al. (1997) reported that the accuracy of the milk fat to protein ratio alone is low due to 
confounding factors such as diet, which might affect this ratio. Furthermore, due to the length of 
the test−day interval, models based on test−day information should be considered particularly 
valuable for herd−level prevalence monitoring rather than individual diagnosis (Van der Drift et al., 
2012).  
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4.4 Milk fatty acids as an indicator of negative energy balance and hyperketonemia  
The milk FA profile has been recognized as a dynamic pattern influenced by lactation stage, 
energy balance and dietary composition (e.g. Gross et al. (2011)). Earlier research from our group 
indicated increases in the short- and medium-chain milk FA with lactation stage, whereas long chain 
fatty acids in milk decrease during the first 10 weeks in lactation (Craninx et al., 2008). Similar 
conclusions were drawn by Van Knegsel et al. (2007b) who indicated the daily production of fatty 
acids ≥ C14 and ≤ C16 increased, meanwhile  fatty acids ≥ C18 decreased as lactation weeks 
progressed. In line with this, Nogalski et al. (2012), reported higher concentrations of milk FA ≤C16 
from cows with lower fat mobilisation. Similarly, in a study by Stoop et al. (2009), lower 
concentrations in odd-chain C5:0 to C15:0 and greater proportions of milk fat C16:0 were associated 
with more severe NEB. Lower proportions of de novo synthesized short chain fatty acids in milk 
during the early lactation and in particular the NEB period might have been caused by excessive 
supply to the mammary gland of long-chain FA which have been reported to inhibit de-novo 
synthesis of those short-chain fatty acids (Palmquist et al., 1993).  
In particular, a decrease from early- to mid-lactation in the secretion of milk fat C18:1 cis-9 has 
been reported (Garnsworthy et al., 2006). As C18:1 cis-9 is the predominant long-chain FA in the 
adipose tissue, it is extensively released through lipolysis during NEB (Rukkwamsuk et al., 2000). 
Accordingly, a strong correlation (r = 0.77) between the calculated NEB (net energy intake minus 
net energy output) and the milk fat C18:1 cis-9 concentration in early lactating cows might not be 
surprising (Gross et al., 2011). Moreover, in a study with feed-restricted cows (induced NEB), 
suffering from a more severe NEB, this correlation was even higher (r = 0.98) (Gross et al., 2011). 
Additionally, a correlation (r = 0.92) was observed between the induced NEB and saturated fatty 
acids in milk. Also, Nogalski et al. (2012) reported milk C18:1 cis-9 to be associated with mobilisation 
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of fat reserves during excessive NEB. A summary of milk fatty acid profiles associated with negative 
energy status is presented in Table 4.  
 
CONCLUSIONS 
Excessive increases in blood BHBA and NEFA reflect poor adaptation of cows to physiological 
changes in the transition period, resulting in adverse effects on production, health and subsequent 
reproductive performance. Mobilised fatty acids modify the composition of milk fat. Accordingly, 
milk fatty acids merit further research to explore their potential as biomarkers of the cows’ energy 
status. 
  
 
Table 1. Overview of studies assessing prevalence of hyperketonemia (blood BHBA ≥ 1.2 mmol/L) in early lactating dairy cows.  
Country Sampling time 
(wk/day) 
No. of samples 
in study 
Prevalence (%) Reference 
 Average Range  
Canada Wk 1−9  1,446 16 8−22 Geishauser et al. (1998a) 
Canada Wk 1 987 24 − Duffield et al. (2009) 
Canada Wk 2 941 25 − Duffield et al. (2009) 
USA 3−16 DIM 1,717 43 26−56 McArt et al. (2011) 
USA 7−14 DIM 771 35 33−40 Ribeiro et al. (2013)* 
EU (10) 2−15 DIM 5,884 22 11−37 Suthar et al. (2013) 
Germany 0−46 DIM 2,450 8 4−12 Hostens et al. (2012) 
Germany 3−39 DIM 252 12 10−15 Mahrt et al. (2015) 
The Netherlands 5−60 DIM 1,678 11 5−22 Van der Drift et al. (2012) 
The Netherlands 7−14 DIM 1,715 47 43−54 Vanholder et al. (2015) 
Based on blood BHBA 0.96 mmol/L, DIM = days in milk, EU (10) = Croatia, Germany, Hungary, Italy, Poland, Portugal, Serbia, 
Slovenia, Spain, and Turkey. 
 
 
  
 
Table 2. Association of blood BHBA and NEFA concentrations and key performance indicators for reproduction in lactating dairy cows. 
 
Indicator Threshold 
level 
(µmol/L) 
Sampling 
time (wk/d) 
No. of 
samples 
in study 
Parameter Outcome 
(% decrease) 
Reference 
BHBA ≥1,000 Wk 1 796 Pregnancy rate at 1st insemination(4) 27 Walsh et al. (2007) 
BHBA ≥1,400 Wk 2  40−50 
BHBA ≥970(1) 3−14 DIM 1,095 Conception within 70 DIM(5) 13 Ospina et al. (2010b) 
BHBA ≥1,200(1) 3−14 DIM 1,672 Herd pregnancy rate(2) 0.8 Ospina et al. (2010a) 
BHBA ≥1,200 Wk 1−8 213 Resumption of cyclicity by 56 DIM(3) 33 Shin et al. (2015) 
    Pregnancy by 360d(3) 32 
NEFA ≥600 3−14 DIM 1,672 Herd pregnancy rate(2) 0.9 Ospina et al. (2010a) 
NEFA ≥720 3−14 DIM 1,095 Conception within 70 DIM(5) 16 Ospina et al. (2010b) 
NEFA ≥600 3 DIM 156 Pregnancy rate(4) 35 Garverick et al. (2013) 
NEFA ≥700 3 DIM 156 Pregnancy rate(4) 32 
(1) Conversion from mg/dL to µmol/L: divided by 0.0103 
(2) Effect on herd pregnancy rate if more than 15% of animals sampled postpartum had BHBA concentration ≥12 mg/dL. Herd pregnancy rate is measured as the average of the two 21−d 
periods post herd voluntary waiting period, DIM = days in milk, wk = week of lactation 
(3) Calculated from the hazard ratio. For ‘Pregnancy by 360 d’, calculation of the hazard ratio was based on the proportion of cows which were not pregnant after 360 DIM. 
(4) Pregnant after first artificial insemination 
(5)  Assessed by time to conception within 70 d post-voluntary waiting period 
 
  
 
Table 3. Performance of milk ketone bodies cow−side tests for diagnosis of hyperketonemia in early lactating dairy cows. 
Milk test Threshold blood 
BHBA (µmol/L) 
Sampling 
time 
(week) 
No. of 
samples 
in study 
Prevalence 
(%) 
 
Se 
(%) 
Sp 
(%) 
PV+ 
(%) 
 
PV- 
(%) 
Reference 
Ac (160 µmol/L) >1200 2−6 125 19 92 57 34 97 Enjalbert et al. (2001) 
AcAc (50 µmol/L)   92 73 45 97  
BHBA (70 µmol/L)   92 64 38 97  
Ketolac (BHBA 100 – 199 µmol/L)   96 63 38 98  
Ketolac (BHBA 50 µmol/L) >1200 1−9 529 16 92 55 29 97 Geishauser et al. (1998a) 
Ketostix strip  5.0 100 100 84  
Bioketone powder  33 100 97 88  
Keocheck powder  28 100 100 88  
Utrecht powder  43 100 100 90  
PinkTest (AcAc≥100 µmol/L) >1400 1 469 12 76 93 60 96 Geishauser et al. (2000) 
Ketolac (AcAc≥50 µmol/L)  91 56 21 98  
Uriscan (AcAc≥500 µmol/L)  13 100 100 90  
Rapignost (AcAc≥500 µmol/L)  3.0 100 100 91  
KetoCheck (AcAc ≥trace) ≥1400 1−2 859 8.0 41 99 - - Carrier et al. (2004) 
KetoTest (BHBA ≥50 µmol/L)  88 90 - -  
Precision Xtra (BHBA 200 µmol/L) ≥1400 1−6 194 5.0 60 89 22 98 Iwersen et al. (2009) 
Precision Xtra ( BHBA 300 µmol/L)     40 97 44 97  
Ketolac (BHBA 100 µmol/L)     90 94 45 99  
Ketolac (BHBA 200 µmol/L)     30 98 50 96  
Se = sensitivity, Sp = specificity, PV+ = positive predictive value, PV- = negative predictive value, Ac = acetone, AcAc = acetoacetate 
 
 
  
 
Table 4. Milk fatty acid concentrations in milk fat as indicators of energy status and reproductive performance in early lactating cows. 
 
Indicator Sampling time 
(wk) 
Samples in 
study, n 
Change in milk fatty acid 
concentration 
Change in reference indicator Reference 
Energy status 
1.C≥14:0, C≤16:0 
2.C≥18:0 
2 −9 16 1.  DIM 
2.  DIM 
Energy retention  Van Knegsel et al. 
(2007b) 
1.C5:0−C15:0 (odd) 
2.C16:0 
9−40 1,993 1.  
2.  
Fat to protein ratio deviation 
from average (FPdev >0.12) 
 
Stoop et al. (2009) 
1.C10:0−C16:0 
2.C18:1 cis−9 
1− 12 30 1.  
2.  
Energy balance  
 (energy intake – energy output) 
 
Gross et al. (2011) 
C18:1 cis−9 2−5 16  Blood BHBA>1.2 mmol/L 
in wk 3, 4, or 5 
Van Haelst et al. 
(2008) 
 
Reproductive performance 
1.C14:0, C16:0 
2.C18:0, C18:1 cis−9 
1−10 87 1.  
2.  
1. Early OLA 
2. Late OLA 
Martin et al. (2015) 
 
1.SFA  
2.MUFA 
1−5 382 1.  
2.  
1.  NUM, DO 
2.  NUM, DO 
Stádník et al. (2015) 
DIM=days in milk, DO=days open, NUM=number of services per conception, OLA=onset of luteal activity, SFA=saturated fatty acid, MUFA=monounsaturated fatty acid, 
FPdev = fat-to-protein deviation 
  
 
 
 
 
CHAPTER 2A 
 
Milk fatty acids as potential biomarkers to early diagnose elevated 
concentrations of blood plasma nonesterified fatty acids in dairy 
cows 
 
 
 
 
 
 
 
 
 
Adapted from: 
Jorjong, S., A. Van Knegsel, J. Verwaeren, M. V. Lahoz, R. M. Bruckmaier, B. De Baets, B. 
Kemp, and V. Fievez. 2014. Milk fatty acids as possible biomarkers to early diagnose elevated 
concentrations of blood plasma nonesterified fatty acids in dairy cows. J. Dairy Sci. 97:7054-
7064. 
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ABSTRACT 
Most cows encounter a state of negative energy balance during the periparturient period, 
which may lead to metabolic disorders and impaired fertility. The aim of this study was to assess 
the potential of milk fatty acids as diagnostic tools of detrimental levels of blood plasma 
nonesterified fatty acids (NEFA), defined as NEFA concentrations beyond 0.6 mmol/L, in a 
data set of 92 early lactating cows fed a glucogenic or lipogenic diet and subjected to 0-, 30-, or 
60-d dry period before parturition. Milk was collected in weeks 2, 3, 4 and 8 (n = 368) and blood 
was sampled weekly from weeks 2 to 8 after parturition. Milk was analysed for milk fatty acids 
and blood plasma for NEFA. Data were classified as “at risk of detrimental blood plasma 
NEFA” (NEFA ≥ 0.6 mmol/L) and “not at risk of detrimental blood plasma NEFA” (NEFA < 
0.6 mmol/L). Concentrations of 45 milk fatty acids and milk fat C18:1 cis-9-to-C15:0 ratio were 
subjected to receiver operating characteristic (ROC) curve analysis to determine the most 
promising diagnostic fatty acids or fatty acids ratio based on the maximum area under the curve 
(AUC). Milk fat C18:1 cis-9 revealed the most promising variable to identify detrimental blood 
plasma NEFA. A false positive rate of 10% allowed to diagnose 46% of the detrimental blood 
plasma NEFA cases based on a milk fat C18:1 cis-9 concentration of at least 230 g/kg fatty acids. 
Additionally, it was assessed whether the milk fat C18:1 cis-9 concentration of week 2 could be 
used as an early warning for detrimental blood plasma NEFA risk during the first 8 weeks in 
lactation. Cows with at least 240 g/kg C18:1 cis-9 in milk fat had about 50% chance to encounter 
blood plasma NEFA values of 0.6 mmol/L or more during the first 8 weeks of lactation, with a 
false positive rate of 11.4%. Profit simulations were based on costs for cows suffering from 
detrimental blood plasma NEFA, and costs for preventive treatment based on daily dosing of 
propylene glycol for 3 weeks. Given the relatively low incidence rate (8% of all observations), 
continuous monitoring of milk fatty acids during the first 8 weeks of lactation to diagnose 
detrimental blood plasma NEFA does not seem cost effective. On the contrary, milk fat C18:1 
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cis-9 of the second lactation week could be an early warning of cows at risk of detrimental blood 
NEFA. In this case, selective treatment may be cost effective. 
 
INTRODUCTION 
Most transition dairy cows are confronted with a negative energy balance (NEB) in early 
lactation caused by 3 primary reasons: increased energy demands at calving, decreased dry matter 
intake (DMI) shortly before and after calving, and lagging DMI compared with energy demand 
for milk production (Ospina et al., 2010c). Additionally, the supply of glucogenic precursors, in 
particular ruminal propionate which is largely converted into glucose in the liver, is often 
insufficient (Heuer et al., 2000). Accordingly, milk linear odd-chain FA (i.e., C15:0 and C17:0) 
might provide information on the cow’s glucose status as they are de novo synthesised from 
propionyl-CoA by rumen bacteria or in the mammary gland (Vlaeminck et al., 2006). 
Glucose insufficiency in the transition period further results in low blood glucose and insulin 
concentrations, inducing body fat mobilisation and transportation of NEFA to several organs, 
among them reproductive tissues and the liver. In the liver, excessive supply of NEFA might 
result in metabolic disorders such as fatty liver and ketosis (Grummer, 1993), which particularly 
take place 2 to 7 weeks after parturition. Additionally, elevated plasma NEFA concentrations 
increase the risk for displaced abomasum, clinical ketosis, metritis, and retained placenta (Ospina 
et al., 2010c). The critical NEFA concentration is about 0.3 mmol/L prepartum and 0.57 
mmol/L postpartum (Ospina et al., 2010b), whereas a concentration of 1.0 mmol/L or more 
post calving has been associated with increased culling rates in the first 2 months of lactation 
(LeBlanc et al., 2005; Chapinal et al., 2011; Seifi et al., 2011). Furthermore, a high blood plasma 
NEFA concentration seems detrimental for dairy cow fertility (Garverick et al., 2013). This has 
been suggested to originate from deteriorated oocyte quality (Leroy et al., 2005).  
Excessive amounts of NEFA, released during body fat mobilisation, are also transferred to 
the milk. As these NEFA are particularly rich in long-chain FA, such as C18:1 cis-9 and C18:0 
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(Hostens et al., 2012), concentrations in milk fat of those FA might be linked to severity of 
NEB. Therefore, the objective of the current study was to assess whether milk FA are potential 
biomarkers for detrimental levels of blood plasma NEFA. For this objective, milk and blood 
plasma sampled during the first 8 weeks after parturition were used. Samples were obtained from 
a large-scale experiment with 92 early lactating cows receiving either a glucogenic or a lipogenic 
diet in early lactation after a normal (60 d) or shortened (30 d) dry period or without dry period. 
The objective was approached in 4 steps: (1) measurement of FA in milk and NEFA in blood 
plasma; (2) receiver operating characteristic (ROC) analysis to determine the milk FA with the 
greatest biomarker potential based on the maximum area under the curve (AUC); (3) assessment 
of the potential value of these milk FA as diagnostic and early warning biomarker; and (4) 
economic validation. 
MATERIALS AND METHODS 
Experimental setup, animals, and housing 
The Institutional Animal Care and Use Committee of Wageningen University and Research 
Centre approved the experimental protocol. Details about the experimental design have been 
reported earlier (Van Knegsel et al., 2014). In short, Holstein-Friesian dairy cows (n = 108) were 
selected from the Dairy Campus Research dairy herd (Wageningen University and Research 
Centre Livestock Research, Lelystad, the Netherlands) for an experiment on the effect of dry 
period length (0, 30, or 60 d) and early lactation diet (glucogenic or lipogenic) on metabolic 
health (assessed through blood plasma BHBA, NEFA, glucose, IGF-1, and insulin). Cows were 
blocked for parity (primiparous or multiparous). Moreover, cows were allocated to the 6 
treatment groups to equally stratify all groups for following parameters: expected calving date, 
milk production in the previous lactation and BCS.  
Cows were housed in a freestall barn with a slatted floor and cubicles. During lactation, cows 
were milked twice daily (0500 and 1630 h). The drying-off protocol for cows with the 30- and 
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60-d dry period consisted of a transition to the far-off ration at d 7 before drying-off, and 
milking once daily at d 4 before drying-off cows. At drying-off, cows were treated with an 
intramammary antibiotic (Supermastidol, Virbac Animal Health, Barneveld, the Netherlands). 
Milk yield was recorded daily. From the original 108 cows in the experiment, 3 cows showed 
health problems post-calving and were not considered further. The health status of the cows was 
checked regularly by the animal care workers, but no further signs of health problems were 
observed in the 105 cows. Hence, from 105 cows of the experiment (17 or 18 in each of the 6 
treatment groups), milk and blood samples were obtained. Blood samples were taken weekly 
from week 3 precalving until week 8 postcalving. Blood was sampled from the coccygeal vein 
into heparinised tubes. Blood plasma was obtained by centrifugation for 15 min at 3,000 × g at 4 
°C. Blood plasma samples were kept at -20°C until analysis for plasma metabolites. Milk 
sampling for FA analysis took place every Friday morning in weeks 2, 3, 4, and 8 postcalving. 
Milk samples were collected in 10-mL tubes and were stored at -20 °C. Frozen milk samples 
were sent to the Laboratory for Animal Nutrition and Animal Product Quality (Faculty of 
Bioscience Engineering, Ghent University, Belgium). From the 105 cows, 13 cows were excluded 
because the data were incomplete (missing milk FA of weeks 2, 3, 4, and 8 or blood NEFA from 
weeks 2 to 8 of lactation). Hence, only 92 of the 105 cows were used in data analysis.  
Prepartum, dry cows received a dry cow ration, lactating cows received a lactating cow ration 
supporting 25 kg of milk. From 3 weeks prepartum until 100 DIM, all cows were fed 1 of the 
experimental concentrates (lipogenic or glucogenic); lactating cows received 1 kg/d of standard 
lactation concentrate in the milking parlour. Forage composition consisted prepartum of grass 
silage, corn silage, wheat straw, and a protein source (rapeseed meal or soybean meal) in a ratio 
of 39:25:25:11 (DM basis). Postpartum to 100 DIM, forage consisted of grass silage, corn silage, 
straw, and a protein source (rapeseed meal or soybean meal) in a ratio 51:34:2:13 (DM basis; 
Tables 1 and 2). 
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Milk analysis  
 The FA profile was obtained after milk fat extraction (mini Röse-Göttlieb method, adapted 
from Chouinard et al. (1997), methylation (Stefanov et al., 2010) and gas chromatographic 
analysis of FAME) (Agilent Technologies 7890A GC System equipped with a flame ionization 
detector, Agilent Technologies, Santa Clara, CA). Samples were injected by split injection (split 
ratio 1:50). The carrier gas was hydrogen, inlet pressure 246.38 kPa. Separation of FAME was 
realised with a Supelco column (SP-2560, Sigma-Aldrich Bellefonte, PA; 75 m × 180 μm × 0.14 
µm). The temperature programme ran from a starting temperature of 70°C for 2 min, increasing 
15°C/min to 150°C; from 150°C to165°C by an increase of 1 °C/min, then 165°C was held for 
12 min; from 165°C to 170°C the temperature increased at 2°C/min, with 170°C held for 5 min 
and from 170 to 215°C, an increase of 5°C/min was applied, with the final temperature kept for 
10 min. Fatty acid methyl esters were determined with Agilent ChemStation software (B.04.03; 
Agilent Technologies) and tridecanoic acid (C13:0; as triacylglyceride; Sigma, Bornem, Belgium) 
was used as internal standard. Fatty acids were expressed as grams per 100 g of FAME. Fatty 
acid peaks were identified through mixtures of methyl ester standards (BR2 and BR3, Larodan 
Fine Chemicals AB, Malmö, Sweden; Supleco 37, Supelco Analytical, Bellefonte, PA; PUFA-3, 
Matreya LLC, Pleasant Gap, PA) based on retention times. Shortchain FA were corrected for 
their respective theoretical relative response factors (Ackman and Sipos, 1964; Wolff et al., 
1995). 
 
  
 
Table 1. Ingredient and calculated1 chemical composition (g/kg of DM, unless otherwise noted) 
of glucogenic and lipogenic concentrate.  
Item Glucogenic  Lipogenic  
Ingredient (g/kg)   
 
 
Rapeseed meal 112.9 170.4 
Corn 530.8  
Palmkernel, expeller   212.6 
Sugar beet pulp 72.3 321.0 
Wheat  39.0 61.2 
Soybean hulls 4.9  
Soyabean meal 86.6 16.9 
Soyabean meal, formaldehyde treated 22.4 18.4 
Rapeseed meal, formaldehyde treated 34.6 59.4 
Energizer RP102  20.1 
Molasses  57.0 47.0 
Vinasses  39.2 
Palm oil 1.0 11.9 
Calcium carbonate 19.3 10.9 
Magnesium oxide 7.1 4.5 
Sodium chloride 7.5 5.1 
Mineral-vitamin mixture3 2.3 2.4 
Calculated chemical composition   
DM (g/kg of product)  873 879 
CP (g/kg of DM)  181 194 
Crude fat  33 71 
NDF  178 379 
ADF  79 222 
ADL  18 50 
Starch  417 28 
Sugars4  77 103 
Ash  79 90 
DVE5  120 120 
OEB6  12 12 
NEL
7 (MJ/kg of DM)  7.7       7.7 
Fatty acid composition8 (g/kg of FAME)     
C12:0   0.53  40.0 
C14:0   1.13  15.6 
C16:0   133  370 
C18:0   139  85.6 
C18:1 cis-9   215  149 
C18:2 cis-9, cis-12   261  93.8 
C18:3 cis-9, cis-12, cis-15   248  169 
1Based on Centraal Veevoederbureau (CVB) table (Veevoederbureau, 2005).2Rumen-protected fat from palm 
oil (IFFCO International, Por Klang, Malaysia).3Premix 2016 (Pre-Mervo UA Cooperation, Utrecht, the 
Netherlands).4Van Vuuren et al. (1993).5DVE = intestinal digestible protein (Tamminga et al., 1994).6OEB = 
degraded protein balance (Tamminga et al., 1994). 7Calculated with the Dutch net energy evaluation (VEM) 
system (Van Es, 1975).8Analysis of fatty acid composition according to Gadeyne et al. (2015). 
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Table 2. Ingredient and calculated chemical composition (g/kg of DM, unless otherwise 
stated) of prepartum and postpartum rations1. 
 Prepartum ration  Postpartum ration 
Diet Dry Lactating  Glucogenic Lipogenic 
Ingredient      
Grass silage 391 484  338 338 
Corn silage  245 321  227 227 
Soybean meal 38 68  46 46 
Rapeseed meal 79 52  36 36 
Rapeseed straw 2 1  10 10 
Wheat straw 245 13  5 5 
Concentrate 0 56  338 338 
Chemical composition      
DM (g/kg of product) 532 453  561 566 
CP (g/kg of DM) 116 159  167 169 
Crude fat  26 31  31 37 
NDF  527 384  318 389 
ADF  326 229  182 224 
Starch  65 117  215 106 
Sugars2  67 80  82 85 
Ash  74 76  76 80 
DVE3  47 80  87 84 
OEB4  10 21  17 17 
NEL
5 (MJ/kg of DM)   5.26 6.48  6.55 6.52 
     
1Based on realised feed intake.2Van Vuuren et al. (1993).3DVE = intestinal digestible protein 
(Tamminga et al., 1994).4OEB = degraded protein balance (Tamminga et al., 1994). 5Calculated 
with the Dutch net energy evaluation (VEM) system (Van Es, 1975). 
. 
Blood plasma metabolite 
Plasma NEFA concentrations were measured enzymatically with a selective analyzer (Cobas Mira 
2, Hoffmann-La Roche, Basel, Switzerland) by the use of commercial kits no. FA115 (Randox 
Laboratories Ltd., Ibach, Switzerland) as described by Van Dorland et al. (2009).   The principle of 
the assay is as follows: NEFA, in the presence of ATP, CoA, and acetyl-CoA synthetase, forms acyl-
CoA and the by-products AMP and pyrophosphate. Then, the product acyl-CoA is oxidised by 
acetyl-CoA oxidase, which produces hydrogen peroxide. Peroxidase acts on the hydrogen peroxide 
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in the presence of 3-methyl-N-ethyl-N-(β-hydroxyethyl)-aniline and 4-aminoantipyrine to form the 
final reaction product that is a purple quinone.  
 
Statistical analysis, calculations, and generation of functions  
Descriptive statistics 
Milk fat C18:1 cis-9 concentration and blood plasma NEFA were subjected to repeated measures 
ANOVA (ANOVA mixed model of SAS Institute Inc., Cary, NC). Lactation week was considered 
as the repeated effect (weeks 2 to 8 for blood plasma NEFA and weeks 2, 3, 4, and 8 for milk fat 
C18:1 cis-9 concentration). Cow was defined as random effect. Dry period length (0, 30, or 60 d), 
diet (glucogenic or lipogenic), week (2 to 8), and the relevant interaction terms were included in the 
model as fixed effects. A first-order autoregressive structure [AR(1)] was the best fit and was used to 
account for within-dry period by diet variation of NEFA, whereas a first-order heterogenous 
structure was used to account for within-dry period by diet variation of milk fat C18:1 cis-9 
concentration.  
 
NEFA threshold definition 
The NEFA threshold in postpartum blood plasma samples was set at 0.6 mmol/L (Ospina et al., 
2010c), where NEFA values greater than or equal to 0.6 mmol/L were classified as 1, which stands 
for “at risk of detrimental blood plasma NEFA”; NEFA values lower than 0.6 mmol/L were 
classified as 0, which stands for “not at risk of detrimental blood plasma NEFA.” 
 
ROC curve analysis 
 Receiver operating characteristic (ROC) curves are frequently used to evaluate classification and 
prediction models. Here, these curves were used to identify those milk FA which show potential to 
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distinguish cases with elevated blood NEFA (≥ 0.6 mmol/L) from non-elevated blood NEFA       
(< 0.6 mmol/L) cases. Each milk FA or FA ratio was screened using such a ROC curve, which 
essentially is a two-dimensional graph in which the true positive rate (sensitivity, Se) is plotted on the 
Y axis and the false positive rate is plotted on the X-axis (100 – Specificity, 100 – Sp). Sensitivity is 
defined as the proportion of cows correctly diagnosed to experience elevated blood plasma NEFA 
based on the milk FA test relative to all cows that effectively had blood plasma NEFA 
concentrations ≥ 0.6 mmol/L. Specificity is the proportion of cows correctly diagnosed not to 
suffer from elevated blood plasma NEFA based on the milk FA test relative to all cows that had 
blood plasma NEFA concentrations < 0.6 mmol/L. Accordingly, a ROC graph depicts relative 
trade-offs between benefits (true positives) and costs (false positives). The diagonal line y = x 
represents the strategy of randomly guessing a class. Accordingly, if a test with an AUC = 0.5 is 
considered non-informative; if 0.5<AUC≤0.7, the test is accurate; if 0.7<AUC≤0.9, it is considered 
very accurate; if 0.9<AUC<1, it is highly accurate; and if AUC = 1, the test is determined perfect 
(Swets, 1988; Ospina et al., 2010c). The 45 milk FA, as well as the milk fat C18:1 cis-9-to-C15:0 ratio, 
were subjected to ROC curve analysis performed by SPSS 22.0 (SPSS Inc., Chicago, IL). The area 
under the curve was used to identify the most promising milk FA for classification into the two 
categories based on blood plasma NEFA concentration (greatest AUC). After this first exploratory 
ROC curve analysis, a second step with linear discriminant analysis was run in which classification 
was based on the most promising milk FA. Finally, the performance of two classification models, 
either based on all milk FA or on the most promising milk FA only, was assessed through cross-
validated discriminant analysis (default leave-one-out procedure in SPSS 22.0).  
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Empirical cumulative probability distributions for diagnosis of detrimental blood NEFA 
Empirical cumulative probability distributions were generated expressing the cumulative 
probability of milk fat C18:1 cis-9 concentration. In particular, the cumulative probability distribution 
of milk fat C18:1 cis-9 concentration in case of elevated and low blood plasma NEFA (detrimental 
blood plasma NEFA cows) were considered and denoted g1and g2, respectively. Denoting the milk 
fat C18:1 cis-9concentration as O (the random variable under study), the corresponding curves were 
constructed through a stepwise increase of the milk fat C18:1 cis-9 concentration o from the 
minimum to the maximum value observed in the study: 
 
        g1(o)  =  
Number of cases with elevated blood plasma NEFA for which O ≤ o
Total number of cases with elevated blood plasma NEFA in the study
 
 
g2 (o)  =  
Number of cases with low blood plasma NEFA for which O ≤ o
Total number of cases with low blood plasma NEFA in the study
 
 
Empirical cumulative probability distributions for early warning of detrimental blood 
plasma NEFA 
In our study, early warning potential for detrimental blood plasma NEFA was assessed. For this 
purpose, milk fat C18:1 cis-9 was determined in week 2 after parturition, whereas cows were 
classified based on detrimental blood plasma NEFA in weeks 2 to 8. For this classification, cows 
were considered at risk of detrimental blood plasma NEFA in early lactation when the maximum 
blood plasma NEFA concentration at any time in this 7-week period was greater than 0.6 mmol/L.  
Empirical probability distributions were generated as described previously (diagnosis), but now 
including milk FA data of week 2 only and the 0 or 1 classification based on the maximum blood  
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plasma NEFA concentration observed in weeks 2 to 8 of lactation. The following cumulative 
probability distributions for use in early warning were considered: the cumulative probability 
distribution of the milk fat C18:1 cis-9 concentration in week 2 of lactation in cases of elevated and 
low blood plasma NEFA in the first 8 weeks in lactation, denoted e1 and e2, respectively. Denoting 
the milk fat C18:1 cis-9 concentration in week 2 as O2 (the random variable under study), the 
corresponding curves were constructed through a stepwise increase of the milk fat C18:1 cis-9 
concentration o from the minimum to the maximum value observed in the study:  
 
e1(o) =
Number of elevated blood plasma NEFA cows in the first 8 weeks in lactation for which O2 ≤ o 
 
Total number of cows with elevated blood plasma NEFA  in first 8 weeks in lactation 
 
 
e2(o)  =
Number of low blood plasma NEFA cows in the first 8 weeks in lactation for which O2 ≤ o 
Total number of cows with low blood plasma NEFA  in first 8 weeks in lactation 
 
 
Logistic curve fitting 
  Further, a logistic curve was fitted to the empirical cumulative probability distributions. This 
curve is described based on the slope (β0), the inflection point of the curve (β1), and the upper limit 
(β2), which here equals 1:  
y  = 
β
2
1+ exp [-β0  × (𝑥 - β1 )] 
 
 
Economic cost function for prevention of detrimental blood plasma NEFA 
 The expected economic cost of detrimental blood plasma NEFA was calculated based on 
following cost parameters and probabilities:  
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a = Financial loss of an ill cow (€) due to a decrease in reproductive performance (i.e. an extension 
of the calving to conception interval with 2 weeks) of detrimental blood plasma NEFA cows. Costs 
were estimated at €25 per case (Geishauser et al., 2001). For the current simulation, costs of €15, 25, 
and 35 were considered. 
b = Financial cost of pre-emptive treatment (€) based on the use of propylene glycol (PEG), which 
is reported to improve fertility and allow effective treatment or prevention of elevated blood plasma 
NEFA development with application rates varying between 200 and 500 g/d during 3 weeks 
(Johnson, 1954; Grummer et al., 1994; Formigoni et al., 1996; Miyoshi et al., 2001) and costs for 
PEG of €1.1 /kg.  
Labour costs (e.g., for pre-emptive PEG treatment or for cow separation for veterinary inspection) 
were not included in the current cost estimations. 
I = The event a cow suffers from elevated blood plasma NEFA.  
R = Milk fat C18:1 cis-9 concentration for that cow.  
A threshold (θ) was selected and it was assumed to pre-emptively treat a cow when R > θ. Hence, 
the probability P (I) for a cow to be ill is then given by  
P (I) = P (I|R ≤ θ) × P (R ≤ θ) + P (I|R > θ) × P (R > θ).  
If the treatment is fully effective to treat detrimental blood plasma NEFA, then P (I|R > θ) = 0 and 
P(I) reduces to 
P (I) = P (I|R ≤ θ) × P (R ≤ θ).   
In those equations, the probability for a random cow to have milk fat C18:1 cis-9 less than θ, P (R 
≤ θ) was assessed as the concentration of the number of observations with R ≤ θ to the total 
number of observations in the study. Similarly, P (R > θ) was assessed as the concentration of the 
number of cows that have R > θ to the total number of cows. 
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 Under this scenario, a cost function C (θ) is built, including 1/ financial loss of a detrimental 
blood plasma cow when not treated, that is, all detrimental blood plasma cows with R ≤ θ; and 2/ 
financial cost of the pre-emptive treatment, that is, all cows with R > θ. Hence, the expected 
economic cost (C) of a cow is  
C (θ) = P (I) × a + P (R > θ ) × b = P (I|R ≤ θ) × P (R ≤ θ) × a + P (R > θ ) × b. 
 
RESULTS 
Milk production, energy balance, and body condition score  
Results of milk production, energy balance and body condition score were previously reported by 
Van Knegsel et al. (2014). In short, average milk yields (kg/d) from weeks 1 to 14 of lactation were 
highest in cows with a 60-day dry period (43.3 kg/g) (P <0.010), whereas cows with a 30-day and 0-
day dry period yielded 38.7 and 32.7 kg/d, respectively. Body condition scores before calving of all 
cows ranged between 3.0 and 3.1. However, after calving in cows with a 60-day dry period the score 
decreased to 2.2 (P < 0.010), whereas cows with 30 and 0-day dry period remained at a BCS of 2.5 
and 3.0, respectively. Losses of body condition are in line with the calculated negative energy 
balance, with the energy balance in cows with a 60-day dry period being lowest.  
 
Classification based on blood plasma NEFA thresholds and influence of experimental 
factors (dietary and dry period management) 
 Of all 368 observations in weeks 2, 3, 4, and 8 after parturition, in 8% of the cases, blood plasma 
NEFA were greater than 0.6 mmol/L. However, in the case of early warning (n = 92), 24% of the 
animals were classified at risk to develop detrimental blood plasma NEFA concentrations during the 
first 8 weeks in lactation. 
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 Blood plasma NEFA concentrations were greater in early lactation (P < 0.001), and blood plasma 
NEFA was affected by dry period management (P < 0.001), but differences became smaller when 
lactation progressed (dry period management by week interaction; P = 0.006; Figure 1a). Particularly, 
omission of the dry period resulted in a lower blood plasma NEFA concentration (P < 0.001; Figure 
1a). Blood plasma NEFA was also affected by diet, with the glucogenic diet suppressing its 
concentration (0.20 vs. 0.25 mmol/L for the glucogenic and lipogenic diet, respectively; P = 0.022). 
 Milk yield production, as well as body condition score previously reported by (Van Knegsel et al., 
2014) 
 
 
Figure 1 (a-b). Blood plasma NEFA concentration (a) and milk fat C18:1 cis-9 concentration (b) of dairy cows fed a 
glucogenic or lipogenic diet (diet) with dry period (DP) length of 0 (black bar), 30 (white bar), or 60 d (grey bar) during 
weeks 2, 3, 4, and 8 of lactation (Wk). Values represent means per week, error bars present standard deviations. P-values 
show main effects and interaction effects. 
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Figure 2. Correlation between blood plasma NEFA and milk fat C18:1 cis-9 concentration of weeks 2, 3, 4, 
and 8 in lactation (n = 368; R2 = 0.38, P<0.001).  
 
Identification of milk FA predominantly linked with blood NEFA concentrations: ROC 
curve analysis and correlations 
Of the 45 milk FA and C18:1 cis-9-to-C15:0 ratio used to perform the ROC curve analysis, milk 
fat C18:1 cis-9 revealed the most promising milk FA to distinguish between elevated and non-
elevated blood NEFA categories as the maximum AUC (0.853) of a classification based on this milk 
FA was higher as compared with other milk FA or milk FA ratios. Cross-validation results for 
grouping based on all variables resulted in an overall classification accuracy of 79.9%. More 
specifically, 80.3 and 75.0% of the cases of the blood plasma NEFA groups 0 (specificity) and 1 
(sensitivity) were classified correctly, respectively. Cross-validation based on the most promising 
milk FA only (i.e., C18:1 cis-9) showed overall classification accuracy of 78.8%, specificity of 79.1%, 
and sensitivity of 75.0%. Hence, classification based on C18:1 cis-9 was only slightly less specific as 
compared with classification based on the full parameter set, whereas sensitivity was maintained. 
Accordingly, the potential of this single milk FA was further emphasised in the current paper. 
 In accordance with blood NEFA concentrations, milk fat C18:1 cis-9 concentration decreased 
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(P < 0.001), with differences becoming smaller and disappearing when the lactation progressed (dry 
period management by week interaction; P < 0.001; Figure 1b). Milk fat C18:1 cis-9 concentration 
was not affected by diet (P = 0.635). Further detailed information on the milk FA composition, in 
relation to the dry period length and glucogenic versus lipogenic ration has been reported by Van 
Knegsel et al. (2014). The relation between milk fat C18:1 cis-9 concentration and blood NEFA is 
further confirmed through the positive relation between both metabolites (Figure 2).  
 
Empirical cumulative probability distributions for diagnosis of detrimental blood NEFA 
 Logistic curves were fitted presenting both the proportion of animals at risk and not at risk of 
detrimental blood plasma NEFA in relation to the milk fat C18:1 cis-9 concentration (ranging from 
12.5 to 30.6 g/100 g FA). The β1 value for the logistic curve of animals with detrimental blood 
plasma NEFA equaled 23.6, which indicates that 50% of all observations having a blood plasma 
NEFA concentration of 0.6 mmol/L or more were associated with a milk fat C18:1 cis-9 
concentration equal to or greater than β1 (Figure 3a). This situation was associated with only 6.5% 
false positives (i.e., animals showing milk fat C18:1 cis-9 values of at least 24 g/100 FA, but with 
blood plasma NEFA < 0.6 mmol/L).  
 
Empirical cumulative probability distributions for early warning of detrimental blood 
plasma NEFA 
 About half of the cows (45%, n = 10) showing detrimental blood plasma NEFA during the first 
8 weeks in lactation showed a milk fat C18:1 cis-9 concentration of 24 g/100 g FA or more in week 
2, with a false positive rate of 11.4%. When the milk fat C18:1 cis-9 concentration was below 20 
g/100 g FA, the risk of encountering detrimental blood plasma NEFA was less than 15% (Figure 
3b)
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Figure 3a. A logistic curve, g1, representing the cumulative probability distribution of milk fat C18:1 cis-9 concentration, 
(O) ≤ o, in case of elevated blood plasma NEFA (NEFA ≥ 0.6 mmol/L; black diamonds) to the total number of cases 
showing detrimental blood plasma NEFA. The logistic curve is characterized by its slope (β0 = 0.54) and inflection point 
(β1 = 23.6). Similarly, cases having nondetrimental blood plasma NEFA proportionally to the total number of cases with 
nondetrimental blood plasma NEFA (g2) in relation to O ≤ o (grey triangles) were presented, with β0 and β1 of 0.57 and 
18.7, respectively.  
 
 
 
 
Figure 3b. A logistic curve, e1, representing the cumulative probability distribution of milk fat C18:1 cis-9 concentration 
of week 2 in lactation (O2) ≤ o with detrimental blood plasma NEFA (≥ 0.6 mmol/L; black diamonds) at any time 
between weeks 2 and 8 in lactation relative to the total number of observations with detrimental blood plasma NEFA. 
The logistic curve is characterized by its slope (β0 = 0.56) and inflection point (β1 = 23.9). Similarly, cows having 
nondetrimental blood plasma NEFA (grey triangles) during the first 8 weeks in lactation proportionally to the total 
number of cows with nondetrimental blood plasma NEFA in relation to O2 ≤ o were presented (e2), with β0 and β1 of 
0.54 and 20.2, respectively. 
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Economic cost function  
 Figures 4a and 4b present the costs associated with selective PEG treatment based on the milk 
fat C18:1 cis-9 concentration. Simulations were performed assuming costs associated with elevated 
blood plasma NEFA could vary between €15 and 35 per case, and costs for 3 weeks of daily PEG 
supplementation varying from 200 to 500 g/d equaled €4.6 to 11.6  per case. The X-axis represents 
increasing thresholds (θ) and simulations were based on selective treatment of animals when R > θ. 
Thresholds varied from 1 unit below the minimum (S1) to 1 unit above the maximum (S2) 
observation in the current study. Accordingly, S2 (extreme right on the X-axis) represents a situation 
where none of the animals are treated, whereas S1 (extreme left on the X-axis) represents a situation 
where all of the animals are treated. When costs reach a local minimum, it is of economic interest to 
selectively treat animals. Figure 4a represents costs associated with selective treatment when 
diagnosing elevated blood plasma NEFA.  
 Finally, Figure 4b represents costs associated with selective treatment of animals based on 
monitoring of milk fat C18:1 cis-9 in week 2 after parturition (early warning). In this case, PEG 
treatment is assumed to prevent blood NEFA concentration to rise to detrimental levels afterward. 
The maximum economic benefit is associated with a selective treatment of animals showing milk fat 
C18:1 cis-9 concentration of 23 g/100 g FA or more. In this case, economic benefits are limited to 
€2 per cow. 
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Figure 4a. Simulated economic cost of selectively treating cases showing  R ≤ Ɵ, based on the milk fat C18:1 cis-9 
concentration (R) with costs estimated for elevated blood plasma NEFA varying from €15 to 35 and daily propylene 
glycol (PEG) dosages varying from 200 to 500 g/d applied over a period of 3 weeks. To ensure clarity of the figures, 
only extreme simulations were presented (i.e., A = €15, B = €35, C = 200 g, and D = 500 g. S1 represents a situation 
where all animals are treated while for S2 none of the animals are treated. 
 
 
 
 
 
Figure 4b. Simulated economic cost of selectively treating cases showing  R ≤ Ɵ, based on the milk fat C18:1 cis-9 
concentration (R) monitored in week 2 after parturition (early warning) with costs estimated for elevated blood plasma 
NEFA varying from €15 to 35  and daily PEG dosages varying from 200 to 500 g/d applied over a period of 3 weeks. 
To ensure clarity of the figures, only extreme simulations were presented (i.e., A = €15, B = €35, C = 200 g, and D = 
500 g). S1 represents a situation where all animals are treated while for S2 none of the animals are treated. 
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DISCUSSION 
Blood plasma NEFA threshold value  
 Serum NEFA concentrations typically increase around parturition (0.4 to 1.2 mmol/L; Leroy et 
al. (2005) and are a major characteristic of the NEB early postpartum. Moreover, elevated blood 
serum NEFA particularly tend to negatively affect reproductive performance and oocyte 
development (Leroy et al., 2005). Elevated blood serum NEFA concentrations were further linked 
to increased incidence of displaced abomasum (Cameron et al., 1998), clinical ketosis, metritis, or 
retained placenta, with critical postpartum blood serum NEFA concentrations varying from 0.57 
mmol/L (Ospina et al., 2010c) to 0.72 mmol/L (Ospina et al., 2010b) and 0.8 mmol/L (Roberts et 
al., 2012). A threshold of 0.6 mmol/L for blood plasma NEFA concentration was used in the 
current study.  
 
Milk FA as an indicator of elevated blood plasma NEFA 
During a period of NEB, NEFA in plasma are increased. The major NEFA released are C16:0, 
C18:0, and C18:1 cis-9 (Hostens et al., 2012), with a further possible conversion of C18:0 to C18:1 
cis-9 in the mammary gland through the action of ∆9-desaturase (Fievez et al., 2003). This explains 
the positive relation in the current study between milk fat C18:1 cis-9 concentrations and blood 
plasma NEFA concentrations. However, the positive correlation between blood NEFA 
concentrations and milk C18:1 cis-9 is only modest (R2 = 0.38), indicating that a direct prediction of 
blood NEFA concentrations from milk C18:1 cis-9 concentration is not accurate (Figure 2). 
Nevertheless, milk fat C18:1 cis-9 was identified to be useful for diagnosis and early warning of cows 
suffering from a severe NEB, i.e. to categorize cows into animals with elevated blood NEFA 
concentrations (> 0.6 mmol/L) or not. Moreover, the thresholds, established here, have only been 
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validated for the current diets and management and further validation under different conditions is 
required.  
 
Potential of milk fat C18:1 cis-9 concentrations as biomarkers for elevated blood plasma 
NEFA as compared with other cow-side tests 
 Currently, on-farm NEFA tests in blood are readily available (i.e., NEFA-C kit, Wako Chemicals 
USA, Inc., Richmond, VA). However, blood tests are laborious and invasive. Moreover, the available 
cow-side blood NEFA test shows additional drawbacks (e.g., requirement of a large number of 
samples to justify the equipment costs and expert training). Hence, this kit is not well adaptable for 
on farm use. This usually impedes testing capabilities to very large farms or veterinary clinics 
(Townsend and Eastridge, 2011). In our study, logistic curves indicated that 64.3% of the animals at 
risk of detrimental blood NEFA showed milk fat C18:1 cis-9 concentration of 24 g/100 g FA or 
higher with a specificity of 84.4%. Interestingly, the cross-validated discriminant analysis showed a 
specificity value of 79.1% and sensitivity of 75%, with an overall correct classification rate of 78.8%. 
 
Cost effectiveness of selective treatment based on biomarker monitoring 
 Cow-side tests will only be used routinely to allow selective treatment of cows at risk when the 
price of such tests does not exceed potential gain. Hence, cost functions were constructed based on 
economic losses for detrimental blood NEFA, between €15 and 35/cow (Geishauser et al., 2001). In 
this study it was assumed that elevated blood plasma NEFA could be pre-emptively treated with 
PEG (200 to 500 g/d during 3 weeks) of which costs were assumed to be €1.1/kg. Propylene glycol 
is a glucogenic precursor that has been used since the 1950s and is still used today for both 
treatment and prevention of ketosis before and after parturition. It effectively seems to increase milk 
production, prevent ketosis, improve reproduction, increase blood glucose, and decrease blood 
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NEFA (Nielsen and Ingvartsen, 2004; Lomander et al., 2012). The economic benefit strongly 
depends on the incidence rate. When a large proportion of animals encounter the metabolic 
problem, the most cost effective solution might be to treat all animals, whereas the opposite is true 
when the incidence rate is low. This is illustrated when considering all NEFA observations 
(diagnosis; n = 368; Figure 4a): only 8% of the observations in weeks 2, 3, 4, and 8, blood plasma 
NEFA were greater than 0.6 mmol/L. Hence, in this case, monitoring milk FA to diagnose and 
selectively treat animals with elevated blood plasma NEFA did not return any economic benefit 
(Figure 4a). Based on the current data set, weekly monitoring of milk fat C18:1 cis-9 to selectively 
treat animals is of no economic interest in general (maximum benefit of less than €0.5/case for the 
situation with the combination of the lowest amount of PEG and the highest cost of €35; Figure 
4a). No treatment is most often associated with the greatest economic return. However, in the case 
of early warning (n = 92), 24% of the animals were classified at risk to develop a detrimental blood 
plasma NEFA during the first 8 weeks in lactation (Figure 4b). In this case, selective treatment of 
cows with milk fat C18:1 cis-9 concentration above 24 g/100 g FA might be economically 
interesting. Based on the current cost effectiveness simulation, a maximum gain of about €2 per case 
was calculated for early warning of detrimental blood plasma NEFA. Obviously, costs for milk FA 
analysis have to be put in this perspective. Hence, milk fat C18:1 cis-9 seems promising as an early 
indicator of detrimental blood plasma NEFA, as it might be routinely analysed through Fourier 
transform infrared spectrometry (Soyeurt et al., 2006; Rutten et al., 2009). A single analysis at a 
specific moment early after parturition (in the current case, 2 weeks after calving) seems of interest 
in this respect as selective treatment of animals showing a milk fat C18:1 cis-9 concentration of 23 
g/100 g FA or more might suffice (Figure 4b). 
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CONCLUSIONS 
Milk fat C18:1 cis-9 shows potential as an early warning biomarker for compromised metabolic 
status in dairy cows during the first 2 months of lactation. Under the current feeding and 
management conditions, a milk fat C18:1 cis-9 concentration of 24 g/100 g FA or more, measured in 
the second week of lactation, could be used as an early warning for elevated blood plasma NEFA   
(≥ 0.6 mmol/L). 
 
  
 
 
 
 
 
 
CHAPTER 2B 
 
 
Milk fatty acids as potential biomarkers to diagnose  
hyperketonemia in early lactation 
 
 
 
 
 
 
 
 
 
 
 
 
 
Adapted from: 
 
Jorjong, S., A. T. M. Van Knegsel, J. Verwaeren, R. M. Bruckmaier, B. De Baets, B. Kemp, and V. 
Fievez. 2015. Milk fatty acids as possible biomarkers to diagnose hyperketonemia in early lactation. J. 
Dairy Sci. 98: 5211-5221. 
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ABSTRACT 
The aim of this study was to assess the potential of milk fatty acids as diagnostic tool for 
hyperketonemia of 93 dairy cows in a 3 × 2 factorial arrangement. Cows were fed a glucogenic or 
lipogenic diet and originally were intended to be subjected to a 0-, 30-, or 60-d dry period. 
Nevertheless, some of the cows, which were intended for inclusion in the 0-d dry period group, 
dried-off spontaneously. Milk was collected in weeks 2, 3, 4, and 8 of lactation for milk fat analysis. 
Blood was sampled from weeks 2 to 8 after parturition for β-hydroxybutyrate (BHBA) analysis. 
Cases were classified into 2 groups: hyperketonemia (BHBA≥ 1.2 mmol/L) and nonhyperketonemia 
(BHBA<1.2 mmol/L). Concentrations of 45 milk fatty acids and ratios of anteiso C15:0-to-anteiso 
C17:0 and C18:1 cis-9-to-C15:0 were subjected to receiver operating characteristics (ROC) curve 
analysis to determine the most promising diagnostic fatty acids or fatty acids ratio based on the 
maximum area under the curve (AUC). The milk fat C18:1 cis-9-to-C15:0 ratio revealed the most 
promising factor for diagnosis of hyperketonemia. Ninety percent of nonhyperketonemia cases 
showed a milk fat C18:1 cis-9-to-C15:0 ratio of 40 or lower, whereas 70% of cows suffering from 
hyperketonemia showed milk fat C18:1 cis-9-to-C15:0 ratio exceeding 40. Additionally, cows with a 
milk fat ratio C18:1 cis-9-to-C15:0 of at least 45 in week 2 after parturition had about 50% chance to 
encounter blood plasma BHBA values of 1.2 mmol/L or more during the first 8 weeks of lactation. 
Of the cows not suffering from hyperketonemia during the first 2 months of lactation, only 9% 
exceeded this week 2 threshold. Practical implementation requires routine analysis of both milk fatty 
acids, which currently is lacking for C15:0. The inclusion of other variables, such as test-day 
information and a more frequent sampling protocol should be considered to further improve 
diagnostic performance of this biomarker.  
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INTRODUCTION 
Negative energy balance is a common phenomenon in the transition period in dairy cows. 
During this period, increase in feed intake is lagging behind increasing energy demand for milk 
production, which results in an often-serious energy imbalance. Mainly the supply of glucogenic 
precursors, in particular the ruminal production of propionic acid, is often insufficient (Heuer et 
al., 2000). As a result, blood glucose and insulin concentrations are low and body fat is mobilised 
and transported as NEFA to several organs, particularly to the liver in which these FA are 
oxidised to produce energy. Due to the limited availability of propionate, however, complete 
oxidation of NEFA is impaired, resulting in the production of ketone bodies (BHBA, 
acetoacetate, and acetone), which might be referred to as hyperketonemia (Herdt, 2000). 
Hyperketonemia or subclinical ketosis is defined when the concentration of blood BHBA is 
above the threshold of 1.2 to 1.4 mmol/L, and is considered a critical metabolic disorder in dairy 
cows (Duffield et al., 2009), whereas, blood BHBA concentrations  ≥3.0 mmol/L has been 
considered the cut-off for cows having clinical ketosis (Oetzel, 2004; McArt et al., 2011). 
Hyperketonemia is detrimental to the cow’s health and production (e.g., BHBA concentrations 
exceeding thresholds of 1.1 or 1.6 mmol/L during the first 2 weeks postpartum were associated 
with a diminished probability of pregnancy (Walsh et al., 2007; Roberts et al., 2012). Moreover, 
milk losses of 1.5 to 2.4 kg/d were linked with BHBA in weeks 2 and 1 after calving, exceeding 
thresholds of 1.2 mmol/L and 1.4 mmol/L, respectively (Chapinal et al., 2012). Similarly, 
Duffield et al. (2009) indicated that blood BHBA above 1.4 mmol/L in the first 2 weeks 
postpartum increased disease risk and resulted in substantial milk yield losses in early lactation 
(−1.88 kg/d). Moreover, in the study of McArt et al. (2012b) in the first 30 DIM, cows with 
subclinical ketosis were 19.3 times more likely to develop displaced abomasum, and 3 times more 
likely to die or be culled than nonketotic cows.  
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Excessive amounts of NEFA, released during body fat mobilisation are transferred to the 
milk. Because these NEFA are particularly rich in long-chain FA such as C18:1 cis-9 and C18:0 
(Hostens et al., 2012), elevated concentrations in milk fat of those FA were identified as valuable 
early warning biomarkers for SCK (Van Haelst et al., 2008). Accordingly, this early warning 
potential of milk FA is considered a major benefit of the prediction of hyperketonaemia from 
the content of FA in milk as compared to measuring milk ketones. However, the findings of Van 
Haelst et al. (2008) were based on a limited data set. Moreover, excessive mobilisation of body 
reserves will not result in the development of SCK when sufficient glucogenic precursors are 
available in the liver (Rukkwamsuk et al., 1999b). Hence, besides a biomarker in milk for body 
fat mobilisation, a biomarker for energy status might be required to accurately assess the cow’s 
risk for hyperketonemia. Milk FA that could provide additional information on the cow’s glucose 
status are odd-chain FA that are positively related to propionate (e.g., C15:0 and C17:0) as they 
are de novo synthesised either by bacteria in the rumen or in the udder with propionate as the 
main precursor (Fievez et al., 2012). Furthermore, the potential of milk FA to provide an early 
warning signal for hyperketonemia was assessed by exploring the possibility of milk FA in week 
2 of lactation to predict hyperketonemia during the first 8 weeks of lactation.  
The objective was approached in 3 steps: (1) measurement of FA profiles (i.e., 45 milk FA 
and 2 milk fat ratios) in milk and BHBA in blood plasma, (2) receiver operating characteristic 
(ROC) analysis to determine the milk FA with the greatest biomarker potential based on the 
maximum area under the curve (AUC), and (3) assessment of the potential value of these milk 
FA as diagnostic biomarkers as well as a predictor of future cases of hyperketonemia. 
Justification for the choice of milk FA ratios considered in the current study is given in the 
discussion section. 
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MATERIAL AND METHODS 
Experimental setup, animals, and housing 
 Samples and data for the current study were obtained from an experiment where dairy cows 
were attributed to different dry period lengths and diets and monitored for 2 successive 
lactations. The current study involved samples and data from the second lactation. The 
experimental design for the second lactation was similar to the first lactation (Jorjong et al., 2014; 
Van Knegsel et al., 2014) with some exceptions as specified below. 
The Institutional Animal Care and Use Committee of Wageningen University and Research 
Centre approved the experimental protocol. The experimental setup and diet composition were 
presented earlier (Van Knegsel et al., 2014). In short, Holstein-Friesian dairy cows (n = 108) 
were selected from the Dairy Campus Research dairy herd (WUR Livestock Research, Lelystad, 
the Netherlands) for 3 × 2 experiment on the effect of dry period length (0, 30, and 60 d) and 
transition diet (glucogenic or lipogenic) on energy balance and metabolic health (assessed by 
plasma BHBA). Cows were blocked for parity (primiparous or multiparous). Moreover, cows 
were allocated to the 6 treatment groups to equally stratify all groups for following parameters: 
expected calving date, milk production in the previous lactation and BCS.  
Cows were housed in a freestall barn with slatted floor and cubicles. During lactation, cows 
were milked twice daily (0500 and 1630 h). The drying-off protocol for cows with the 30- and 
60-d dry period consisted of a transition to the far-off ration at d 7 before drying-off, and 
milking once daily from d 4 before drying-off. At drying-off, cows were treated with an 
intramammary antibiotic (Supermastidol, Virbac Animal Health, Barneveld, the Netherlands). 
Milk yield was recorded daily. Dry cows received a dry cow ration, which was composed of grass 
silage, corn silage, soybean meal, rapeseed meal, and rapeseed straw or wheat straw in a ratio of 
39:25:4:8:25 (DM basis). Prepartum lactating cows received a lactating cow ration supporting 25 
kg of milk. From d 10 before the expected calving and onward, cows of all treatments were fed 1 
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kg/d glucogenic or lipogenic concentrate, which was increased stepwise postcalving with 0.5 
kg/d until the concentrate supply reached 8.5 kg/d. The glucogenic concentrate specifically 
contained more corn, which was largely replaced by sugar beet pulp, palm kernel, and rumen-
protected palm oil in the lipogenic concentrate. Forage was supplied ad libitum and was 
composed of grass silage, corn silage, straw (wheat straw or rapeseed straw), and a protein source 
(rapeseed meal or soybean meal) in a ratio of 50:34:4:11 (DM basis). Diets were formulated to be 
isocaloric (net energy basis; VEM system; Van Es (1975)) and equal in intestinal digestible 
protein and degraded protein balance (Tamminga et al., 1994). Details of the chemical 
composition of the diets were presented by Jorjong et al. (2014) (Chapter 2A) and Van Knegsel 
et al. (2014). Treatments were planned to be imposed on cows for 2 successive lactations. During 
or after the first lactation, some cows left the experiment for different reasons (mainly failure to 
become pregnant). Furthermore, at least 30 d before the second lactation, milk production of 
part of the cows (n = 15) within the 0-d dry period group in the first lactation was below 4 kg/d. 
We decided to give these cows a dry period as, essentially, they spontaneously dried off. The 
drying-off protocol for these cows consisted of a transition to the far-off ration, but they were 
not treated with an intramammary antibiotic. Hence, the dry period treatment in the second 
lactation in practice consisted of 4 classes (0, 0→30 group, 30, or 60 d). From the 108 cows, 15 
cows were excluded because data were incomplete (missing milk FA of weeks 2, 3, 4, and 8; 
blood plasma BHBA from weeks 2 to 8 of lactation; or both). Hence, only 93 cows were used in 
the data analysis. The health status of the cows was checked regularly by the animal care 
personnel, and animals were treated for diseases if required. Details on the incidence of clinical 
ketosis and other diseases (i.e., endometritis and retained placenta/uterine infections are included 
in the Results section). 
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Blood sampling 
Blood samples were taken weekly from week 3 precalving until week 8 postcalving. Blood was 
sampled from the coccygeal vessel into evacuated tubes (Vacuette, Greiner BioOne, 
Kremsmunster, Austria) containing EDTA. Blood plasma was obtained by centrifugation for 10 
min at 2,900 × g at 4°C. Blood plasma samples were kept at -20°C until analysis for plasma 
metabolites. 
  
Milk sampling and analysis 
Milk sampling for FA analysis took place every Friday morning in weeks 2, 3, 4, and 8 
postcalving. Milk samples were collected in 10-mL tubes and were stored at -20°C. Frozen milk 
samples were sent to the Laboratory for Animal Nutrition and Animal Product Quality (Faculty 
of Bioscience Engineering, Ghent University, Belgium). Milk analysis was described in Chapter 
2A. 
 
Blood plasma metabolites assay 
Concentration of plasma BHBA was measured enzymatically with a selective analyzer (Cobas 
Mira 2, Hoffmann-La Roche, Basel, Switzerland) by the Veterinary Physiology group (Veterinary 
Physiology, Vetsuisse Faculty, University of Bern, Bern, Switzerland) using commercial kit no. 
RB1007 from Randox Laboratories (Ibach, Switzerland), as described by Graber et al. (2012) 
The kinetic enzymatic method to measure the concentration of BHBA in plasma is based on the 
oxidation of BHBA to acetoacetate by the enzyme BHBA dehydrogenase. Concomitant with this 
oxidation, the cofactor NAD+ is reduced to NADH and the associated change of absorbance is 
directly correlated with the BHBA concentration. 
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Statistical analysis, calculations, and generation of functions  
Descriptive statistics 
The milk FA characteristic that was identified as the most promising biomarker to classify 
hyperketonemia cases (i.e., C18:1 cis-9-to-C15:0 ratio, see further) as well as blood plasma BHBA 
were subjected to a repeated measures ANOVA (ANOVA mixed model of SAS Enterprise 
Guide 5). Data were normalised before this analysis (natural logarithm transformation; SPSS 
22.0, SPSS Inc., Chicago, IL). Lactation week was considered as the repeated effect (weeks 2 to 8 
for blood plasma BHBA and weeks 2, 3, 4, and 8 for milk fat C18:1 cis-9-to-C15:0 ratio). Cow 
was defined as random effect. Dry period treatment (0, 0→30, 30, or 60 d), diet (glucogenic or 
lipogenic), and their interaction terms were included in the model as fixed effects. In attempting 
to choose the best covariance structure, the Akaike information criterion was used to select the 
best model structure. A first-order autoregressive structure [AR(1)] was the best fit and was used 
to account for within-dry period × diet variation of BHBA, whereas a first-order heterogenous 
structure was used to account for within-dry period × diet variation of milk fat C18:1 cis-9-to-
C15:0 ratio. Furthermore, the relation between milk fat C18:1 cis-9-to-C15:0 ratio and blood 
plasma BHBA was assessed through linear regression (SPSS 22.0). 
 
BHBA threshold definition 
Classification of the observation was based on blood plasma BHBA thresholds, where 
postpartum BHBA values greater than or equal to 1.2 mmol/L were classified as 1, which stands 
for hyperketonemia (LeBlanc et al., 2005; Van der Drift et al., 2012; McArt et al., 2013a); cases 
with blood plasma BHBA values lower than 1.2 mmol/L were classified as 0, indicating 
nonhyperketonemia. 
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ROC analysis for the most critical milk FA 
The aim of ROC analysis is to find the most promising milk FA for diagnosis 
hyperketonemia. The 45 milk FA, as well as the milk FA ratios anteiso C15:0-to-anteiso C17:0 and 
C18:1 cis-9-to-C15:0, were subjected to a receiver operating characteristic (ROC) analysis 
performed by SPSS 22.0. ROC curves present sensitivity versus 100 – specificity. Here, 
sensitivity is defined as the proportion of cows correctly diagnosed to experience 
hyperketonemia based on the milk FA test relative to all cows that effectively had 
hyperketonemia (i.e. blood plasma BHBA concentrations ≥ 1.2 mmol/L). Specificity is the 
proportion of cows correctly diagnosed not to suffer from hyperketonemia based on the milk 
FA test relative to all cows that had hyperketonemia (i.e. blood plasma BHBA concentrations < 
1.2 mmol/L. This analysis was run as described in Chapter 2A, with identification of the most 
promising milk FA based on the maximum AUC (Swets, 1988; Ospina et al., 2010c). 
 
Logistic regression 
The logistic regression analysis was performed for all 4 weeks separately (weeks 2, 3, 4, and 8). 
Additionally, inclusion of the 2 milk fat ratios (anteiso C15:0-to-anteiso C17:0 and C18:1 cis-9-to-
C15:0) was based on expert knowledge as explained in the Discussion section. After the first 
exploratory ROC curve analysis, a further step, logistic regression analysis was run in which 
classification was based on a single milk FA characteristic (i.e., the most promising milk fat). The 
logistic regression analysis was based on data of weeks 2, 3, and 4 as the incidence of 
hyperketonemia in week 8 was limited (see Results section) and no milk FA data were available 
for weeks 1, 5, 6 and 7. The performance of both classification models (based either on all milk 
FA and ratios or on a single FA characteristic) were assessed through cross-validated logistic 
regression (10-fold cross-validation procedure in SPSS 22.0).  
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Empirical cumulative probability distributions for diagnosis of hyperketonemia  
 Empirical cumulative probability distributions were generated, expressing the cumulative  
probability of the milk fat C18:1 cis-9-to-C15:0 ratio. In particular, the cumulative probability 
distribution of the milk fat C18:1 cis-9-to-C15:0 ratio in case of hyperketonemia and 
nonhyperketonemia, respectively, was considered and denoted h1 and h2, respectively. Denoting 
the milk fat C18:1 cis-9-to-C15:0 ratio as R (the random variable under study), the corresponding 
curves were constructed through a stepwise increase of the milk fat C18:1 cis-9-to-C15:0 ratio 
from the minimum to the maximum value observed in the study: 
 
h1(r) = 
Number of hyperketonemia cases for which R≤r
Total number of hyperketonemia cases in the study 
 
h2(r) = 
Number of nonhyperketonemia cases for which R≤r 
Total number of nonhyperketonemia cases in the study 
 
 
Empirical cumulative probability distributions for prediction of hyperketonemia during 
the first 8 weeks in lactation 
In this study, prediction of hyperketonemia during the first 8 weeks in lactation was assessed. 
For this purpose, the milk fat C18:1 cis-9-to-C15:0 ratio was determined in week 2 after 
parturition, whereas cows were classified based on blood plasma BHBA in weeks 2 to 8. For this 
classification, cows were considered suffering from hyperketonemia in early lactation when the 
maximum blood plasma BHBA concentrations at any time in this 7-week period was greater 
than 1.2 mmol/L. Empirical probability distributions were generated as described before, but 
now including milk FA data of week 2 only and using the 0 or 1 classification based on the 
maximum blood plasma BHBA concentration observed from weeks 2 to 8 in lactation. The 
cumulative probability distribution of the milk fat C18:1 cis-9-to-C15:0 ratio in week 2 of 
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lactation in case of hyperketonemia and nonhyperketonemia in the first 8 weeks in lactation, 
denoted e1 and e2, respectively. Denoting the milk fat C18:1 cis-9-to-C15:0 ratio in week 2 as R2 
(the random variable under study), the corresponding curves were constructed through a 
stepwise increase of the milk fat C18:1 cis-9-to-C15:0 ratio from the minimum to the maximum 
value observed in the study: 
e1(r) = 
Number of hyperketonemia cows in first 8 weeks in lactation for which R2 ≤r 
Total number of hypertketonemia cows in first 8 weeks in lactation
       
e2(r) = 
Number of nonhyperketonemia cows in first 8 weeks in lactation for which R2 ≤r  
Total number of nonhyperketonemia cows in first 8 weeks in lactation
 
 
Logistic curve fitting 
Further, a logistic curve was fitted to the empirical cumulative probability distributions 
performed by nonlinear regression (SPSS 22.0). This curve is described based on the slope (β0), 
the inflection point of the curve (β1) and the upper limit (β2), which here equals 1:  
y  = 
β
2
1 + exp [–β0  × (𝑥 – β1 )] 
 
 
RESULTS 
 
Milk production, energy balance, and body condition score  
Results of milk production, energy balance and body condition score were previously 
reported  (Chen et al., 2016). In short, average milk yields (kg/d) from weeks 1 to 9 of lactation 
were highest in cows with a 60-day dry period (42.8 kg/d) (P < 0.010), whereas cows with a 
0→30-day, 30-day and 0-day dry period yielded 40.6, 38.5 and 37.8 kg/d, respectively. Body 
 64 
 
condition scores before calving were highest in cows in the 0→30 group (4.2) (P < 0.010), 
whereas BCS of cows with a 0-day, 30-day and 60-day dry period were 3.8, 3.5 and 3.2, 
respectively. After calving BCS showed the same trend as before calving, cows with a 0→30 had 
the highest BCS (3.4) (P < 0.010), whereas the BCS of the 0-day, 30-day and 60-day dry period 
groups were 3.0, 2.7, and 2.3, respectively. Although, the loss in BCS was comparable for all 
groups (loss of 0.8 to 0.9 unit), cows with 0→30-day dry period had the lowest calculated 
negative energy balance (-338 kJ/kg0.75 per day) (P < 0.010), whereas the energy balance was 
highest for the cows with a 0-day dry period (-206 kJ/kg0.75 per day), whereas the calculated 
energy balances of cows with a 30-day and 60-day dry period were -234 and -270 kJ/kg0.75 per 
day, respectively. 
 
Classification based on blood plasma BHBA thresholds and influence of experimental 
factors (dietary and dry period management) 
 Of all 372 observations in weeks 2, 3, 4, and 8 after parturition, 19.6% were classified as 
suffering from hyperketonemia. When considering animal as an observational unit as in the case 
of hyperketonemia prediction during the first 8 weeks in lactation (n = 93), 41% (n = 38) of the 
animals were classified as suffering from hyperketonemia at any time during the first 8 weeks in 
lactation. Two−thirds of the hyperketonemia cows (n = 25) exceeded the BHBA threshold in 
multiple weeks (Figure 1a). Nevertheless, cows with a single observation exceeding the BHBA 
threshold were not treated differently from cows having multiple observations because of too 
limited group sizes (Figure 1a). Additionally, 13 cows (with all of them belonging to the 
hyperketonemia group) were found to suffer from 1 of the 3 following diseases: clinical ketosis, 
endometritis, or retained placenta/uterine infections. Three cows (8%) were diagnosed to suffer 
from clinical ketosis, 2 (5%) had endometritis and 8 (21%) suffered from retained 
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placenta/uterine infections. Details on the distribution of these cows within the treatment 
groups are given in Table 2 
The risk for hyperketonemia decreased when progressing in lactation (26.9 to 6.5% from 
weeks 2 to 8 of lactation), as blood plasma BHBA concentrations decreased with time (P = 
0.001) (Figure 1b). Blood plasma BHBA was affected by dry period management (P = 0.041) 
(Figure 1b). Particularly, the subgroup that spontaneously dried off (group 0→30) showed 
increased levels of blood plasma BHBA. In addition, blood plasma BHBA was not affected by 
any of the interaction effects, but was affected by diet, with the glucogenic diet suppressing 
concentrations of this plasma metabolite (average BHBA over 8 weeks: 0.86 vs. 1.12 mmol/L; P 
= 0.005 for the glucogenic and lipogenic diet, respectively).  
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Figure 1 (a-c). Number of cows with blood plasma BHBA concentrations 
not exceeding the threshold value of 1.2 mmol/L or exceeding the threshold 
once up to 7 times between 2 and 8 weeks in lactation and based on a weekly 
sampling frequency (a). Blood plasma BHBA concentration with 
hyperketonemia incidence rates (in parentheses), as determined based on a 
weekly sampling frequency (b) and milk fat C18:1 cis-9-to-C15:0 ratio of dairy 
cows fed a glucogenic or lipogenic diet (diet) with dry period length of 0 
(black bar), 0→30 (light grey bar), 30 (white bar) or 60 d (dark grey bar) 
during weeks 2, 3, 4, and 8 of lactation (c). Values represent means per week; 
error bars present standard deviations; and P-values show main and 
interaction effects. 
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Table 1. The average of milk fat and milk fat ratios for hyperketonemia and non-hyperketonemia cases, based on blood plasma BHBA (≥1.2 and 
<1.2 mmol/L, respectively; SD in parentheses). 
 
Status n Milk fat C18:1 cis-9 
(g/100 g FA) 
Milk fat ratio 
C18:1 cis-9-to-C15:0 
Milk fat ratio 
Anteiso C15:0-to-anteiso C17:0 
Non-hyperketonemia 299 20.6 (4.06) 25.6 (10.89) 0.88 (0.172) 
Hyperketonemia 73 26.3 (4.16) 50.0 (16.46) 0.64 (0.143) 
P-value  < 0.001 < 0.001 < 0.001 
 
Table 2 Overview of the distribution (no. of cows) within treatments of cows diagnosed to suffer from clinical ketosis, endometritis, and retained 
placenta/uterine infections.  
 Lipogenic diet Glucogenic diet 
Dry period length/disease 0 0→30 30 60   0      0→30      30  60 
Clinical ketosis (n=3) - - 1 - - 1 - 1 
Endometritis (n=2) - 1 - - - - - 1 
Retained placenta/uterine infections (n=8) 1 - 4 1 - 1 1 - 
 
 
  
 
Table 3. Fatty acid proportions (g/100 g FA) in milk fat of dairy cows in early lactation1 after 0, 0→30, 30, or 60 d dry period and fed either a glucogenic (G) or a 
lipogenic (L) diet (LSM ± SEM). 
Item Dry period length  Ration  P-value 2 
0 0→30 30 60 SEM G L SEM Dry 
period 
Ration D x R 
Cows (no.) 11 15 29 38  48 45     
C4:0 3.77a 4.07b 3.91ab 3.92ab 0.03 3.82a 4.03b 0.03 0.04 <0.01 0.09 
C6:0 2.43 2.31 2.41 2.37 0.02 2.43a 2.33b 0.02 0.33 0.04 0.63 
C8:0 1.39 1.27 1.37 1.33 0.02 1.41a 1.26b 0.02 0.12 <0.01 0.84 
C10:0 2.97a 2.47b 2.88 a 2.76ab 0.06 3.01 2.52 0.06 0.01 <0.01 0.69 
C12:0 3.91a 3.00b 3.58 a 3.57a 0.07 3.44 3.61b 0.07 <0.01 0.94 0.45 
Total short chain FA 3 14.96a 13.48b 14.58ab 14.38ab 0.17 14.59 14.13 0.17 0.05 0.06 0.80 
C14:0 11.04a 9.0b 10.39a 10.41a 0.14 10.51a 9.98b 0.14 <0.01 <0.01 0.94 
C14:1 0.90 0.81 0.82 0.81 0.01 0.84 0.79 0.01 0.04 <0.01 0.02 
C15:0 0.94 0.67 0.83 0.86 0.02 0.89a 0.76b 0.02 <0.01 <0.01 0.05 
C16:0 32.68 28.17 29.66 30.60 0.24 29.37a 31.01b 0.24 <0.01 0.04 0.61 
C16:1cis-9  1.87a 2.25 b 1.90a 1.87 a 0.04 1.92 1.96 0.04 <0.01 0.28 0.63 
Total medium chain FA 4 48.02a 42.02c 44.23b 45.14b 0.32 44.27 45.14 0.32 <0.01 0.90 0.41 
C17: 0 0.11 0.10 0.12 0.11 0.00 0.12 0.11 0.00 0.50 0.76 0.90 
C17:1cis-9  0.09 0.11 0.10 0.10 0.00 0.10 0.10 0.00 0.41 0.54 0.72 
C18:0 9.16a 9.83b 10.01b 9.71ab 0.09 9.96a 9.54b 0.09 0.04 0.27 0.02 
C18:1cis-9  18.82a 24.60c 21.68b 21.39b 0.37 21.48 21.92 0.37 <0.01 0.09 0.71 
C18:2 n-6 1.26a 1.45b 1.33a 1.29a 0.02 1.44a 1.21b 0.02 0.05 <0.01 0.35 
C18:3 n-3 0.33 0.36 0.35 0.35 0.01 0.36 0.34 0.01 0.39 0.29 0.31 
Total long chain FA 5 32.44a 39.86c 36.58b 35.78b 0.46 36.47 36.10 0.46 <0.01 0.38 0.53 
  Milk fatty acid ratios            
anteisoC15:0-to-anteisoC17:0 0.95a 0.73b 0.83c 0.84c 0.00 0.85a 0.81b 0.00 <0.01 <0.01 0.38 
C18:1 cis-9-to-C15:0 23.1a 41.5b 30.4c 28.1c 0.81 28.8a 32.0a 0.81 <0.01 <0.01 0.25 
a,b Values within dry period length within a row with different superscript letters differ (P < 0.05), 1 Week 2, 3, 4, and 8 relative to calving, 2 D = dry period; R = ration, 3 Total short 
chain FA include FA: C7:0, C9:0, C10:1, C11:0, and C12:1, 4 Total medium chain FA include FA: C16:1 trans-9, C16:1 cis-11, C16:1 cis-13, and C16:1 trans-6, trans-7, trans-8, 5 Total 
long chain FA include FA: C18:1 trans-6, C18:1 trans-7, C18:1 trans-8, C18:1 trans-9, C18:1 trans-10, C18:1 trans-11, C18:1 cis-12, C18:1 cis-13, C18:1 cis-14, C18:1 cis-15, C18:2 cis-9, 
trans-11, C20:1, C20:3, C20:4, C20:5, and C22 
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Identification of milk FA predominantly linked with blood plasma BHBA: ROC curve 
analysis, logistic regression and correlations 
Given the highest incidence of hyperketonemia during the first month of lactation, milk FA 
data from weeks 2, 3, and 4 were used to identify the most powerful variable for diagnosis of 
hyperketonemia. The 45 milk FA, and the ratios of anteiso C15:0-to-anteiso C17:0 and C18:1 cis-9-
to-C15:0 were used in a ROC curve analysis to determine the most promising biomarker. The 
milk fat C18:1 cis-9-to-C15:0 ratio had the highest AUC (0.903) and was used further for 
diagnosis of hyperketonemia by logistic regression analysis. An overall classification accuracy of 
87.3% was obtained based on a 10-fold cross-validation. For this grouping was based on all milk 
FA variables and included observations of all weeks (weeks 2, 3, 4, and 8). More specifically, 93.9 
and 55.9% of the cases of the nonhyperketonemia group 0 (specificity) and hyperketonemia 
group 1 (sensitivity) were correctly classified, respectively. Ten-fold cross-validation based on the 
maximum AUC from ROC analysis (i.e., the milk FA C18:1 cis-9-to-C15:0 ratio) showed the 
following performance: overall classification accuracy of 82.3%, specificity of 95.0%, and 
sensitivity of 38.4%. Hence, overall classification accuracy based on C18:1 cis-9-to-C15:0 only 
was somewhat lower as compared with classification based on the full variable set. A similar 
logistic regression was performed using milk C18:1 cis-9-to-C15:0 ratio of week 2 to predict 
occurrence of hyperketonemia during any of the first 8 weeks in lactation. Ten-fold cross-
validation showed an overall classification accuracy of 75.2%, specificity of 78.5%, and sensitivity 
of 75.3%.  
 In accordance with blood plasma BHBA concentration, the milk fat C18:1 cis-9-to-C15:0 ratio 
decreased with week in lactation (P < 0.001). This ratio was affected by dry period (P < 0.001) 
and diet (P = 0.002). None of the interactions were significant (Figure 1c). Detailed information 
on the milk FA composition, in relation to the dry period length and glucogenic vs. lipogenic 
ration is given in Table 3. The relation between milk fat C18:1 cis-9-to-C15:0 ratio and blood 
plasma BHBA is further confirmed by the positive relation between both metabolites (Figure 2). 
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Nevertheless, the R2 value is relatively modest (0.47) (P < 0.001), indicating a limited potential 
for direct prediction of the blood plasma BHBA concentration from the milk fat C18:1 cis-9-to-
C15:0 ratio.  
 
 
 
Figure 2. Correlation between blood plasma BHBA and milk fat ratio C18:1 cis-9-to-C15:0 of weeks 2, 3, 
4, and 8 of lactation (n = 372; R2 = 0.47, P<0.001). 
 
Empirical cumulative probability distributions for diagnosis of hyperketonemia 
The cumulative proportion of hyperketonemia cases to the total number of hyperketonemia 
cases, observed in weeks 2, 3, 4, and 8 was plotted against the milk fat C18:1 cis-9-to-C15:0 ratio 
(ranging from 4.8 to 87.2) to which a logistic curve was fitted. This logistic curve is characterized 
by a parameter β1, which equaled 49.1, indicating that one-half of the hyperketonemia 
observations were associated with a milk fat C18:1 cis-9-to-C15:0 ratio of at least 49 (Figure 3). 
Similarly, a logistic curve was fitted for non-hyperketonemia observations, which allowed to 
assess the false positive rate for each milk fat C18:1 cis-9-to-C15:0 ratio. A milk fat C18:1 cis-9-to-
C15:0 ratio above 40 was observed for 10% of the non-hyperketonemia cases (false positive 
rate). Interestingly, only 30% of the hyperketonemia cases were associated with milk fat C18:1 
cis-9-to-C15:0 ratio below 40 (Figure 3). Similar curves were constructed for weeks 2, 3, and 4 
separately (week 8 was excluded due to the low hyperketonemia incidence rate). The logistic 
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curve of the hyperketonemia cases is characterized by a parameter β1, which decreased from 
week 2 to week 4 in lactation (54.4, 53.0, and 43.4, for weeks 2, 3, and 4, respectively, Figure 4a). 
This indicates that the threshold of the milk fat C18:1 cis-9-to-C15:0 ratio, which half of the 
hyperketonemia observations exceeded, decreased with time after parturition. Similarly, a logistic 
curve was fitted for non-hyperketonemia observations, which indicated 10% of the non-
hyperketonemia cases exceeded milk fat C18:1 cis-9-to-C15:0 ratios of 45, 38, and 35 in weeks 2, 
3, and 4, respectively (Figure 4b). 
 
 
 
Figure 3. A logistic curve, h1, representing the cumulative probability distribution of hyperketonemia 
cases (BHBA ≥ 1.2 mmol/L) showing a milk fat C18:1 cis-9-to-C15:0 ratio (R) ≤ r (black diamonds) to 
the combined number of hyperketonemia cases from weeks 2, 3,  4, and 8 of lactation. The logistic curve 
is characterized by its slope (β0 = 0.10) and inflection point (β1 = 49.1). Similarly, non-hyperketonemia 
cases proportional to the total number of non-hyperketonemia cases (h2) were presented in relation to (R) 
≤ r (grey triangles), with β0 and β1 of 0.17 and 24.6, respectively, was presented as 1-FP (false positive 
rate). 
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Figure 4a. A logistic curve, h1, representing the cumulative probability distribution of hyperketonemia 
cases (BHBA ≥ 1.2 mmol/L) showing a milk fat C18:1 cis-9-to-C15:0 ratio (R) ≤ r to the total number of 
hyperketonemia cases of weeks 2, 3, and 4 of lactation. The logistic curve is characterized by its slope (β0 
= 0.10, 0.10, and 0.11 for weeks 2, 3, and 4, respectively) and inflection point (β1 = 54.4, 53.0 and 43.4 for 
weeks 2, 3, and 4, respectively).  
 
 
 
 
 
 
 
Figure 4b. A logistic curve, h2, representing the cumulative probability distribution of non-
hyperketonemia cases (BHBA < 1.2 mmol/L) showing a milk fat C18:1 cis-9-to-C15:0 ratio (R) ≤ r to the 
total number of non-hyperketonemia cases of weeks 2, 3, and 4 of lactation. The logistic curve is 
characterized by its slope (β0 = 0.16, 0.20, and 0.21 for weeks 2, 3, and 4, respectively) and inflection 
point (β1 = 31.3, 26.9, and 24.5 for weeks 2, 3, and 4, respectively). Specificity of 90%, which corresponds 
with a false positive (FP) rate of 10%, was presented as 1-FP. 
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Empirical cumulative probability distributions for prediction of hyperketonemia during 
the first 8 weeks in lactation 
One-half of the cows showing hyperketonemia during the first 8 weeks in lactation (n = 19) 
showed a milk fat C18:1 cis-9-to-C15:0 ratio of 45 or more in week 2 with a false positive rate of 
9.0%. Only 15% of the hyperketonemia cows had a milk fat C18:1 cis-9-to-C15:0 ratio of 30 or 
lower, whereas one-half of the non-hyperketonemia cows had these low ratios in milk fat (β1 
value of logistic curve for non-hyperketonemia cases; Figure 5).  
 
 
 
Figure 5. A logistic curve, e1, representing the cumulative probability distribution of cows suffering from 
hyperketonemia (BHBA ≥ 1.2 mmol/L at any time in week 2 to 8 in lactation) showing a milk fat C18:1 
cis-9-to-C15:0 ratio in week 2 of lactation (R2) ≤ r (black diamonds) relative to the total number of cows 
suffering from hyperketonemia. The logistic curve is characterized by its slope (β0 = 0.09) and inflection 
point (β1 = 48.1). Similarly, cows not suffering from hyperketonemia (grey triangles) during the first 8 
weeks in lactation proportional to the total number of non-hyperketonemia cows (e2) were presented in 
relation to R2 ≤ r, with β0 and β1 of 0.18 and 30.6, respectively. Specificity of 90%, which corresponds 
with a false positive (FP) rate of 10% was presented as 1-FP. 
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DISCUSSION 
Blood plasma BHBA threshold values  
 Duffield (2000) reported hyperketonemia prevalence of 8.9 to 34% for dairy cows in the first 
8 weeks of lactation. This is in agreement with the hyperketonemia incidence rate (BHBA ≥ 1.2 
mmol/L) observed in the current study, which decreased as expected when progressing from 
weeks 2 to 8 in lactation (26.9 to 6.5%; Figure 1b). However, these incidence rates should be 
considered with caution given the weekly sampling protocol, which might have resulted in 
misclassification of some cows and, hence, underestimation of the incidence. A more 
appropriate sampling protocol for hyperketonemia should rely on a higher sampling frequency 
(e.g., 3 samplings/week; McArt et al. (2013a)). Hyperketonemia is simply a condition referring to 
circulation of increased levels of ketone bodies, mainly BHBA. Consequently, blood BHBA has 
been used as an indicator for hyperketonemia with 1.2 mmol/L being used as threshold 
concentration (McArt et al., 2013a). This BHBA threshold value is justified given negative effects 
on the cow’s health and as a consequence negative effects on the dairy farms economics when 
blood plasma BHBA exceeds this concentration. Blood BHBA ≥ 1.2 mmol/L from 2 to 15 
DIM were associated with odds ratios of 1.5, 9.5, and 5.0 for metritis, clinical ketosis and 
displaced abomasum, respectively (Suthar et al., 2013). Roberts et al. (2012) reported an 
increased risk of culling within the first 60 DIM associated with a blood BHBA threshold ≥ 1.2 
in week 1 (odds ratio = 1.8), and ≥ 1.6 mmol/L in week 2 postpartum (odds ratio = 3.2). 
Moreover, Walsh et al. (2011) showed cows with serum BHBA in the first and second week of 
lactation above 1.0 mmol/L and 1.4 mmol/L, respectively, showed a 20% lower success rate to 
conceive at first insemination. In addition, the odds of left-displaced abomasum were 8 times 
greater in cows with serum BHBA ≥ 1.2 mmol/L (LeBlanc et al., 2005). Ospina et al. (2010b) 
reported lower BHBA thresholds (BHBA ≥ 10 mg/dL which is equivalent to 0.96 mmol/L) to 
be associated with a 13% decrease in pregnancy rate.  
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Milk FA or their ratios as biomarkers of hyperketonemia: Physiological background 
A former preliminary study indicated elevated milk fat C18:1 cis-9 concentrations for 
hyperketonemia cases (Van Haelst et al., 2008). This is in accordance with the positive relation 
between milk fat C18:1 cis-9 and blood plasma NEFA concentration (Jorjong et al., 2014). 
Indeed, increased concentrations of NEFA in blood plasma result in major changes in FA supply 
to the mammary gland with C16:0, C18:0, and C18:1 cis-9 being the predominant NEFA released 
(Hostens et al., 2012), with a further possible conversion of C18:0 to C18:1 cis-9 in the mammary 
gland through the action of ∆9-desaturase (Fievez et al., 2003). Although not in all cases (e.g., 
Ospina et al. (2013) found only 18% of the variability in BHBA concentration to be explained by 
NEFA during the first 2 weeks in lactation), BHBA and NEFA are often linked. Effective 
development of hyperketonemia and production in the liver of BHBA not only depend on the 
supply to the liver of NEFA, but also on the availability of glucose or glucogenic precursors 
(Van Knegsel et al., 2007c). Indeed, Itoh et al. (1998) noted that hyperketonemia is associated 
with increased concentrations of NEFA and decreased concentrations of glucose in blood. 
Hence, the ratio C18:1 cis-9-to-C15:0 has been included as an additional predictive variable in our 
study, given milk C15:0 originates from rumen propionate (Fievez et al., 2012). This ratio indeed 
has been identified as the most discriminating variable. The progressive decrease in C18:1 cis-9-
to-C15:0 ratio (Figures 1c, 4a, and 4b) is in line with the decreasing pattern of milk long-chain 
FA in early lactation and the increase observed for milk odd- and branched-chain fatty acid 
(OBCFA) with chain lengths of 14 and 15 carbon atoms (Craninx et al., 2008). Accordingly, 
information on this natural variation in milk FA concentrations should be incorporated in 
classification models based on these milk FA to improve their performance. Another milk FA 
ratio was included (i.e., anteiso C15:0-to-anteiso C17:0). The rationale to include this ratio is based 
on FA elongase activity. Loor et al. (2007) indicated that mRNA expression encoding for 
elongase of family member 6 (ELOVL6) was downregulated in ketotic cows. Studies with 
cultured human intestinal cells revealed the potential of branched-chain FA to be elongated by 
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the action of this enzyme (Ran-Ressler et al., 2010). Based on daily milk secretion of anteiso 
C17:0, which exceeded its daily duodenum flow, we suggested the possibility of elongation of 
this branched-chain FA from anteiso C15:0 in animal tissues (Vlaeminck et al., 2015). Similarly, iso 
C15:0 elongation to iso C17:0 was suggested. However, the current gas chromatographic analysis 
did not allow for accurate determination of iso C17:0 due to co-elution with C16:1 cis-7. Down-
regulation of the activity of this elongase was hypothesised to result in an increased anteiso C15:0-
to-anteiso C17:0 ratio in cows suffering from hyperketonemia. However, in the current study the 
anteiso C15:0-to-anteiso C17:0 ratio in milk of these cows was lower (Table 1). This might be due 
to a confounding effect related to more excessive fat mobilisation in cows suffering from 
hyperketonemia. Indeed, released NEFA also might affect the milk fat anteiso C15:0-to-anteiso 
C17:0 ratio because adipose tissue is enriched in OBCFA of longer chain length. Craninx et al. 
(2008) indicated a ratio of C15 OBCFA to C17 OBCFA of 1:3 in adipose tissue of beef, whereas 
anteiso C15:0 and anteiso C17:0 in milk fat of nonhyperketonemia cows were presented in similar 
amounts. Accordingly, the greater amounts of anteiso C17:0 in milk fat of hyperketonemia cows 
most probably reflected a larger contribution from mobilised fat. 
 
Potential of milk fat characteristics as biomarkers of hyperketonemia compared with 
other cow-side tests 
Although the current experimental setup could have been improved, particularly with regard 
to sampling frequency, some first comparisons are made below to position the currently 
identified most powerful milk FA diagnostic within the range of cow-side tests which are 
available. A 10-fold cross validation for classification of hyperketonemia cases based on this milk 
FA ratio resulted in an average sensitivity of 38.4% and specificity of 95.0%. Whereas specificity 
is highly acceptable, sensitivity is low. Other tests that rely on the detection of a single metabolite 
(i.e., most often ketone bodies) in blood, milk, or urine show variable performance; with the 
Precision Xtra for BHBA in whole blood being one of the most frequently performed tests, with 
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sensitivity and specificity values of 88 and 96% at BHBA ≥ 1.2 mmol/L (Iwersen et al., 2009). 
Despite its high accuracy, this test has the major drawback of requiring invasive blood sampling. 
Urine collection is not invasive, and the performance of Ketostix (cutoff point ‘small’) to detect 
acetoacetate showed sensitivity and specificity values of 78 and 96%, respectively (Carrier et al., 
2004). However, urine collection also has some limitations as it is labour intensive, particularly 
because urine production should be stimulated to allow pure sample collection with some cows 
failing to urinate. Additionally, these tests rely on visual interpretation of a colour change, which 
may influence the result. Obviously, milk is the most convenient body fluid for collection, but 
milk tests are usually less sensitive than urine tests in monitoring hyperketonemia. Geishauser et 
al. (1998a) evaluated the performance of Ketolac BHB strip test (threshold at 50 µmol of 
BHBA/L of milk), which showed a sensitivity and specificity of 92 and 55%, respectively, 
whereas a threshold at 100 µmol of BHBA/L of milk indicated sensitivity and specificity values 
of 72 and 89%, respectively. Four other tests (i.e., Ketostix strip, Bioketone powder, Ketocheck 
powder, and Utrecht powder) detecting acetoacetate in milk showed rather low sensitivities (5, 
33, 28, and 43%, respectively), whereas all tests were highly specific (specificity > 99%). 
Alternative tests assessing the concentration of ketone bodies in milk are reported (e.g., 
KetoCheck Powder for detection acetoacetate (cut-off points: ≥ trace) with a sensitivity and 
specificity of 41 and 99%, respectively). The KetoTest strip for the detection of BHBA 
(threshold between 50 and 100 µmol of BHBA/L of milk) showed sensitivity and specificity 
ranges between 73 to 88% and 90 to 96%, respectively (Carrier et al., 2004). Duffield et al. (1997) 
found a milk protein to fat ratio of less than or equal to 0.75 to be another potential test for 
hyperketonemia, which yielded a sensitivity of 58% and specificity of 69%. Although sensitivity 
and specificity are most commonly used to compare classification tests, it should be realised 
these values depend on class distribution. Because logistic regression analysis required 
independent input data and because milk fat C18:1 cis-9-to-C15:0 ratio changed with progress in 
lactation (Figures 4a and 4b), separate classification models needed to be developed for weeks 2, 
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3, and 4, which resulted in a relatively low number of observations (n = 93) for model cross-
validation. Hence, model performance might improve when more independent data would 
become available. Furthermore, the former cow-side tests, like the milk fat C18:1 cis-9-to-C15:0 
ratio we proposed from the current research, all rely on the use of a single metabolite in blood, 
urine, or milk for the diagnosis of hyperketonemia. However, Van der Drift et al. (2012) 
indicated classification of hyperketonemia to be considerably improved when combining Fourier 
transform infrared spectrophotometry predictions of milk acetone and milk BHBA with test day 
information. Due to limitations of the current experimental setup, it was not considered useful to 
further fine-tune and optimise the model using the current data set. Nevertheless, addition of 
test day information, for example, should be emphasised in the future when further developing a 
hyperketonemia diagnostic test based on the milk fat C18:1 cis-9-to-C15:0 ratio.  
 
CONCLUSIONS 
Milk fat C18:1 cis-9-to-C15:0 ratio shows potential for diagnosis of hyperketonemia in dairy 
cows. A ratio between 34 and 45 seems to be a valuable threshold in this respect, based on the 
current data set. Differentiation should be made in relation to the lactation week when milk 
sampling takes place. 
  
 
 
 
 
 
 
CHAPTER 3 
 
 
 
Correction for basal milk fat C18:1 cis-9 level improves the 
robustness of milk fat C18:1 cis-9 to diagnose for elevated plasma 
NEFA concentrations of dairy cows in early lactation 
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ABSTRACT 
 Milk fat C18:1 cis−9 allows to distinguish between early lactating dairy cows with elevated vs. 
non−elevated blood plasma NEFA (≥ vs. < 0.6 mmol/L). The robustness of this relation was 
evaluated using 2 data sets in a cross−data set validation approach (experiments 1 and 2) 
providing data and samples of cows between 8 and 14 DIM. Furthermore, an independent data 
set (experiment 3) was used to assess application under practical conditions in which information 
of plasma NEFA concentrations is not available. First, previously established absolute cut−off 
values of milk fat C18:1 cis−9, separately determined based on datasets of both experiments 1 
and 2, were evaluated in a cross−data set validation. Robustness of these cut−off values to 
diagnose elevated plasma NEFA was poor. Hence, it was assessed whether a cut−off value, 
corrected for a basal milk fat C18:1 cis−9 level, was more robust. To that end, the 
experiment−dependent basal milk fat C18:1 cis−9 concentration was determined as the average 
milk fat C18:1 cis-9 concentration of cows with blood NEFA concentrations below 0.6 mmol/L 
and was subtracted from the corresponding C18:1 cis−9 cut-off values of each experiment. 
Corrected cut−off values obtained as such were 3.85 (experiment 1) and 4.11 (experiment 2) 
g/100 g FA. For each experiment, observations were corrected in a similar way, through 
subtraction of the experiment−dependent basal level. Cross−data set evaluation based on these 
corrected cut−off values and observations resulted in specificities of 90% and sensitivities of 
about 50%, which were comparable to the intra−experiment performance as determined before. 
However, under practical conditions, knowledge on plasma NEFA status is absent, which 
impairs this approach. Alternatively, the experiment−dependent basal level was determined as 
the average of the 80% lowest milk fat C18:1 cis−9 concentrations within each experiment. 
Finally, the average corrected cut−off value 3.98 g/100 g FA, was applied to classify 
observations obtained under practical conditions. Evaluation using this independent data set 
confirmed the robustness of the proposed approach both in terms of corrected average cut−off 
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value, as well as for the determination of the experiment−dependent basal milk fat C18:1 cis−9 
level.  
INTRODUCTION 
 Most cows in early lactation inevitably encounter a period of negative energy balance (NEB) 
since dry matter intake (energy input) and milk production (energy output) are imbalanced. 
When energy requirements exceed intake, fat reserves are mobilised, resulting in increased 
NEFA circulating in blood. Long-chain FA, particularly C18:0 and C18:1 cis−9 are increased in 
the liver (Rukkwamsuk et al., 2000) and transferred to the milk (Hostens et al., 2012). 
Accordingly, increased milk fat C18:1 cis−9 was reported during periods of NEB in lactating 
dairy cows (Van Haelst et al., 2008; Gross et al., 2011; Krempasky et al., 2014). Inversely, early 
lactating cows with low plasma NEFA levels (< 0.6 mmol/L) consistently showed lower milk fat 
C18:1 cis−9 concentrations than cows with elevated levels of plasma NEFA (≥ 0.6 mmol/L) 
(Jorjong et al., 2014). This plasma NEFA threshold was derived from Ospina et al. (2010c), 
reporting postpartum plasma NEFA concentrations of 0.57 mmol/L as a critical level for 
prediction of displaced abomasum, clinical ketosis, metritis, and retained placenta in the first 
month of lactation. This milk FA is of particular interest given the ease to sample milk, as well as 
the possibility for its routine analysis (Stefanov et al., 2010). A cut−off value of 24 g C18:1 cis−9 
per 100 g FA was established and corresponded with a 50% chance to encounter elevated plasma 
NEFA levels during the first 8 weeks of lactation with a specificity of more than 90% (Jorjong et 
al., 2014). The latter performance characteristics were deduced from an intra−experiment 
validation (Jorjong et al., 2014), but the robustness of this cut−off value has not yet been tested 
across experiments. Nevertheless, confounding effects such as diet composition (Delbecchi et 
al., 2001), stage of lactation, breed and parity or their interactions also might affect the milk fat 
C18:1 cis−9 concentration (Grummer, 1991; Soyeurt et al., 2006; Craninx et al., 2008), as well as 
variation in ∆9 − desaturase activity of the mammary gland, resulting in the conversion of C18:0 
to C18:1 cis−9. Therefore, inter−experiment validation and optimisation of the milk C18:1 cis−9 
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based test is required, which was the objective of the present study. Such an inter-experiment 
validation also would be required for the milk test based on the C18:1 cis−9 to C15:0 ratio for 
diagnosis of hyperketonemia, as described in Chapter 2B. However, except for the dataset of 
experiment 2 used in the latter chapter, the other datasets available for this research only 
contained a limited number of hyperketonemic cases, which excluded inter-experiment 
validation for this test.  
 
MATERIALS AND METHODS 
Experimental setup of experiments 1 and 2 
A cross−data set approach was addressed by obtaining samples and data from 2 consecutive 
lactations (experiments 1 and 2, described in detail in Chapters 2A and 2B, respectively) where 
dairy cows were attributed to varying dry period lengths and diets rich in glucogenic or lipogenic 
nutrients. A detailed description of data collection and sample analysis was given by Jorjong et al. 
(2014); Van Knegsel et al. (2014) and Jorjong et al. (2015). For the current cross−data set 
approach, milk and plasma samples collected in the second week of lactation (between 8 and 14 
DIM) were considered. 
 
Experimental setup, animals, and housing of experiment 3 
Experiment 3 was based on an independent data set, which was obtained from a dairy herd of 
more than 2,000 animals in northern Germany and included data from 141 Holstein cows (40 
primiparous and 101 multiparous) at 3 and 10 DIM. Eight cows at 3 DIM, and 4 cows at 10 
DIM were excluded from the data set because milk or blood samples were missing. This 
experiment was conducted from September 4 to 28, 2013. Transition cows were housed in a 
separate loose housing stable with cubicles filled with sand. Cows stayed in the transition stable 
from 2 months pre partum until about 14 d postpartum. Cows were milked 3 times daily and fed 
a total mixed ration (TMR) including maize and alfalfa silage, dried maize grain, soybean meal 
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and sugar beet pulp. All cows were treated with 600 mL of propylene glycol immediately after 
calving. Additionally, cows were checked with a Ketostick (Precision Xtra, Abbott, USA) to 
determine the blood BHBA concentration on Monday, Wednesday and Friday during the first 2 
weeks of lactation. Cows with a blood BHBA value greater than 1.4 mmol/L were drenched 
with an extra 600 mL/d of propylene glycol for 3 consecutive days (2 out of 141 cows).  
 
Blood NEFA and milk FA analysis of experiment 3 
From each cow, blood samples were taken at d 3 and 10 postpartum from the coccygeal vein 
into a tube containing EDTA (Vacuette, Greiner BioOne; MLS, Menen, Belgium). The blood 
samples were centrifuged at 3,360 × g for 10 min within 1 h after collection. Plasma samples 
were stored at −20 ºC until analysis. At the same day, milk samples were collected from 4 
quarters in 20−ml tubes by hand at the end of the morning milking, then filtered through 
cheesecloth to avoid contamination, e.g. hair, and stored at −20 ºC until analysis. Blood samples 
were analysed for NEFA concentrations by means of an automated colourimetrical analyser 
(Konelab 20 XTi Clinical chemistry analyser, Thermo Electron Corp., Vantaa, Finland) at the 
Flemish Veterinary Health Service (Dierengezondheidszorg−Vlaanderen, Torhout, Belgium) 
using a commercial kit (cat no. FA115) from Konelab/DPC T series (Thermo Electron Corp., 
Vantaa, Finland). Milk samples were analysed for milk FA concentrations by gas 
chromatographic analysis as described earlier by Jorjong et al. (2014). 
 
Categorisation of observations based on blood NEFA concentrations 
For all 3 experiments and per sampling day, cows were classified into 2 groups, i.e. showing 
elevated plasma NEFA or not, with plasma NEFA cut−off at 0.6 mmol/L.  
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Origin of absolute cut-off values  
In an earlier study, an absolute cut−off value of 24 g/100 g FA C18:1 cis−9 was established 
by Jorjong et al. (2014) (experiment 1, n = 92) for diagnosis of elevated plasma NEFA (≥ 0.6 
mmol/L), with the intra−experimental validation reaching specificity and sensitivity values of 90 
and 50%, respectively. Similarly, a cut−off value of milk fat C18:1 cis−9 of 27 g /100 g FA was 
generated based on the data set of experiment 2 (n = 93), also resulting in an intra−experiment 
validated specificity of 90% and sensitivity of 50%.  
 
Cross-validation and generation of corrected cut-off values 
In the present study, cross−data set validation was performed in 3 ways. First, the robustness 
of both absolute cut-off values were used in a cross-data set validation (i.e., 24 g C18:1 cis−9/100 
g FA was used as cut−off to classify data of experiment 2 and 27 g C18:1 cis−9/100 g FA was 
used to classify data of experiment 1). Second, both cut−off values, as well as individual 
observations were corrected for an experiment−dependent basal level. The latter was calculated 
for each experiment individually as the average milk fat C18:1 cis−9 concentration of cows with 
plasma NEFA concentrations below 0.6 mmol/L. For each observation, the difference as 
compared with this basal level was calculated. Additionally, new cut−off values, corrected for the 
experiment−dependent basal level of either experiment 1 or 2 were calculated by subtracting 
basal levels (i.e., 20.2 and 22.9 g/100 g FA, respectively) from the original absolute cut−off 
values (i.e., 24 and 27 g/100 g FA, respectively). Third, an approach to determine the 
experiment−dependent basal level without knowledge of plasma NEFA concentrations, as under 
practical circumstances, was assessed and validated. For this, the milk fat C18:1 cis−9 
concentrations of all observations within each experiment were ranked from low to high. 
Average milk fat C18:1 cis−9 concentrations of the 65, 70, 75, 80, 85, or 90% lowest values were 
calculated. Each of these 6 values was used as the experiment−dependent basal level and was 
subtracted from the original observations in each of the 3 experiments. As such, for both 
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experiments 1 and 2, 6 validation assessments were carried out. The classification performance 
was evaluated using the corrected cut−off values which allowed to assess the most appropriate 
way to calculate the experiment−dependent basal level. Finally, the robustness to diagnose 
elevated plasma NEFA concentrations by the corrected cut−off value, in combination with the 
determination of the basal level as the average of the 80% lowest milk fat C18:1 cis−9 
concentrations was assessed using a totally independent data set obtained from a commercial 
farm (experiment 3). 
 
Assessment of test performance 
For all validation assessments, performance was evaluated by calculating sensitivity (Se), 
specificity (Sp), accuracy, positive and negative predictive values (PV+, PV−), odds ratio (OR), 
and positive likelihood ratios (LR+) using a 2×2 contingency table. Sensitivity is defined as the 
proportion of positive test subjects (plasma NEFA ≥ 0.6 mmol/L) that were effectively 
classified positive (i.e., true positives, TP) in the total group of positive subjects (i.e., both TP 
and false negatives, FN) (TP/(TP+FN)). Specificity is defined as the proportion of negative 
subjects (plasma NEFA<0.6 mmol/L) that were effectively classified negative (i.e., true 
negatives, TN) in the total group of negative subjects (i.e., both TN and false positives, FP) 
(TN/(TN+FP)). Accuracy is calculated as the proportion of the positive subjects with a positive 
test and the negative subjects with a negative test relative to all subjects 
(TP+TN)/(TP+TN+FP+FN). Positive predictive value is the proportion of positive test 
subjects that are effectively positive relative to all subjects with a positive test result 
(TP/(TP+FP)), and vice versa for the negative predictive value calculated as (TN/(TN+FN)). 
Odds ratio (OR) of a test is the ratio of the odds of the positive test in ‘diseased’ subjects relative 
to the odds in subjects without ‘disease’; (TP/FN)/(FP/TN). Moreover, LR+ is defined as the 
ratio of the expected test result in ‘diseased’ subjects to the subjects without ‘disease’. The 
 86 
 
positive likelihood ratio indicates how much more likely the positive test outcome is to occur in 
‘diseased’ subjects compared with those without ‘disease’. It is simply calculated as Se/(1−Sp). 
 
RESULTS AND DISCUSSION 
Concentrations of blood plasma NEFA and milk fat C18:1 cis-9 
Average plasma NEFA concentrations of the 2 categories (elevated vs. non−elevated plasma 
NEFA) from the 3 experiments are presented in Figure 1a. Observations with plasma NEFA 
concentrations ≥ 0.6 mmol/L were categorized in the ‘elevated plasma NEFA group’. Overall, 
average plasma NEFA concentration was highest in experiment 3 (0.62 mmol/L), followed by 
experiment 2 (0.58 mmol/L), whereas the lowest average plasma NEFA concentration was 
observed in experiment 1 (0.51 mmol/L). Average milk fat C18:1 cis−9 concentrations followed 
this overall difference between experiments (Figure 1b). The proportion of observations with 
elevated plasma NEFA (prevalence) was higher in experiment 2 than in experiment 1 (0.35 vs. 
0.24, respectively). Prevalence (0.16) of elevated plasma NEFA in experiment 3 was lower, 
although the concentration of milk fat C18:1 cis−9 was higher than in the first 2 experiments 
(26.4 g C18:1 cis−9/ 100 g FA), which might be related to the earlier sampling times (3 and 10 
DIM in experiment 3 vs. 8 to 14 DIM in experiments 1 and 2) as milk fat C18:1 cis−9 levels have 
been found to decrease from the onset of lactation until week 10 (Craninx et al., 2008). C18:1 
cis−9 is the predominant fatty acid in adipose tissue and the primary fatty acid released into 
plasma by fat mobilisation (Rukkwamsuk et al., 2000). Accordingly, the transition period, during 
which NEB is nearly ubiquitously experienced, is characterized by elevated concentrations of this 
fatty acid in the liver and plasma (Rukkwamsuk et al. (2000); Sato and Inoue (2006); Douglas et 
al. (2007), as well as a higher uptake of C18:1 cis−9 by the mammary gland as compared with 
later lactation stages (Kay et al., 2005). Although mobilisation of fat reserves predominantly 
affects milk fat C18:1 cis−9 in early lactation, dietary factors also could play a role. Given the 
extensive ruminal biohydrogenation of unprotected unsaturated fatty acids (Glasser et al., 2008), 
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total dietary supply of C18−fatty acids rather than the specific dietary supply of C18:1 cis−9 will 
determine milk fat C18:1 cis−9. Indeed, about half of C18:0, the end product of rumen 
biohydrogenation of C18−unsaturated fatty acids, is suggested to be converted in the mammary 
gland by the activity of the ∆9–desaturase enzyme, also named stearoyl−coenzyme A desaturase 
(SCD) (Enjalbert et al., 1998). Differences in dietary C18−fatty acid supply could perhaps 
partially explain differences in milk C18:1 cis−9 between the 3 experiments, although all diets 
were based on grass or alfalfa silage, maize silage, sugar beet pulp and soybean meal without 
extra fat supplement, except for the lipogenic diets in experiments 1 and 2 (Van Knegsel et al., 
2014). Hence, dietary treatments within experiments 1 and 2 (lipogenic vs. glucogenic diets) 
showed larger differences in fat supply than differences between experiments. However, milk fat 
C18:1 cis−9 did not differ between cows fed the lipogenic or glucogenic diets (Van Knegsel et al., 
2014).   
 
Figure 1a. Average concentrations of nonesterified fatty acids for observations grouped according to 
plasma NEFA: either elevated (≥ 0.6 mmol/L) (black bars) or not (< 0.6 mmol/L) (grey bars) as 
measured in week 2 (between 8 and 14 DIM) of lactation (experiments 1 and 2) or on 3 and 10 DIM 
(experiment 3). Data represent means (±SD). 
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Figure 1b. Average concentrations of milk fat C18:1 cis−9 for observations grouped according to plasma 
NEFA: either elevated (≥ 0.6 mmol/L) (black bars) or not (< 0.6 mmol/L) (grey bars) as measured in 
week 2 (between 8 and 14 DIM) of lactation (experiments 1 and 2) or on 3 and 10 DIM (experiment 3). 
Data represent means (±SD). 
 
Performance of tests based on the absolute cut-off values of milk fat C18:1 cis-9  
The potential was assessed of absolute milk fat C18:1 cis−9 levels to classify observations of 
early lactating cows into 2 groups, either with elevated plasma NEFA or not. Results of this 
classification are presented in Table 1. The absolute cut−off value of 24 g C18:1 cis−9/100 g FA 
obtained from experiment 1 was validated using data from experiment 2, which resulted in a 
sensitivity of 70% and specificity of 55%. Similarly, the cut−off value of 27 g C18:1 cis−9/100 g 
FA, obtained based on data of experiment 2, was validated using data from experiment 1, 
resulting in very low sensitivity of 18%. The cut−off value obtained from experiment 1 was 
surprisingly lower than that of experiment 2, despite the same feeding regimen in both 
experiments (Jorjong et al., 2014; Van Knegsel et al., 2014; Jorjong et al., 2015). As cows were 
followed during 2 successive lactations, parity number differed between experiments 1 and 2. 
Friggens et al. (2007a) indicated that first parity cows mobilised less fat reserves than older cows, 
with differences between parities decreasing as lactation number progressed. Nevertheless, a 
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direct effect of parity on milk fat C18:1 cis−9, which could interfere with the relationship 
between blood NEFA and milk fat C18:1 cis−9 is unknown.  
 
Optimisation of milk C18:1 cis-9 tests: assessing changes to experiment-dependent basal 
levels 
Given the poor robustness of the absolute milk fat C18:1 cis−9 cut−off value (i.e., 24 or 27 
g/100 g FA), new cut−off values, corrected for an experiment−dependent basal level were 
calculated by subtracting basal levels from the absolute cut−off values. The 
experiment−dependent basal level was calculated as the average milk fat C18:1 cis−9 
concentration of the cows with plasma NEFA concentrations below 0.6 mmol/L for both 
experiments 1 and 2 and equalled 20.15 and 22.89 (g/100 g FA), respectively. Cut−off values for 
the ‘corrected approach’ were quite similar, i.e. 3.85 g/100 g FA (i.e., 24.00−20.15) and 4.11 
g/100 g FA (i.e., 27.00−22.89), as derived from experiments 1 and 2, respectively, and were used 
for cross−data set validation as before. For this, milk fat C18:1 cis−9 observations also were 
corrected for the same experiment−dependent basal level. Overall, this cross−data set validation 
generated specificities of at least 90% associated with sensitivities of about 50% and overall 
accuracy rates above 75%, similar to our former study (Jorjong et al., 2014). In the latter, as well 
as in the current study, a high specificity (90%) was aimed at, since farmers generally seem to 
prefer detection systems that produce a low number of false alerts and particularly alerting for 
the more severe cases (Mollenhorst et al., 2012). Indeed, the ideal cut−off value depends on the 
purpose of each situation. For example, high specificities are emphasised to confirm healthy 
animals, while a high sensitivity is of particular interest to rule out sick animals. Over the 2 
experiments, OR and LR+ values also indicated a better performance through this corrected 
approach than through classification based on absolute cut−off values (Table 1). Additionally, 
both predictive values (PV (+) and PV (−)) generally were greater when compared with the 
cross−data set validation using the absolute cut−off values (Table 1). Predictive values of the 
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negative test (PV (−) were always higher than 77%, implying that for both cross−data set 
validations at least 77% of all observations with a negative test result were truly negative. 
Predictive values of the positive test (PV (+)) were 59 and 77%, implying that up to three 
quarters of the observations that tested positive were truly positive. 
 
Determining the experiment-dependent basal level without plasma NEFA information 
Given the lack of knowledge about the plasma NEFA status of a herd under practical 
conditions, an alternative approach to determine the experiment−dependent basal level, 
applicable under practical conditions, was assessed. Therefore, milk fat C18:1 cis−9 
concentrations for all observations within each experiment were ranked from low to high. Then, 
the basal milk fat C18:1 cis-9 level was calculated as the average of the lowest 65, 70, 75, 80, 85 or 
90% values. Afterwards, a cross−data set validation was run as described before. The 
experiment−dependent basal levels determined as the average C18:1 cis−9 concentration of the 
80% lowest milk fat C18:1 cis−9 concentrations were comparable to those calculated as the 
average C18:1 cis−9 concentrations of the healthy animals (i.e., 19.7 vs. 20.2 g/100 g FA and 22.6 
vs. 22.9 g/100 g FA for the basal 80% average and the average of the healthy animals for 
experiments 1 and 2, respectively). Furthermore, the classification performance, based on the 
performance parameters used in the current study (i.e., Se, Sp, accuracy, PV+, PV−, OR and 
LR+), was similar or better when using the basal 80% average in comparison with the basal 65, 
70, 75, 85 and 90% average (data not shown). Moreover, classification performance of 
observations corrected for a basal level calculated as the 80% average or calculated as the average 
of the healthy cows was equal (Table 1). 
 
Validation under practical conditions  
Finally, this approach was validated using an independent data set (experiment 3). Not only 
dietary and herd management conditions differed from the former 2 experiments, but also milk 
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sampling. Milk sample in experiment 3 was collected by strip sampling, whereas a flow−through 
collection system was used for sampling in experiments 1 and 2. A preliminary comparison at 
our lab, simultaneously applying both sampling methods on 13 cows, indicated some minor, 
though significant differences in concentrations of some FA, among which milk fat C18:1 cis−9 
(19.8 vs. 18.4 g/100 g FA, using the flow−through rather than strip sampling, respectively). It 
was hypothesised that potential differences caused by the sampling method would also be 
included in the experiment−dependent basal level. Hence, for this validation, the average of the 
milk fat C18:1 cis-9 cut−off value, i.e. 3.98 (average of 3.85 and 4.11) was used and milk fat C18:1 
cis−9 observations were corrected for the experiment−dependent basal level, calculated as the 
average of the 80% lowest milk fat C18:1 cis−9 values (Table 2). The overall accuracy when 
applying this approach to a completely independent data set was similar as observed in the 
cross−experiment validation. Higher sensitivities at d 3 may indicate earlier sampling times to be 
of particular interest to rule out sick animals, whereas specificity and sensitivity values at d 10 
were more comparable to those of the experiment validations where samples were taken 
between 8 and 14 DIM (experiments 1 and 2). Higher sensitivity at d 3 also resulted in an OR 
that was more than 3 times higher than on d 10 (PV+ and LR+ were comparable for both days). 
Predictive values of a negative test were higher than in the first 2 experiments and indicated that 
89 to 95% of all cows that tested negative were truly negative. However, predictive values of a 
positive test were considerably lower (36 to 38%). This might be related to the low prevalence 
rate (16%) of elevated blood NEFA on this farm.  
 
CONCLUSIONS 
The approach proposed here to determine the basal level under practical conditions seems 
feasible, but might be currently limited to big herds (e.g., experiment 3) where a large number of 
cows are in the beginning of lactation simultaneously and hence are under the same dietary 
conditions, allowing to determine the experiment−dependent basal level as proposed here. 
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Indeed, this might pose problems on smaller farms, with only 5 to 10 calvings a month. Further 
research is required, e.g. under practical conditions, to deal with this challenge. 
  
 
 Table 1. Characteristics of the validation test using absolute cut−off values of milk fat C18:1 cis−9 (g/100 g FA) for diagnosis elevated levels of 
plasma NEFA (> 0.6 mmol/L), as well as cut−off values obtained through a ‘corrected approach’. Cut−off values were obtained based on data sets 
from experiments1 and 2 and cross validation using the data set of experiments 2 and 1, respectively.  
 
Original data set Validation data set and characteristics 
Exp.        Cut−off    
.               
                      value 
Exp. Basal 
level 
(g/100 g FA) 
Prevalence 
(%) 
Se 
(%) 
95% CI 
for Se (%) 
Sp 
(%) 
95% CI 
for Sp (%) 
Accuracy 
(%) 
PV(+) 
(%) 
PV(−) 
(%) 
OR LR(+) 
Absolute approach 
1 24.0 2 − 35 70 53 to 83 55 42 to 67 60 46 77 2.8 1.6 
2 27.0 1 − 24 18 7 to 39 97 90 to 99 78 67 79 7.6 6.4 
Experiment-dependent correction using a basal level based on milk fat 18:1 cis−9 concentrations of healthy cows (NEFA<0.6 mmol/L) 
1 3.85 2 22.9 35 52 35 to 68 92 82 to 96 77 77 77 12 6.2 
2 4.11 1 20.2 24 45 27 to 65 90 81 to 95 79 59 84 7.5 4.6 
Experiment-dependent correction using a basal level based on 80% lowest milk fat C18:1 cis−9 concentrations 
1 3.85 2 22.6 35 58 41 to 73 90 80 to 95 78 76 79 12 5.8 
2 4.11 1 19.7 24 55 35 to 73 89 79 to 94 80 60 86 9.3 4.8 
  
 
Table 2. Validation of the cut−off value (3.98 g/100 g FA) to diagnose elevated levels of plasma NEFA at d 3 or 10 postpartum based on 
the difference between the observed milk fat C18:1 cis−9 concentrations and the experiment−dependent basal level determined as the 
average of the 80% lowest milk fat C18:1 cis−9 concentrations using a totally independent experiment.  
 
Basal milk fat C18:1 
cis−9 (g/100 g FA) 
Se  
(%) 
95% CI for 
Se (%) 
Sp  
(%) 
95% CI for 
Sp (%) 
Accuracy 
(%) 
PV+  
(%) 
PV− 
(%) 
OR LR+ 
Day 3 postpartum (n =133)         
22.5 81 60 to 92 75 66 to 82 76 38 95 13 3.2 
Day 10 postpartum (n=137)         
23.4 45 27 to 65 84 77 to 90 78 36 89 4.5 2.9 
  
 
 
 
 
 
Chapter 4 
 
 
Relationships between milk fatty acids in early lactation and 
subsequent reproductive performance 
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ABSTRACT 
Negative energy balance and hyperketonemia in early lactating dairy cows have been suggested to 
impair subsequent reproductive performance. As the former is associated with changes in milk fatty 
acid composition, the objective of this study was to investigate the relationship between milk fatty 
acids (FA) and subsequent reproductive performance. Two experiments were conducted with 92 
(experiment 1) and 93 cows (experiment 2) which allowed to assess reproductive performance in 
terms of first milk progesterone rise, resumption of normal ovarian cyclicity, as well as calving to 
pregnancy interval. Progesterone concentrations, available in milk sampled thrice weekly from week 
2 until 100 days in milk (DIM), allowed to determine the onset of luteal activity (at least 2 succeeding 
milk samples with progesterone ≥ 2 ng/ml) and to classify observations into 3 categories (normally, 
abnormally or not resuming ovarian cyclicity within 100 DIM). Additionally, weekly blood plasma 
BHBA and NEFA (weeks 2 to 8 after calving), as well as (corrected) milk fat C18:1 cis-9 and milk fat 
C18:1 cis-9-to-C15:0 ratio (weeks 2 to 4 after calving) were available. These parameters were 
compared across the 3 formerly mentioned categories and further allowed to run survival analyses in 
which days to first progesterone rise after calving or calving to pregnancy interval were investigated 
for the dataset of experiments 1 and 2, grouped by blood plasma BHBA (≥ vs. < 1.2 mmol/L, 
experiment 2 only), blood plasma NEFA (≥ vs. < 0.6 mmol/L), corrected milk fat C18:1 cis-9 (≥ vs. 
< 3.98 g/100 g FA) and milk fat C18:1 cis-9-to-C15:0 ratio (≥ vs. < 45 g/g, experiment 2 only). In 
experiment 1, none of the blood metabolites nor milk fatty acid parameters differed between the 
groups showing normal, abnormal or no resumption of ovarian cyclicity within 100 DIM. However, 
in experiment 2 blood plasma BHBA concentration, milk fat C18:1 cis-9-to-C15:0 ratio and 
corrected milk fat C18:1 cis-9 concentrations increased in cows which did not resume ovarian 
cyclicity within 100 DIM compared with normally resuming cows. However, neither blood plasma 
BHBA nor NEFA concentrations were associated with days to first progesterone rise or calving to 
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pregnancy interval. Interestingly, cows having a corrected milk fat C18:1 cis-9 concentration 
exceeding the threshold of 3.98 g/100 g FA (as established in Chapter 3) or milk fat C18:1 cis-9-to-
C15:0 ratio exceeding the threshold of 45 g/g (as established in Chapter 2B) were delayed in first 
milk progesterone rise and showed a prolonged calving to pregnancy interval. In conclusion, milk fat 
C18:1 cis-9-to-C15:0 ratio and corrected milk fat C18:1 cis-9 concentration are associated with 
seriously delayed resumption of ovarian cyclicity ( 100 DIM) and prolonged calving to pregnancy 
interval, although these associations only seemed relevant in situations of more severe NEB (i.e. 
experiment 2 vs. experiment 1). 
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INTRODUCTION 
Negative energy balance (NEB) is a known risk factor for declined reproductive performance in 
dairy cows, with a strong association reported between NEB and the decreased reproductive 
performance commonly seen in early lactating cows (Ingvartsen, 2006). During the period of NEB, 
fat reserves are mobilised to compensate the high energy demand for milk production, resulting in 
changes of blood metabolites and hormones involved in energy metabolism after calving. Several 
studies have reported that concentrations of blood BHBA and NEFA in this period are associated 
with impaired reproductive performance (Walsh et al., 2007; Ospina et al., 2010b). In addition, de 
Vries and Veerkamp (2000) reported the nadir of NEB is correlated with a delay in the postpartum 
start of luteal activity. Moreover, Walsh et al. (2007), reported that cows suffering from subclinical 
ketosis during the first 2 weeks of lactation were 50% less likely to conceive at first service than the 
ones not encountering subclinical ketosis. Inversely, increasing energy balance and enhanced body 
condition were related to a greater number of large follicles and improved follicular development in 
postpartum dairy cows. Also, others indicated that cows with better energy status had fewer small 
follicles (1-9 mm) and a greater number of follicles of 10-15 mm in diameter (Lucy et al., 1992). This 
might be related to less favorable conditions in which follicles are developing in cows suffering from 
NEB, as plasma metabolites, such as NEFA, are transferred towards follicular fluid (Leroy et al., 
2005). Indeed, NEFA, added in an in vitro oocyte maturation model at concentrations observed in 
vivo impaired the developmental capacity of the oocyte (Leroy et al., 2005) potentially through 
modification of expression of genes involved in major pathways related to lipid and carbohydrate 
metabolism (Van Hoeck et al., 2015). Furthermore, both timing and depth of NEB interactively 
determine the extent to which NEB limits luteal function in postpartum estrous cycles and 
subsequent maintenance of pregnancy (Butler et al., 1981; Butler and Smith, 1989). 
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Given the economic losses associated with poor reproductive performance (Inchaisri et al., 2010), 
major research efforts address nutritional and managerial measures to temper consequences of NEB 
(Butler, 2000; Van Knegsel et al., 2007a; McArt et al., 2011; Van Knegsel et al., 2014).  Accordingly, 
monitoring of the latter to ensure correct interventions is of utmost importance. Obviously, 
biomarkers associated with NEB could be of interest, provided that they are directly linked to 
reproductive performance. Changes in milk fat (de Vries and Veerkamp, 2000) and milk fat to 
protein ratio were proposed for this purpose given their link with energy balance and reproductive 
performance (Geishauser et al., 1998b; Heuer et al., 1999). In line with this, Podpečan et al. (2010) 
reported that only 40% of the cows having a milk fat to protein ratio greater than 1.34 were 
pregnant within 120 days in milk (DIM), whereas 80% of the cows were pregnant with a milk fat to 
protein ratio below 1.34. However, major changes in milk fat and milk fat to protein ratio with 
lactation stage hampered the reliability of these indicators for reproductive performance (Madouasse 
et al., 2010). Milk fatty acids (FA) might be an alternative as their concentration in milk fat reflects 
utilisation of energy reserves and NEB (Bauman et al., 2006; Stoop et al., 2009; Gross et al., 2011). 
Earlier research from our group showed that milk fat C18:1 cis-9 concentrations and the milk fat 
C18:1 cis-9-to-C15:0 ratio particularly increased when cows were in NEB and/or encountered 
hyperketonemia during early lactation (Van Haelst et al., 2008; Jorjong et al., 2014; Jorjong et al., 
2015). In addition, others already suggested a link between specific milk FA and reproductive 
performance: milk fat C18:1 cis-9 concentrations were higher in cows with late onset of luteal activity 
during the first 6 weeks of lactation (Martin et al., 2015), whereas Stádník et al. (2015) reported 
concentrations of monounsaturated FA to be elevated in cows with prolonged days open. 
To our knowledge, studies reporting the link between milk FA composition and reproductive 
performance are limited. Therefore, the objective of the present study was to investigate the 
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relationship between milk FA assessed during early lactation and reproductive performance, i.e. first 
progesterone rise, resumption of normal ovarian cyclicity, as well as calving to pregnancy interval.  
 
MATERIALS AND METHODS 
Origin of milk and blood samples 
A detailed description of the experimental set-up,  data collection and sample analysis was given 
by Jorjong et al. (2014) (chapter 2A, experiment 1); Van Knegsel et al. (2014) and Jorjong et al. 
(2015) (Chapter 2B, experiment 2). In short, data were obtained from 2 consecutive lactations where 
dairy cows were attributed to varying dry period lengths and diets rich in glucogenic or lipogenic 
nutrients. Following analyses were considered for the current study: Fatty acids determined in milk 
samples from weeks 2, 3, and 4 in lactation and BHBA and NEFA in weekly blood plasma samples 
collected in weeks 2 to 8 in lactation. Further, milk progesterone data were available from milk 
samples taken thrice weekly from week 2 of lactation until 100 DIM and stored at -20 °C until 
progesterone analysis, from which resumption of ovarian cyclicity was deduced (see further). 
Additionally, for this study, the dataset was extended with calving to pregnancy information for the 
92 and 93 cows of experiments 1 and 2, respectively.  
 
Blood and milk analysis  
Blood plasma samples were analysed for BHBA and NEFA concentrations, milk for FA. More 
details on the analytical and sampling procedures of experiments 1 and 2 were described in Chapters 
2A and 2B, respectively.  
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Milk progesterone analysis  
Progesterone in milk was determined by an enzyme immunoassay (Ridgeway Science Ltd., 
Gloucestershire, UK) as described by Roelofs et al. (2006). The intra-assay and inter-assay 
coefficients of variation were 9.7% and 12.5%, respectively. Additional details were previously 
reported by Chen et al. (2015).  
 
Calving to pregnancy 
The voluntary waiting period before artificial insemination was 50 days. Insemination relied on 
activity-based estrous detection using Lely Qwes-HR Activity Tags (Lely, Maassluis, the 
Netherlands) mounted on the neck collar of the dairy cows. Activity data were recorded in a 2-h 
interval and artificial insemination was performed 12 h after detection of estrus. Additionally, cows 
were monitored visually by the farmer for estrous signs. Pregnancy status was determined by 
ultrasonography 60 days after artificial insemination. The calving to pregnancy interval was recorded 
during 365 DIM. However, the farm management could decide to cull experimental cows earlier 
when suffering from severe leg or udder problems, abortion, pneumonia or nonpregnancy (Chen et 
al., 2015). Nevertheless, none of the experimental cows could be culled before 170 DIM 
Management decisions differed slightly between experiment 1 and 2, resulting in 27 (of the 92) cows 
being not pregnant or culled during 365 DIM in experiment 1, whereas only 3 (of the 93) cows of 
experiment 2 were in this situation.   
 
Resumption of ovarian cyclicity  
Resumption of ovarian cyclicity was determined based on milk progesterone concentrations and 
defined as the first day that milk progesterone concentrations were greater than 2 ng/mL for 2 
successive measurements (Rajamahendran et al., 1990). Ovarian cycle length was defined as the 
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interval between occurrence of luteal activity in one ovarian cycle and its occurrence in the next 
ovarian cycle. Both onset and length of the ovarian cycle were then used to distinguish among 3 
groups, i.e. normal, abnormal or no resumption of ovarian cyclicity within 100 DIM. Normal 
resumption of ovarian cyclicity was defined as the onset of luteal activity occurring at 45 DIM or 
less, followed by regular ovarian cycles of 18 to 24 days in length (Chen et al., 2015). Abnormal 
resumption of ovarian cyclicity within 100 DIM referred to cows for which the ovarian cyclicity 
resumed within the considered timeframe of 100 DIM, but either (i) the onset of luteal activity 
occurred later than 45 DIM, (ii) the onset of luteal activity occurred at 45 DIM or less but was 
followed by one or more ovarian cycles with delayed luteolysis (ovarian cycle length ≥20 days) or 
(iii) the onset of luteal activity occurred at 45 DIM or less but luteal activity was absent for more 
than 14 days between 2 ovarian cycles.  
  
Categorising the dataset for survival analysis  
For both experiments, blood plasma NEFA concentrations were used to group cows having 
NEFA ≥ 0.6 mmol/L (elevated blood plasma NEFA) or NEFA < 0.6 mmol/L (nonelevated blood 
plasma NEFA) (Jorjong et al., 2014). Similarly, blood plasma BHBA concentrations were used to 
classify cows suffering from hyperketonemia (BHBA ≥1.2 mmol/L) or not (BHBA<1.2 mmol/L) 
as previously reported (Jorjong et al., 2015). Blood plasma BHBA or NEFA concentrations were the 
maximum concentrations observed during the first 8 weeks (weeks 2, 3, 4, 5, 6, 7 and 8) of lactation. 
Based on the results from Chapter 3, 3.98 g/100 g FA was proposed as threshold to split animals 
into 2 groups, based on their corrected milk fat C18:1 cis-9 concentrations in week 2 of lactation (< 
or ≥ 3.98 g/100 g FA). The corrected milk fat C18:1 cis-9 concentrations were obtained by 
subtracting an experiment-dependent basal level from each observation of week 2 (see Chapter 3). 
The latter was calculated as the mean of the 80% lowest milk fat C18:1 cis-9 concentrations in week 
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2. Finally, cows were grouped based on the milk fat C18:1 cis-9-to-C15:0 ratio in week 2 of lactation 
(≥ or < 45 g/g, i.e. threshold reported in Chapter 2B). 
  
Statistical analysis  
Data of the 3 groups, classified based on the resumption of the ovarian cyclicity (i.e., normal, 
abnormal or no resumption of ovarian cyclicity within 100 DIM) were subjected to ANOVA 
through SAS 9.4 (SAS Institute Inc., Cary, NC) to assess differences among groups in 
concentrations of blood plasma BHBA and NEFA, milk fat C18:1 cis-9-to-C15:0 ratio, milk fat 
C18:1 cis-9 concentrations, and corrected milk fat C18:1 cis-9 concentrations. Data were analysed 
separately per experiment (experiment 1 and experiment 2), and sampling weeks (2, 3 and 4 weeks in 
lactation). Calving to pregnancy interval was also subjected to ANOVA to assess differences among 
the 3 groups. Differences between group means were statistically compared using a Tukey-Kramer 
test. Statistical significance was determined at P < 0.050 and trends are discussed if P ≤ 0.100.  
Second, survival analysis was performed to compare the calving to first progesterone rise interval 
and the calving to pregnancy interval within the study period (365 DIM) for each of the 2 groups, 
distinguished based on either blood plasma NEFA concentrations or corrected milk fat C18:1 cis-9 
concentrations of both experiment 1 and experiment 2 and grouped based on blood plasma BHBA 
concentrations or milk fat C18:1 cis-9-to-C15:0 ratio in experiment 2. The latter 2 groupings were 
not considered for experiment 1, due to the limited number of hyperketonemia cases (n = 8). 
Survival analysis aims at evaluating the time it takes (i.e., the survival time which in this case is either 
‘the interval between calving and first progesterone rise’ or ‘the interval between calving and 
pregnancy’) for an event (in this case ‘first progesterone rise’ or ‘pregnancy’) to occur. Some cows 
did not show a milk progesterone rise or did not get pregnant in the defined timeframe (i.e. 100 
DIM for progesterone rise or 365 DIM for pregnancy) or were culled before the end of the study 
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period. These data are included in the survival analysis, but are indicated as ‘censored data’. Kaplan-
Meier survival curves were constructed in which the proportion of animals without milk 
progesterone rise or non-pregnant animals (i.e. ‘the survival probability’) was plotted against the time 
from the starting point (i.e. time from calving) (SPSS 23, SP Inc., Chicago, IL). 
 
RESULTS 
Resumption of ovarian cyclicity  
In experiment 1, neither blood plasma concentrations of BHBA nor NEFA, assessed in weeks 2, 
3, or 4 in lactation (Table 1), differed between groups which resumed either normally or abnormally 
or did not resume ovarian cyclicity within 100 DIM. As a consequence, milk FA biomarkers (milk 
fat C18:1 cis-9 concentrations, milk fat C18:1 cis-9-to-C15:0 ratio and corrected milk fat C18:1 cis-9 
concentrations) were not different among those 3 groups. Nevertheless, in experiment 2 (Table 2), 
cows which did not resume ovarian cyclicity within 100 DIM showed higher blood plasma BHBA 
concentrations (P < 0.05) and had or tended to have (P = 0.038 to 0.102) an increased milk fat 
C18:1 cis-9-to-C15:0 ratio in weeks 2 to 4 of lactation as compared with cows which normally 
resumed ovarian cyclicity within 100 DIM. However, cows which abnormally resumed ovarian 
cyclicity within 100 DIM did not differ from the normal group (for both blood plasma BHBA and 
the milk fat C18:1 cis-9-to-C15:0 ratio) nor from the group which did not resume within 100 DIM 
(only for the milk fat C18:1 cis-9-to-C15:0 ratio). Moreover, on average, the corrected milk fat C18:1 
cis-9 concentrations of cows not resuming ovarian cyclicity within 100 DIM exceeded the threshold 
of 3.98 g/100 g FA in all 3 weeks and significantly differed from the corrected milk fat C18:1 cis-9 
concentrations of normally resuming cows (P < 0.050; Table 2).  
Differences between both experiments might be related to a more severe status of NEB 
observed in experiment 2. Indeed, average concentrations of blood metabolites (NEFA and BHBA) 
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of experiment 2 exceeded those of experiment 1, a difference which was also reflected in the milk 
FA biomarkers. Noteworthy is also that 80 and 70% of the cows which did not resume ovarian 
cyclicity within 100 DIM showed a corrected milk fat C18:1 cis-9 concentrations above 3.98 in weeks 
2 and weeks 3 or 4, respectively. This value (3.98) corresponded to the threshold established in 
Chapter 3 to diagnose detrimental blood plasma NEFA.  
 
  
 
Table 1. Blood metabolites and milk FA in lactation weeks 2, 3, and 4 of experiment 1 for groups normally, abnormally or not resuming 
ovarian cyclicity within 100 DIM (mean; standard error of the mean, SEM). 
Item Week 2  Week 3  Week 4 
 nor-
mal1 
abnor-
mal2 
>100 
DIM3 
SEM P- 
value 
nor-
mal1 
abnor-
mal2 
>100 
DIM3 
SEM P-
value 
nor-
mal1 
abnor-
mal2 
>100 
DIM3 
SEM P- 
value 
Cows, n 
(proportion,%)  
40  
(43.5) 
38  
(41.3) 
14 
(15.2) 
  
40 
(43.5) 
38 
(41.3) 
14 
(15.2) 
  
40 
(43.5) 
38 
(41.3) 
14 
(15.2) 
  
BHBA (mmol/L) 
(proportion, %)4 
0.66 
(2.5) 
0.69 
(7.9) 
0.59 
(0.0) 
0.030         0.542 
0.63 
(2.5) 
0.70 
(5.3) 
0.62  
(0.0) 
0.043 0.718 
0.58 
(2.5) 
0.59  
(0.0) 
0.56  
(0.0) 
0.023 0.919 
NEFA (mmol/L) 
(proportion, %)5 
0.34 
(20.0) 
0.35 
(15.8) 
0.42 
(28.6) 
0.027 0.645 
0.29 
(10.0) 
0.32 
(13.2) 
0.35 
(21.4) 
0.025 0.625 
0.28 
(10.0) 
0.33 
(10.5) 
0.33 
(21.4) 
0.023 0.530 
C18:1 cis-9-to-C15:0 
(g/g) (proportion, %)6 
24.3  
(5.0) 
24.6 
(2.6) 
26.4 
(7.1) 
1.037 0.789 
19.6  
(0.0) 
20.9  
(0.0) 
22.6  
(0.0) 
0.765 0.404 
21.1 
(2.5) 
21.1  
(0.0) 
24.6  
(0.0) 
0.866 0.342 
C18:1 cis-9 (g/100 g 
FA) (proportion, %)7 
20.4 
(25.0) 
21.2 
(18.4) 
22.0 
(21.4) 
0.363 0.314 
19.2 
(7.5) 
19.3 
(2.6) 
19.9 
(7.1) 
0.309 0.737 
19.6 
(7.5) 
19.3 
(7.9) 
21.3 
(28.6) 
0.334 0.131 
Corrected C18:1 cis-9 
(g/100 g FA)9 
(proportion, %)8 
3.20 
(35.0) 
2.70 
(21.1) 
2.68 
(21.4) 
0.237 0.571 
2.46 
(17.5) 
2.25 
(18.4) 
2.62 
(21.4) 
0.212 0.818 
2.90 
(20.0) 
2.12 
(15.8) 
3.00 
(28.6) 
0.233 0.238 
1 normal resumption of ovarian cyclicity defined as onset of luteal activity (OLA) occurring at 45 DIM or less, followed by regular ovarian cycles of 18 to 24 days in 
length, 2 combination of 3 types of abnormal resumption of ovarian cyclicity, i.e. (i) cows having OLA occurring later than 45 DIM postpartum, (ii) cows with OLA at 45 
DIM or less but followed by one or more ovarian cycles with delayed luteolysis ( 20 days) and (iii) cows showing no luteal activity for more than 14 days between 2 
ovarian cycles, 3 >100 DIM defined as cows not resuming ovarian cyclicity within 100 DIM, 4-8 proportion of cows having blood metabolites or milk FA equal to or 
above thresholds, i.e.  BHBA≥1.2 mmol/L, NEFA≥0.6 mmol/L, C18:1 cis-9-to-C15:0 ratio ≥45 (g/g), C18:1 cis-9  ≥27 (g/100 g FA) and corrected C18:1 cis-9 ≥ 3.98 
(g/100 g FA) (expressed relative to all cows included in either the ‘normal’, ‘abnormal’ or ‘> 100 DIM’ subgroup), 9 corrected milk fat C18:1 cis-9 concentrations were 
calculated by subtracting the 80% lowest C18:1 cis-9 concentrations from each observation (see Chapter 3). 
  
 
Table 2. Blood metabolites and milk FA in lactation weeks 2, 3, and 4 of experiment 2 for groups normally, abnormally or not resuming 
ovarian cyclicity within 100 DIM (mean; standard error of the mean, SEM). 
Item Week 2 Week 3 Week 4 
 nor-
mal1 
abnor-
mal2 
>100 
DIM3 
SEM 
P- 
value 
nor-
mal1 
abnor-
mal2 
>100 
DIM3 
SEM 
P-
value 
nor-
mal1 
abnor-
mal2 
>100 
DIM3 
SEM 
P- 
value 
Cows, n 
(proportion,%) 
35 
(37.6) 
38 
(40.9) 
20 
(21.5) 
  
35 
(37.6) 
38 
(40.9) 
20 
(21.5) 
  
35 
(37.6) 
38 
(40.9) 
20 
(21.5) 
  
BHBA (mmol/L) 
(proportion, %)4 
0.85a 
(14.3) 
1.18a 
(26.3) 
1.79b 
(45.0) 
0.101 0.002 
0.85a 
(11.4) 
0.95a 
(18.4) 
1.78b 
(45.0) 
0.102 0.001 
0.80a 
(17.1) 
0.96a 
(26.3) 
1.43b 
(40) 
0.080   0.011 
NEFA (mmol/L) 
(proportion, %)5 
0.43 
(11.4) 
0.44 
(21.1) 
0.55 
(40.0) 
0.024 0.115 
0.38 
(8.6) 
0.43 
(21.1) 
0.45 
(20.0) 
0.024 0.510 
0.33 
(5.7) 
0.31 
(7.9) 
0.41 
(20) 
0.020   0.183 
C18:1 cis-9-to-C15:0 
(g/g) (proportion, %)6 
34.1a 
(8.6) 
38.4ab 
(18.4) 
43.7b 
(50.0) 
1.673 0.102 
27.8a 
(2.9) 
32.4ab 
(15.8) 
38.4b 
(30.0) 
1.550 0.038 
27.2a 
(8.6) 
30.4ab 
(18.4) 
37.6b 
(30) 
1.520   0.040 
C18:1 cis-9 (g/100 g 
FA) (proportion, %)7 
23.4 
(20.0) 
24.0 
(21.1) 
25.4 
(40.0) 
0.436 0.260 
22.0 
(5.7) 
22.6 
(15.8) 
23.8 
(45.0) 
0.435 0.311 
21.4 
(8.6) 
21.8 
(10.5) 
23.6 
(25.0) 
0.420   0.156 
Corrected C18:1 cis-9 
(g/100 g FA)9 
(proportion, %)8 
2.81a 
(20.0) 
3.24a 
(23.7) 
5.41b 
(80.0) 
0.283 0.002 
2.62a 
(22.9) 
3.15a 
(23.7) 
5.69b 
(70.0) 
0.291 <0.001 
2.42a 
(17.1) 
2.99a 
(21.1) 
5.45b 
(70.0) 
0.293 0.003 
1 normal resumption of ovarian cyclicity defined as onset of luteal activity (OLA) occurring at 45 DIM or less, followed by regular ovarian cycles of 18 to 24 days in length, 2 
combination of 3 types of abnormal resumption of ovarian cyclicity, i.e. (i) cows having OLA occurring later than 45 DIM postpartum, (ii) cows with OLA at 45 DIM or 
less but followed by one or more ovarian cycles with delayed luteolysis ( 20 days) and (iii) cows showing no luteal activity for more than 14 days between 2 ovarian cycles, 
3 >100 DIM defined as cows not resuming ovarian cyclicity within 100 DIM, 4-8 proportion of cows having blood metabolites or milk FA equal to or above thresholds, i.e.  
BHBA≥1.2 mmol/L, NEFA≥0.6 mmol/L, C18:1 cis-9-to-C15:0 ratio ≥45 (g/g), C18:1 cis-9 ≥27 (g/100 g FA) and corrected C18:1 cis-9 ≥ 3.98 (g/100 g FA) (expressed 
relative to all cows included in either the ‘normal’, ‘abnormal’ or ‘> 100 DIM’ subgroup), 9 corrected milk fat C18:1 cis-9 concentrations were calculated by subtracting the 
80% lowest C18:1 cis-9 concentrations from each observation (see Chapter 3). 
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Calving to first progesterone rise interval 
The Kaplan-Meier ‘time-to-event’ (survival) analysis was performed for the parameter ‘calving to 
first progesterone rise interval’. Four survival analyses were done (for experiment 1, 2 survival 
analyses, see further) in which 2 classes were compared. Classes were distinguished based on either 
(i) the maximum blood plasma BHBA concentrations observed during the first 8 weeks of lactation 
(≥ or < 1.2 mmol/L, i.e. suffering from hyperketonemia or not), (ii) the maximum blood plasma 
NEFA concentrations observed during the first 8 weeks of lactation (≥ or < 0.6 mmol/L, i.e. 
suffering from elevated blood plasma NEFA or not), (iii) the corrected milk fat C18:1 cis-9 
concentration in week 2 of lactation (≥ or < 3.98 g/100 g FA, i.e. the threshold established in 
Chapter 3), and (iv) the milk fat C18:1 cis-9-to-C15:0 ratio in week 2 of lactation (≥ or < 45 g/g, i.e. 
threshold reported in Chapter 2B). Due to the limited cases of hyperketonemia in experiment 1 (n = 
8), survival analyses based on blood BHBA concentrations and the milk fat C18:1 cis-9-to-C15:0 
ratio were only performed for experiment 2. None of the parameters showed differences between 
classes in experiment 1 (survival plots not shown). Calving to first progesterone rise interval (days) 
did not differ between cows classified based on their blood plasma NEFA concentrations (< or ≥ 
0.6 mmol/; P = 0.252; Figure 1) or BHBA level (< vs. ≥ 1.2 mmol/L; P = 0.103; Figure 2), although 
the groups with elevated blood metabolites seemed to show a delay of first progesterone rise. A 
prolonged calving to first progesterone rise interval was observed in cows having a corrected milk 
fat C18:1 cis-9 concentration ≥ 3.98 g/100 g FA as compared with cows having a corrected milk fat 
C18:1 cis-9 concentration < 3.98 g/100 g FA (P = 0.014) with median of 42 and 26 days, respectively 
(Figure 3). In addition, cows in the group with a milk fat C18:1 cis-9-to-C15:0 ratio ≥ 45 g/g tended 
to delay first progesterone rise (median at 39 days), compared with cows having a milk fat C18:1 cis-
9-to-C15:0 ratio < 45 g/g with a median interval until first progesterone rise of 26 days (P = 0.082) 
(Figure 4).  
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Figure 1. Kaplan-Meier time to event plot demonstrating the effect of blood 
plasma NEFA concentrations on calving to first P4 rise interval (days) 
from 93 cows (experiment 2). Median time to event was 29 and 33 days for 
NEFA concentrations <0.6 mmol/L (green line, n = 61) and NEFA 
concentrations ≥ 0.6 mmol/L (red line, n = 32), respectively (P = 0.252). 
 
Figure 2. Kaplan-Meier time to event plot demonstrating the effect of blood 
plasma BHBA concentrations on calving to first P4 rise interval (days) 
from 93 cows (experiment 2). Median time to event was 26 and 35 days for 
BHBA concentrations <1.2 mmol/L (green line, n = 55) and BHBA 
concentrations ≥ 1.2 mmol/L (red line, n = 38), respectively (P = 0.103). 
 
Figure 3. Kaplan-Meier time to event plot demonstrating the effect of 
corrected milk fat C18:1 cis-9 concentrations (COA) on calving to first 
P4 rise interval (days) from 93 cows (experiment 2). Median time to event 
was 26 and 42 days for corrected milk fat C18:1 cis-9 concentrations < 3.98 g/ 
100 g FA (green line, n = 61) and corrected milk fat C18:1 cis-9 concentrations 
≥ 3.98 g/ 100 g FA (red line, n = 32), respectively (P = 0.014).  
 
Figure 4. Kaplan-Meier time to event plot demonstrating the effect of milk 
fat C18:1 cis-9-to-C15:0 ratio (Ratio) on calving to first P4 rise interval 
(days) from 93 cows (experiment 2). Median time to event was 26 and 39 days 
for milk fat C18:1 cis-9-to-C15:0 ratio < 45 (g/g) (green line, n = 69) and milk 
fat C18:1 cis-9-to-C15:0 ratio ≥ 45 (g/g) (red line, n = 24), respectively (P = 
0.082).  
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Link between resumption of ovarian cyclicity and pregnancy 
Table 3 presents some associations between resumption of the ovarian cyclicity and pregnancy 
parameters (number and proportion of pregnant cows and calving to pregnancy interval). In 
experiment 1, up to 71% of the cows in the group not resuming ovarian cyclicity within 100 DIM 
were not pregnant or were culled within the first year after calving, whereas for the normally 
resuming cows, this was only 12.5%. Moreover, of the cows that got pregnant, the group not 
resuming ovarian cyclicity within 100 DIM experienced a considerably prolongedcalving to 
pregnancy interval, which was about 91 days longer compared with normally resuming cows. In 
experiment 2, similar differences between groups were found: in the group not resuming ovarian 
cyclicity within 100 DIM proportionally less cows got pregnant and if pregnant, calving to pregnancy 
interval was 85 days longer compared with normally resuming cows. Nevertheless, proportions of 
pregnant cows should not be compared across experiments, given the differences in management 
strategy in experiment 1 compared with experiment 2 (more culling in the former). 
  
 
Table 3. Descriptive analysis of calving to pregnancy interval (days) in each group of cows in experiments 1 and 2 within 365 DIM (mean; 
standard error of the mean, SEM). 
Item Normal1 Abnormal2 >100 DIM3 SEM P-value 
Experiment 1 (cows, n)  40 38 14   
  Pregnant cows, n (%)4 35 (87.5) 26 (68.4) 4 (28.6)   
  NP or culled cows, n (%)5 5 (12.5) 12 (31.6) 10 (71.4)   
  Calving to pregnancy (days) 110.9a 139.3a 201.8b 0.075 0.018 
Experiment 2 (cows, n)   35 38 20   
  Pregnant cows, n (%)4 35 (100.0) 38 (100.0) 17 (85.0)   
  NP or culled cows, n (%)5 0 (0.0) 0 (0.0) 3 (15.0)   
  Calving to pregnancy (days) 102a 122.6a 186.8b 0.078 <0.001 
1 normal resumption of ovarian cyclicity defined as onset of luteal activity (OLA) occurring at 45 DIM or less, followed by regular ovarian cycles of 18 to 
24 days in length, 2 combination of 3 types of abnormal resumption of ovarian cyclicity, i.e. (i) cows having OLA occurring later than 45 DIM 
postpartum, (ii) cows with OLA at 45 DIM or less but followed by one or more ovarian cycles with delayed luteolysis ( 20 days) and (iii) cows showing 
no luteal activity for more than 14 days between 2 ovarian cycles, 3>100 DIM defined as cows not resuming ovarian cyclicity within 100 DIM, 4 number 
of cows being pregnant before culling between 170 and 365 DIM, 5NP; number of cows which were not  pregnant before culling or within 365 DIM 
when not culled earlier or which were culled between 170 and 365 DIM. 
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Calving to pregnancy interval 
The Kaplan-Meier ‘time-to-event’ (survival) analysis was performed for the parameter ‘calving to 
pregnancy interval’. Similar to the survival analysis based on first progesterone rise, 4 survival 
analyses were done for experiment 1 and experiment 2 in which 2 classes were compared. Classes 
were distinguished based on the same parameters as in the analysis of ‘calving to first progesterone 
rise interval’ (see above).  For none of the parameters, classes differed in calving to pregnancy 
interval for experiment 1 (P > 0.05). However, in experiment 2, cows classified in the ‘elevated 
NEFA’ (blood plasma NEFA ≥0.6 mmol/L) or ‘hyperketonemia’ (blood plasma concentrations of 
BHBA ≥ 1.2 mmol/L) group seemed to show a prolonged calving to pregnancy interval, although 
both groups did not differ significantly (P = 0.190 ; Figure 5 for blood plasma NEFA and P = 0.285; 
Figure 6 for blood plasma BHBA). A significantly increased calving to pregnancy interval was 
observed in the group of cows having a corrected milk fat C18:1 cis-9 concentration ≥ 3.98 g/100 g 
FA as compared with cows with a corrected milk fat C18:1 cis-9 concentration < 3.98 g/100 g FA (P 
< 0.001) (Figure 7). Additionally, the calving to pregnancy interval tended to be prolonged in cows 
with a milk fat C18:1 cis-9-to-C15:0 ratio ≥ 45 g/g (P = 0.068) (Figure 8). 
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Figure 5. Kaplan-Meier time to event plot demonstrating the effect of blood 
plasma NEFA concentrations on calving to pregnancy interval from 93 
cows (experiment 2). Median time to event was 103 and 124 days for NEFA 
concentrations <0.6 mmol/L (green line, n = 61) and NEFA concentrations ≥ 
0.6 mmol/L (red line, n = 32), respectively (P = 0.190). 
 
Figure 6. Kaplan-Meier time to event plot demonstrating the effect of blood 
plasma BHBA concentrations on calving to pregnancy interval from 93 
cows (experiment 2). Median time to event was 103 and 124 days for BHBA 
concentrations <1.2 mmol/L (green line, n = 55) and BHBA concentrations ≥ 
1.2 mmol/L (red line, n = 38), respectively (P = 0.285). 
 
Figure 7. Kaplan-Meier time to event plot demonstrating the effect of 
corrected milk fat C18:1 cis-9 concentrations (COA) on calving to 
pregnancy interval from 93 cows (experiment 2). Median time to event was 
96 and 143 days for corrected milk fat C18:1 cis-9 concentrations < 3.98 g/ 
100 g FA (green line, n = 61) and corrected milk fat C18:1 cis-9 concentrations 
≥ 3.98 g/ 100 g FA (red line, n = 32), respectively (P < 0.001).  
 
 
Figure 8. Kaplan-Meier time to event plot demonstrating the effect of milk 
fat C18:1 cis-9-to-C15:0 ratio (Ratio) on calving to pregnancy interval 
from 93 cows (experiment 2). Median time to event was 106 and 124 days for 
milk fat C18:1 cis-9-to-C15:0 ratio < 45 (g/g) (green line, n = 69) and milk fat 
C18:1 cis-9-to-C15:0 ratio ≥ 45 (g/g) (red line, n = 24), respectively (P = 
0.068). 
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DISCUSSION 
 
In the present study, a dual hypothesis was tested. Firstly, cows encountering elevated blood 
plasma BHBA or NEFA concentrations in early lactation were hypothesised to show impaired 
reproductive performance. Secondly, the latter was hypothesised to be reflected in concentrations of 
milk FA which had been earlier identified as potential indicators of energy status and/or 
hyperketonemia (Jorjong et al., 2014; Jorjong et al., 2015). Milk progesterone data were used to allow 
a physiologically-based categorisation of cows, i.e. normal, abnormal or no resumption of ovarian 
cyclicity within 100 DIM. Progesterone plays an important role in regulating changes in the uterine 
environment, early progesterone stimulation alters endometrial secretions and advances conceptus 
development (Garrett et al., 1988). In the present study, milk progesterone at 2 ng/mL was used as a 
threshold to detect resumption of ovarian cyclicity. Cows were separated into 3 groups using 45 
DIM as a cut-off to classify resumption of ovarian cyclicity. This is in line with several studies 
reporting most cows have resumed ovarian cyclicity within 50 DIM (Bulman and Lamming, 1978; 
Bulman and Wood, 1980). In the current 2 experiments, only 37.6 and 43.5 % of the cows resumed 
normally, which is considerably lower than what has been found about 20 years ago (53.5 %) in high 
yielding Flemish herds (Opsomer et al., 1998).  
In experiment 1, no association was found between resumption of ovarian cyclicity and blood 
plasma BHBA and NEFA concentrations, whereas the former was increased in animals not 
resuming ovarian cyclicity within 100 DIM in experiment 2. This might be related to more severe 
conditions of hyperketonemia, occurring in experiment 2. Indeed, average blood BHBA 
concentrations of the seriously delayed group of experiment 2 exceeded the blood plasma BHBA 
threshold (1.2 mmol/L) considered in the current study, with 45 % of the animals in the seriously 
delayed group exceeding this threshold. The threshold considered here is in line with postpartum 
threshold values for blood plasma BHBA concentrations reported in literature (0.96, and 1.4 
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mmol/L), which have been associated with increased incidence of diseases, reduced milk production 
and reduced pregnancy rates (Ospina et al., 2010a; Ospina et al., 2010c; Chapinal et al., 2012). 
Hyperketonemia is considered a ‘threshold disease’, which means detrimental effects are assumed to 
occur at elevated blood plasma BHBA concentrations only, whereas lowering blood plasma BHBA 
below the threshold concentration is expected to be of little to no biological significance to the cow. 
For instance, BHBA thresholds associated with reduced pregnancy success after first insemination 
were always associated with blood BHBA thresholds exceeding 1.0 mmol/L (Walsh et al., 2007; 
McArt et al., 2012b). Accordingly, blood plasma BHBA concentrations observed in experiment 1, 
might have been too low to affect the resumption of the ovarian cyclicity. Nevertheless, also in 
experiment 1, 15% of the cows did not start ovarian cycling within 100 DIM (compared with 21.5% 
in experiment 2). This implies that delayed resumption of ovarian cyclicity still occurs even when 
blood plasma BHBA concentrations are considerably below the threshold. As such, elevated blood 
plasma BHBA concentration obviously is not the only factor involved in or related to delayed 
resumption of ovarian cyclicity, which is a multifactorial problem. The findings for blood plasma 
BHBA in experiment 2 were also reflected in milk FA biomarkers, with the milk fat C18:1 cis-9-to-
C15:0 ratio exceeding the 45 g/g threshold in half of the cows suffering from delayed resumption of 
ovarian cyclicity. 
Despite several literature sources reporting the detrimental effect of a negative energy balance on 
reproductive performance, blood plasma NEFA concentrations were not associated with 
abnormalities (including delays) in the resumption of the ovarian cyclicity (Tables 1 and 2; Figure 1), 
nor an extended interval between calving and pregnancy (Figure 5) in the present study. Earlier 
research indicated that both timing and depth of NEB interactively determine the extent to which 
the NEB limits luteal function in postpartum estrous cycles and subsequent maintenance of 
pregnancy (Butler et al., 1981; Butler and Smith, 1989). As an example, the nadir of NEB has been 
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associated with a delay in first ovulation (Beam and Butler, 1999) or onset of luteal activity (Butler 
and Smith (1989); de Vries and Veerkamp (2000). Whereas differences in blood NEFA 
concentrations were not significant, the corrected milk fat C18:1 cis-9 concentration – identified as a 
proxy for blood NEFA (Chapters 2A and 3) - increased in cows of experiment 2 not resuming 
ovarian cyclicity within 100 DIM compared with cows resuming ovarian cyclicity normally (Table 2 
and Figure 3). In experiment 2, up to 80% of the cows experiencing a delayed resumption of ovarian 
cyclicity showed a corrected milk fat C18:1 cis-9 concentration exceeding the threshold of 3.98 
(g/100 g FA), as established in Chapter 3. Also others  have associated a late onset of luteal activity 
with higher milk C18:1 cis-9 and C18:0 concentrations (Martin et al. (2015). In experiment 1, this 
association between (corrected) milk C18:1 cis-9 concentrations and resumption of ovarian cyclicity 
has not been observed. As discussed before in relation to hyperketonemia, this might be related to 
more severe conditions of NEB occurring in experiment 2, which are reflected in more elevated 
(corrected) milk fat C18:1 cis-9 concentrations (Table 2 vs. Table 1). Nevertheless, the discrepancy 
between blood NEFA (no association with resumption of ovarian cyclicity) and corrected milk 
C18:1 cis-9 concentration remains striking with the latter appearing as a better indicator for impaired 
resumption of luteal activity (Table 2 and Figure 3). Potentially, this could be related to the major 
influence of sampling time (e.g. related to feeding time) on blood NEFA concentrations whereas 
milk FA proportions are stable over the 2 daily milkings. Additionally, stress during blood collection 
can increase blood NEFA (Leroy et al., 2011). In contrast, milk sample collection is easy and does 
not disturb the animal.   
Finally, this study clearly indicates the important implications of delayed resumption of ovarian 
cyclicity on the calving to pregnancy interval, which was considerably delayed when ovarian cyclicity 
did not resume within 100 DIM (Table 3). In experiment 1, more than 70% of the cows not 
resuming ovarian cyclicity within 100 DIM were culled between 170 and 365 DIM or not pregnant 
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within 1 year after calving. Literature data concerning the link between pregnancy outcome and 
indicators of NEB or hyperketonemia are somewhat equivocal: Chapinal et al. (2012), did not 
observe an association between pregnancy at first artificial insemination and blood NEFA or BHBA 
concentrations exceeding thresholds of 0.7 or 1.4 mmol/L in week 1 and 1.0 or 1.2  mmol/L in 
week 2 of lactation, respectively. However, other studies, such as Walsh et al. (2007) reported cows 
having blood plasma BHBA concentrations between 1.0 and 1.4 mmol/L in the first 2 weeks of 
lactation to be 50% less likely to be pregnant after first insemination. In another study of the latter 
group, a somewhat lower BHBA threshold (≥ 0.97 mmol/L) was associated with a reduced chance 
(13 % lower) of pregnancy (Ospina et al., 2010b). Additionally, authors indicated blood plasma 
NEFA concentrations exceeding 0.6 (Ospina et al., 2010a) to 0.72 (Ospina et al., 2010b) mmol/L to 
be detrimental for reproductive performance (16 % lower pregnancy rate) (Ospina et al., 2010b). 
Although the blood plasma metabolites BHBA and NEFA were not associated with prolonged 
intervals to pregnancy in the current study, an association was found with the milk fat C18:1 cis-9-to-
C15:0 ratio (Figure 8) and the corrected milk fat C18:1 cis-9 concentration (Figure 7). Animals 
exceeding the thresholds for milk fat C18:1 cis-9 (≥ 3.98 g/100 g FA) or the milk fat C18:1 cis-9-to-
C15:0 ratio (≥ 45 g/g) showed a delay in pregnancy of 47 (Figure 7) and 18 (Figure 8) days, 
respectively.  
 
CONCLUSIONS 
This study showed that a seriously delayed resumption of ovarian cyclicity ( 100 DIM) and 
prolonged calving to pregnancy interval is associated with elevated blood plasma BHBA 
concentrations and/or increased milk fat C18:1 cis-9-to-C15:0 ratio and corrected milk fat C18:1 cis-9 
concentrations. However, these associations only became obvious in situations of more severe NEB 
(i.e. experiment 2 vs. experiment 1).  
  
 
 
 
 
 
  
 
 
 
 
 
CHAPTER 5 
 
General discussion & Future perspectives
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Introduction 
The objective of this thesis was to assess whether milk fatty acids (FA), monitored during early 
lactation in dairy cows, are potential biomarkers for elevated blood plasma NEFA concentration, 
hyperketonemia, as well as subsequent reproductive performance. For this purpose, single milk FA 
models to diagnose NEB (chapter 2A) and/or hyperketonemia (chapter 2B) were developed based 
on the C18:1 cis-9 concentrations in milk fat and the C18:1 cis-9-to-C15:0 ratio, respectively. Cut-off 
values were determined for these models in order to reach a specificity level of 90%. As 
generalisability of these absolute cut-off values seemed limited, correction for an experiment-
dependent basal level was required (chapter 3). Finally, blood plasma BHBA, milk fat C18:1 cis-9-to-
C15:0 ratio (≥ 45 g/g) and corrected milk fat C18:1 cis-9 (≥ 3.98 g/100 g FA) were associated with 
resumption of ovarian cyclicity and calving to pregnancy interval (chapter 4). This discussion focuses 
on the association between milk FA and NEB, the potential of milk FA to diagnose animals 
suffering from NEB in comparison with other tools in the market and the feasibility to apply newly 
developed milk FA-based models in a test-day approach. Additionally, the association between 
biomarkers of NEB or hyperketonemia and reproductive performance until now only seems modest 
and is suggested to be limited to situations with more severe NEB (chapter 4) which needs further 
research (see below). An overview of the outcome of this PhD research is schematised in Figure 4.  
 
Potential of milk fatty acids as biomarkers for negative energy balance and hyperketonemia 
Others already indicated an association between changes in energy status in early lactation and 
milk FA concentrations (e.g. see overview in Table 4 of Chapter 1). The current research aimed at 
further exploring and extending those associations to establish cut-off values of milk FA for the 
diagnosis of elevated blood plasma concentrations of NEFA and as biomarkers for hyperketonemia. 
These cut-off values were chosen to reach specificity (Sp) levels of at least 90% (i.e. not more than 
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10% false positives). This choice was made since farmers generally seem to prefer detection systems 
that produce a low number of false alerts while particularly alerting for the more severe cases 
(Mollenhorst et al., 2012). As such, it might be argued that the biomarkers from our study are more 
effective for not treating healthy cows (Sp  90%), but much less effective for not missing sick cows 
(modest Se of 45 to 55 %). As the ultimate aim of the study was to use the biomarkers of NEB or 
hyperketonemia to predict reproductive performance, a high Sp level was considered valuable as it 
would allow farmers to particularly emphasise on ‘healthy’ animals for heat detection and early 
insemination.  
Nevertheless, concepts presented in this dissertation allow to easily identify alternative cut-off 
values, e.g. associated with much higher Se, based on the logistic curves presented in Figures 3 of 
both Chapter 2A and 2B, as well as to assess its economic relevance (e.g. based on Figures 4a and 4b 
in Chapter 2A). Nevertheless, combined Se and Sp of the milk FA models as presented in the 
current dissertation should be improved before transfer to practice could be considered, although 
the proposed milk FA tests to determine NEB or hyperketonemia perform better than e.g. single 
tests based on milk fat or milk fat to protein ratio (Van Knegsel et al., 2010). However, the 
hyperketonemia test based on the ratio fat of C18:1 cis-9-to-C15:0 ratio (Sp = 90%, Se = 50%) in 
milk did not provide a better alternative than a single milk test based on BHBA or acetone (Sp = 
71%; Se = 80%; overall accuracy = 83%). In the latter case, Van der Drift et al. (2012) successfully 
included additional information such as parity and season to improve the milk BHBA or milk 
acetone test performance, resulting in Se of 82.4%, Sp of 83.8%, and overall accuracy of 88.5%. A 
similar approach, in which milk FA tests would be combined with other information (such as parity 
and season) and perhaps with other milk tests could result in the required improvement of the 
currently developed milk FA based tests. An extended milk C18:1 cis-9 test to diagnose detrimental 
blood plasma NEFA might be of particular interest as routine analysis of this milk FA is possible 
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through Fourier transform infrared spectrometry (Soyeurt et al., 2006; Martens, 2013). However, 
scope to include the C18:1 cis-9-to-C15:0 in a routine test is more challenging as quantification of the 
latter milk FA still requires GC analysis (Stefanov et al., 2013). 
Another way to improve the milk FA test performance, is to specifically target groups with a 
higher prevalence of elevated blood NEFA or hyperketonemia. Indeed, Se, Sp as well as overall 
accuracy are performance criteria which are largely influenced by relative class distributions. Higher 
prevalence rates could be obtained by pre-screening early lactating animals based on information 
extracted from inexpensive data which are already available or could become available in the near 
future from robot milking systems (e.g. milk production, milk protein, milk fat) (Huybrechts et al., 
2014). Additionally, sampling frequency as applied in the experiments used in the frame of the 
current PhD research possibly might have led to some underestimation of the prevalence as cows 
were only sampled once per week (Jorjong et al., 2014; Jorjong et al., 2015). Particularly, cases of 
hyperketonemia might have been missed as its incidence peaks around 4 to 5 days postpartum and 
improved case detection has been suggested through frequent sampling of cows, particularly during 
the first 2 weeks postpartum (McArt et al., 2012b). 
 
Potential of additional milk FA concentrations or milk fat content to improve milk C18:1 cis-
9-based tests to diagnose elevated blood plasma NEFA 
In the current PhD research, the area under the ROC curve was used to identify the most 
promising milk FA or milk FA ratio for diagnosis of elevated blood plasma NEFA concentrations 
(Chapter 2A) or hyperketoneamia (Chapter 2B). Further tests were then developed based on this 
single milk FA parameter. However, combination of the most promising milk FA with other milk 
FA or with milk fat content potentially could be hypothesised to potentially improve the test 
 123 
 
performance. This is further explored in the next two paragraphs for diagnosis of elevated blood 
plasma NEFA.  
 
Milk fat C18:1 cis-9 concentration vs. its combination with C18:0 as biomarkers for elevated 
blood plasma NEFA  
A large proportion of milk fat C18:1 cis-9 originates of desaturation from C18:0 (Enjalbert et al., 
1998). As a result, variation in ∆9−desaturase activity might influence milk C18:1 cis-9 
concentrations. Accordingly, the combination of both the product and its precursor (i.e. sum of 
C18:1 cis-9 and C18:0) could minimise the effect of this confounding factor. Hence, the sum of 
C18:0 and C18:1 cis-9 might be hypothesised to be a better indicator for elevated blood plasma 
NEFA as compared with milk C18:1 cis-9. As indicated earlier in Chapter 2A, milk fat C18:1 cis-9 
concentrations of 24 g/100 g FA could be used as a threshold to categorize blood NEFA 
concentrations (below or above 0.6 mmol/L) with 90% specificity and 50% sensitivity in the first 8 
weeks of lactation (Chapter 2A, Figure 3b). To assess the potential of the C18:0 + C18:1 cis-9 sum as 
biomarker, empirical cumulative probability distribution curves were constructed in a similar way 
(Figure 1). Allowing 10% false positives, i.e. 90% specificity, a threshold of 32 g/100 g FA could be 
deduced for the sum of milk C18:0 + C18:1 cis-9 concentrations (Figure 1). Further, these 
cumulative probability distributions demonstrated the latter threshold to be associated with a 
sensitivity of 50%, which is exactly the same as shown before based on milk fat C18:1 cis-9 only. 
Hence, despite the increase in milk fat C18:0 concentration during early lactation (Hostens et al. 
(2012) and its ‘precursor-relation’ with milk C18:1 cis-9, the sum of milk fat C18:0 and C18:1 cis-9 
does not seem to hold more information than milk fat C18:1 cis-9 alone. As routine analysis based 
on FTIR seems much more accurate for milk fat C18:1 cis-9 than milk fat C18:0 (coefficient of 
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determination (r2) of 0.75 vs. 0.38, respectively; (Rutten et al., 2009), future research should not 
focus on the combination of C18:0 and C18:1 cis-9, but rather on the latter only.  
  
Figure 1. A logistic curve, e1, representing the cumulative probability distribution of milk fat C18:0+C18:1 cis-9 
concentration of week 2 in lactation (O2) ≤ o with detrimental blood plasma NEFA (≥ 0.6 mmol/L; black diamonds) at 
any time between weeks 2 and 8 in lactation relative to the total number of observations with detrimental blood plasma 
NEFA. The logistic curve is characterized by its slope (β0) and inflection point (β1). Similarly, cows having 
nondetrimental blood plasma NEFA (grey triangles) during the first 8 weeks in lactation proportionally to the total 
number of cows with nondetrimental blood plasma NEFA in relation to O2 ≤ o were presented as e2 with β0 and β1. 
 
Milk fat content, milk fat C18:1 cis-9 concentrations or their combination as biomarkers for 
elevated  blood plasma NEFA  
In Chapter 2A, predictions of elevated blood plasma NEFA were based on the proportion of 
C18:1 cis-9 in the milk fat (g/100 g FA) under the assumption that the high proportion of this FA in 
circulating NEFA will enrich milk triacylglycerols  in this FA. However, another major effect of 
increased FA uptake by the mammary gland due to elevated NEFA in periods of pronounced NEB 
is the increase in the total amount of fat in the milk (g/L). The latter is a worse predictor of NEB: 
when a Sp of 90% was targeted, Se-values only reached levels of 35% (Figure 2). Similar Se-Sp (39-
87%) were reported for detection of NEB on test-day information (Heuer et al., 2000), but the milk 
fat cut-off value was lower in the latter study compared with our dataset (48 vs. 60 g/L), which is 
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related to differences in sampling time (weeks 2 to 12 in the study of Heuer et al. (2000) vs. week 2 
in our study). Nevertheless, combination of milk fat content (g/L) and the proportion of C18:1 cis-9 
in the milk fat (g/100 g FA), i.e. the C18:1 cis-9 concentration in milk (g/L) rather than the 
concentration in milk fat potentially might be a better predictor of NEB (Figure 3). Indeed, Se-
values associated with a Sp-level of 90% reached levels of about 62 % (Figure 3) with a cut-off value 
corresponding to 13.0 g/L. However, the robustness of C18:1 cis-9 content in milk (g/L) as 
biomarker should be further validated across experiments, as several factors other than fat 
mobilization might affect fat content (g/L), such as mastitis or changes in milk production. 
 
Figure 2. A logistic curve, e1, representing the cumulative probability distribution of milk fat concentrations (g/L) of 
week 2 in lactation (O2) ≤ o with detrimental blood plasma NEFA (≥ 0.6 mmol/L; black diamonds) at any time between 
weeks 2 and 8 in lactation relative to the total number of observations with detrimental blood plasma NEFA. The 
logistic curve is characterized by its slope (β0) and inflection point (β1). Similarly, cows having nondetrimental blood 
plasma NEFA (grey triangles) during the first 8 weeks in lactation proportionally to the total number of cows with 
nondetrimental blood plasma NEFA in relation to O2 ≤ o were presented as e2 with β0 and β1.  
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Figure 3. A logistic curve, e1, representing the cumulative probability distribution of milk fat C18:1 cis-9 concentrations 
(g/L) of week 2 in lactation (O2) ≤ o with detrimental blood plasma NEFA (≥ 0.6 mmol/L; black diamonds) at any time 
between weeks 2 and 8 in lactation relative to the total number of observations with detrimental blood plasma NEFA. 
The logistic curve is characterized by its slope (β0) and inflection point (β1). Similarly, cows having nondetrimental blood 
plasma NEFA (grey triangles) during the first 8 weeks in lactation proportionally to the total number of cows with 
nondetrimental blood plasma NEFA in relation to O2 ≤ o were presented as e2 with β0 and β1. 
  
 
Association between milk fatty acids and subsequent reproductive performance 
As NEB in early lactation had been suggested to negatively affect reproductive performance, a 
link was expected between the latter and milk FA which had been identified as biomarkers of the 
former. Negative energy balance in the first 3 weeks of lactation was reported to affect the 
resumption of ovarian cyclicity (Butler, 2001), whereas elevated blood plasma ketones were related 
to extended time until first ovulation (Reist et al. (2000). In the present study, an association was 
found between elevated blood plasma BHBA and not resuming ovarian cyclicity within 100 DIM 
(Chapter 4, Table 2), which further resulted in a prolonged calving to pregnancy interval (Chapter 4, 
Table 3). As elevated NEFA is generally considered a prerequisite for hyperketonemia (Herdt, 2000), 
it might be surprising that the average blood plasma NEFA-concentration of the ‘non-resuming 
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group’ did not exceed the blood plasma NEFA cut-off (0.6 mmol/L) (Chapter 4, Table 2).  Indeed, 
BHBA and NEFA are often linked, although also in some former studies only a limited  correlation 
(R2 = 0.18) between blood BHBA and NEFA concentrations was observed (Ospina et al. (2013). 
Development of hyperketonemia and production in the liver of ketones also depend on the 
availability of glucose or glucogenic precursors (Van Knegsel et al., 2007c). Accordingly, it might be 
hypothesized that initiation of BHBA formation is determined by glucose rather than NEFA supply. 
If so, blood NEFA concentrations associated with hyperketonemia might be lower (and perhaps 
below the NEFA-threshold of 0.6 mmol/L) when the animal’s glucose status is (very) low. This also 
could be the reason why the incidence of hyperketonemia in experiment 2 (41%, Chapter 2B) 
exceeds the incidence rate of elevated blood plasma NEFA (35%, calculated from data presented in 
Figure 1a of Chapter 3).  
Formerly mentioned associations between blood plasma BHBA concentrations (Chapter 4, Table 
2) and reproductive parameters were also found for its milk FA biomarker, i.e. milk fat C18:1 cis-9-
to-C15:0 ratio (Chapter 2B). Furthermore, cows with a milk fat C18:1 cis-9-to-C15:0 ratio exceeding 
45 g/g showed a delayed first progesterone rise and prolonged calving to pregnancy interval. These 
delays were also observed when cows were classified based on the corrected milk fat C18:1 cis-9 
threshold of 3.98 g/100 g FA. Other studies reporting associations between milk FA and 
reproductive performance are currently still limited. One study Martin et al. (2015) reported milk fat 
C18:1 cis-9 and C18:0 concentrations increased in cows experiencing late resumption ovarian 
cyclicity. Stádník et al. (2015) found a relationship between an increased content of 
monounsaturated fatty acid and prolonged days open. Nevertheless, in these studies, no cut-off 
values were proposed. On the other hand, earlier studies attempted to establish cut-off values for 
the milk fat to protein ratio in relation to reproductive performance. As an example, Podpečan et al. 
(2008) reported a milk fat to protein greater than 1.34 to be associated with a prolonged calving to 
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conception interval. In accordance with the latter study, (Loeffler et al., 1999; Gábor et al., 2008) 
indicated a high milk fat to protein ratio to be associated with  reduced pregnancy rates and 
decreased risk of pregnancy. In addition, milk fat to protein ratios exceeding 1.5 during the first-test-
day (Heuer et al., 1999) were negatively correlated with fertility, i.e. increased calving to conception 
interval and number of service per conception. On the other hand, Madouasse et al. (2010) reported 
the milk fat to protein ratio only to have a low ability to predict the calving to conception interval. In 
line with this, (Martin et al., 2015) did not find a relation between the onset of the luteal activity and 
the milk fat to protein ratio. Given the conflicting results related to the milk fat to protein ratio, it is 
worthwhile to further explore the usefulness of the biomarkers identified in the current PhD, i.e. 
milk fat C18:1 cis-9-to-C15:0 ratio and corrected milk fat C18:1 cis-9, in relation to reproductive 
performance.  
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Figure 4. Overview of the associations studied during the current PhD research: Full 
green lines indicate robust associations were established, whereas full red line indicates no 
associations were found. Dashed green lines indicate potential associations (e.g. association 
confirmed under certain conditions). Grey dotted line indicates that this part of the 
originally intended research has not been performed due to a limited number of 
hyperketonemic animals in two of the three datasets available for the current study. 
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Negative energy balance (NEB) is a common phenomenon in the transition period in dairy cows. 
During this period, increase in feed intake is lagging behind the increasing energy demand for milk 
production, which often results in a serious energy imbalance. Metabolic adaptations to cope with 
high energy demand include fat mobilisation from body fat reserves, prioritisation of the mammary 
gland for glucose utilisation and enhanced gluconeogenesis in the liver. However, on average 15 % 
up to half of the early lactating cows in a high yielding herd will encounter excessive NEB which is 
associated with disease development, decrease in milk production and impaired reproductive 
performance. Because of important economic losses as well as animal health and welfare problems, 
attempts are made to monitor NEB. The blood metabolites beta-hydroxybutyrate (BHBA) and non-
esterified fatty acids (NEFA) are commonly used to diagnose NEB and/or hyperketonemia in the 
transition period. In addition, cow-side tests are available in the market for diagnosis of blood 
BHBA, but analysis of blood NEFA is currently limited to laboratory settings only. Nevertheless, 
blood NEFA have been suggested to be a better indicator for NEB than blood BHBA as the former 
precede hyperketonemia. As mobilised fatty acids are partially transferred to the mammary gland, 
changes in the milk FA profile might be explored as potential diagnostics for elevated blood NEFA 
concentrations and hyperketonemia, which was the aim of the current PhD study. More specifically, 
in the current study, blood NEFA and BHBA were used as reference test for diagnosis of NEB and 
hyperketonemia, with thresholds at 0.6 mmol/L and 1.2 mmol/L, respectively.  
Chapter 1, consists of a literature review, describing the physiological background of the negative 
energy balance during the transition period of cows and evidence for changes in the milk FA profile 
to reflect fat mobilisation.  
Chapter 2A, aimed to assess the potential of milk fatty acids to diagnose NEB. Forty-five milk 
fatty acids, as well as the milk fat C18:1 cis-9-to-C15:0 ratio were subjected to receiver operating 
characteristic (ROC) curve analysis to determine the most promising diagnostic fatty acid or fatty 
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acid ratio based on the maximum area under the curve (AUC). Milk fat C18:1 cis-9 revealed the most 
promising variable to identify detrimental blood plasma NEFA. It was assessed whether the milk fat 
C18:1 cis-9 concentration of week 2 could be used as a biomarker for early warning of the risk to 
encounter detrimental blood plasma NEFA during the first 8 weeks in lactation. Cows with at least 
24 g/ 100 g FA C18:1 cis-9 in milk fat had about 50% chance to encounter blood plasma NEFA 
values of 0.6 mmol/L or more during the first 8 weeks of lactation, with a false positive rate of 
11.4%. 
Particularly insufficient supply of glucogenic precursors in the liver might further push animals in 
NEB towards hyperketonemia.. Similarly to the former chapter, in chapter 2B, milk FA and ratios 
of anteiso C15:0-to-anteiso C17:0 and C18:1 cis-9-to-C15:0 were subjected to ROC curve analysis to 
determine the most promising diagnostic FA or FA ratio based on the maximum AUC. The milk fat 
C18:1 cis-9-to-C15:0 ratio revealed the most promising variable for diagnosis of hyperketonemia. A 
ratio between 34 and 45 seemed to be a valuable threshold in this respect. Specifically, a milk fat 
C18:1 cis-9-to-C15:0 ratio of at least 45 (g/g) in week 2 could be used as an early warning for 
hyperketonemia during the first 8 weeks in lactation.  
However, the cross-experiment robustness of these absolute cut-off values is limited and 
correction for an experiment-dependent basal level is required (Chapter 3), but determination of the 
latter under practical conditions might be particularly challenging in dairy farms with a relatively 
limited number of animals. The cross-experiment validation was limited to C18:1 cis-9 as biomarker 
of elevated blood NEFA as two out of the three datasets available for this research only contained a 
limited number of hyperketonemic cases, which excluded inter-experiment validation of the C18:1 
cis-9-to-C15:0 test to diagnose hyperketonemia.  
As energy status during the transition period may affect reproductive performance, the 
relationship was explored between milk FA, identified as biomarkers of NEB (Chapter 2A) or 
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hyperketonemia (Chapter 2B) on the one hand, and reproductive performance, i.e. resumption of 
ovarian cyclicity, as well as calving to pregnancy interval on the other hand. In the present study 
(experiment 2 only) associations were shown between blood plasma BHBA concentrations, milk fat 
C18:1 cis-9-to-C15:0 ratios and corrected milk fat C18:1 cis-9 concentrations and reproductive 
performance: blood plasma BHBA concentrations were higher in cows not resuming ovarian 
cyclicity within 100 DIM, whereas blood plasma NEFA concentrations were not associated with 
resumption of ovarian cyclicity. Furthermore, cows with a milk fat C18:1 cis-9-to-C15:0 ratio 
exceeding 45 g/g showed a delayed first progesterone rise and prolonged calving to pregnancy 
interval. These delays were also observed when cows were classified based on the corrected milk fat 
C18:1 cis-9 threshold of 3.98 g/100 g FA (Chapter 4).  
In conclusion, this PhD research showed the potential of the corrected milk fat C18:1 cis-9 
concentration and milk fat C18:1 cis-9-to-C15:0 ratio to diagnose NEB and provide an early warning 
for hyperketonemia, as well as future reproductive problems. Further research particularly should 
focus on the transfer of these biomarkers into practice in combination with additional biomarkers or 
other information to establish more robust models. 
  
 
 
 
 
 
 
Samenvatting
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Negatieve energiebalans (NEB) is een veel voorkomend verschijnsel in de transitieperiode rond 
kalven bij melkkoeien. Gedurende deze periode blijft de verhoging van de voederopname achter op 
de stijgende energiebehoefte nodig voor de melkproductie, wat vaak leidt tot een ernstige verstoring 
van de energiebalans. Metabolische aanpassingen die deze hoge energievraag proberen op te vangen, 
omvatten onder meer mobilisatie van lichaamsreserves en een verhoogde gluconeogenese in de 
lever. Bovendien krijgt de uier in deze periode absolute voorrang voor glucosegebruik in het 
lichaam. Toch zal gemiddeld 15% tot de helft van de recent gekalfde koeien in een hoogproductieve 
kudde overmatige NEB ondervinden, wat geassocieerd wordt met ziekteontwikkeling, een 
verminderde melkproductie en een verstoord reproductievermogen. Vanwege deze belangrijke 
economische verliezen maar ook de problemen met de gezondheid en het welzijn van de dieren, 
worden pogingen ondernomen om NEB te monitoren. De bloed metabolieten beta-hydroxybutyraat 
(BHBA) en niet-veresterde vetzuren (NEFA) worden doorgaans gebruikt om NEB en/of 
hyperketonemie te diagnosticeren in deze transitieperiode. Hiervoor zijn testen beschikbaar in de 
markt die op het landbouwbedrijf kunnen worden gebruikt voor de diagnose van BHBA in bloed. 
De analyse van NEFA in bloed is echter momenteel beperkt tot een laboratorium omgeving. 
Niettemin worden bloed NEFA verondersteld om een betere indicator voor NEB te zijn dan bloed 
BHBA omdat een verhoging van bloed NEFA hyperketonemie voorafgaat. Omdat gemobiliseerde 
vetzuren gedeeltelijk worden getransfereerd naar de uier, kunnen veranderingen in het 
melkvetzuurprofiel worden onderzocht als mogelijk diagnosemiddel voor verhoogde bloed NEFA 
concentraties en hyperketonemie, wat het doel was van de voorliggende doctoraatsstudie. Meer in 
het bijzonder, worden in de huidige studie bloed NEFA en BHBA gebruikt als referentietest voor de 
diagnose van NEB en hyperketonemie, met drempelwaarden van respectievelijk 0,6 mmol/L en 1,2 
mmol/L.  
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Hoofdstuk 1, bestaat uit een literatuurstudie die de fysiologische achtergrond van de negatieve 
energiebalans tijdens de overgangsperiode van de koeien beschrijft en het bewijsmateriaal levert voor 
het feit dat veranderingen in het melkvetzuurprofiel een indicatie zijn voor vetmobilisatie. 
Hoofdstuk 2A, heeft als doel het potentieel van melkvetzuren bij het diagnosticeren van NEB te 
beoordelen. Uit vijfenveertig melkvetzuren, evenals de melkvet C18:1 cis-9-tot-C15:0 verhouding 
werd het meest veelbelovende diagnostische vetzuur of de meest veelbelovende vetzuurverhouding 
geselecteerd. Voor deze selectie werd gebruik gemaakt van de zogenaamde ‘operating characteristic 
(ROC) curve analyse’ waarbij de maximale oppervlakte onder de curve (AUC) werd gebruikt om de 
meest beloftevolle melkvetzuurparameter te identificeren. De concentratie van C18:1 cis-9 in melkvet 
bleek de meest veelbelovende variabele om verhoogde en nadelige concentraties aan bloedplasma 
NEFA te identificeren. Verder werd nagegaan of de melkvet C18:1 cis-9 concentratie gemeten in de 
2e week na kalven  gebruikt kan worden als een biomerker voor een vroegtijdige waarschuwing voor 
het risico op het optreden van verhoogde bloedplasma NEFA concentraties tijdens de eerste 2 
maanden van de lactatie. Koeien met een concentratie in het melkvet van ten minste 24 g/100 g FA 
aan C18:1 cis-9 hadden ongeveer 50% kans om bloedplasma NEFA waarden van 0,6 mmol/L of 
meer te ondervinden tijdens de eerste 2 maanden van de lactatie, met een aandeel van vals positieve 
resultaten van 11,4%.  
Vooral een ontoereikend aanbod van glucogene precursoren in de lever kunnen dieren in een 
NEB verder in de richting van hyperketonemie duwen. Net als in het vorige hoofdstuk, werden in 
hoofdstuk 2B, melkvetzuren en de verhoudingen van zowel anteiso C15:0-tot-anteiso C17:0 als van 
C18:1 cis -9-tot-C15:0 aan een ROC curve analyse onderworpen om het meest veelbelovende 
diagnostische melkvetzuur of de meest beloftevolle melkvetzuurverhouding te vinden op basis van 
de maximale AUC. De melkvet C18:1 cis-9-tot-C15: 0 verhouding bleek de meest veelbelovende 
variabele voor de diagnose van hyperketonemie. Een verhouding tussen 34 en 45 bleek in dit 
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opzicht een belangrijke drempelwaarde. Meer specifiek kan een melkvet C18:1 cis-9-tot-C15:0 
verhouding van ten minste 45 (g/g) in week 2 gebruikt worden als een vroege waarschuwing voor 
hyperketonemie gedurende de eerste 2 maanden van de lactatie. 
De robuustheid van deze absolute cut-off-waarden over verschillende experimenten heen is 
echter beperkt en de correctie voor een experiment-afhankelijk basaal niveau bleek nodig 
(hoofdstuk 3). De bepaling van laatstgenoemd basaal niveau kan onder praktijkomstandigheden 
echter bijzonder lastig zijn op melkveebedrijven met een relatief beperkt aantal dieren. De validatie 
op basis van datasets van verschillende experimenten werd beperkt tot C18:1 cis-9 als biomerker van 
verhoogde bloed NEFA omdat twee van de drie datasets, beschikbaar voor dit onderzoek, slechts 
een beperkt aantal hyperketonemische gevallen bevatten, wat een inter-experimentele validatie van 
de C18:1 cis-9-tot-C15:0 verhouding om hyperketonemie te diagnosticeren, uitsloot. 
Omdat de energie-status tijdens de transitieperiode de reproductieve prestaties kan beïnvloeden, 
werd de relatie onderzocht tussen melkvetzuren, geïdentificeerd als biomerkers van NEB (hoofdstuk 
2A) of hyperketonemie (hoofdstuk 2B) aan de ene kant, en reproductieve prestaties anderzijds. 
Volgende parameters werden in beschouwing genomen voor het beoordelen van de reproductieve 
prestaties: de hervatting van de ovariële cyclus en het interval tussen afkalven en dracht. In de 
huidige studie (alleen in experiment 2) werden associaties aangetoond tussen bloedplasma BHBA 
concentraties, de melkvet C18:1 cis-9-tot-C15:0 verhouding en de gecorrigeerde melkvet C18:1 cis-9-
concentraties enerzijds en de reproductieve prestaties anderzijds:. Verhoogde bloedplasma BHBA 
concentraties werden waargenomen bij koeien waarvan de ovariële cyclus niet hervatte binnen de 
eerste 100 dagen na kalven. De bloedplasma NEFA concentraties daarentegen werden niet 
geassocieerd met de hervatting van de ovariële cyclus. Bovendien bleek de eerste stijging van 
progesteron in de melk vertraagd bij koeien met een melkvet C18:1 cis-9-tot-C15:0-verhouding van 
meer dan 45 g/g en bleken deze dieren ook gekenmerkt door een verlengd interval van ‘afkalven tot 
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dracht’. Deze vertragingen werden ook waargenomen wanneer de koeien werden ingedeeld op basis 
van de gecorrigeerde melkvet C18:1 cis-9 drempel van 3,98 g/100 g FA (Hoofdstuk 4). 
Samenvattend toont dit doctoraatsonderzoek het potentieel aan van de gecorrigeerde melkvet 
C18:1 cis-9 concentratie en de melkvet C18:1 cis-9-tot-C15:0 verhouding om NEB te diagnosticeren 
en vooraf te waarschuwen voor hyperketonemie, alsmede voor toekomstige problemen met de 
voortplanting. Toekomstig onderzoek zou zich met name moeten richten op de implementatie van 
deze biomerkers onder praktijkomstandigheden in combinatie met bijkomende (bestaande) 
biomerkers of andere informatie om meer robuuste modellen te bekomen. 
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